Method for restoring function and utilizing non-functional gene products through an inductive CAS system

The guide RNA/Cas endonuclease system efficiently and cost-effectively restores functional gene products and edits nucleotide sequences in cells by introducing double-strand breaks and single nucleotide changes, addressing the limitations of existing genome editing technologies.

KR103044614B1Active Publication Date: 2026-11-06PIONEER HI BREED INTERNATIONAL INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
KR1020187012259
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-07-07
Filing Date
2016-10-17
Publication Date
2026-11-06
Estimated Expiration
2036-10-17

AI Technical Summary

Technical Problem

Existing genome editing technologies, such as designer zinc finger nucleases and transcriptional activator-like effector nucleases, are costly and time-consuming due to their low specificity, requiring redesign for each target site, and lack scalability for targeting multiple locations within the genome.

Method used

A guide RNA/Cas endonuclease system is used to introduce a double-strand break in non-functional genes, restoring their function without a polynucleotide template, and edit nucleotide sequences through non-homologous end junctions, enabling efficient and scalable genome modifications in cells, including plants, by forming a guide RNA/Cas complex that can introduce single nucleotide changes without DNA introduction.

Benefits of technology

This system allows for cost-effective, efficient, and scalable restoration of functional gene products and editing of nucleotide sequences in cells, including plants, without the need for polynucleotide templates, using mRNA or protein molecules to deliver the guide RNA/Cas complex.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112018042471056-PCT00008_ABST
    Figure 112018042471056-PCT00008_ABST
Patent Text Reader

Abstract

Compositions and methods are provided for restoring the function of non-functional gene products within the genome of a cell. The methods and compositions provide an effective system for restoring the function of non-functional gene products using a guide polynucleotide / Cas endonuclease system and for modifying or altering target sites within the genome of a plant, plant cell, or seed. The invention also describes a method for modifying nucleotide sequences within the genome of a cell using a restored functional selection marker, as well as a method for editing nucleotide sequences within the genome of said cell without introducing a polynucleotide modification template into the cell. Compositions and methods are also provided for delivering Cas endonuclease, sgRNA, and a guide RNA / Cas complex without DNA.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] This application claims the benefit of U.S. Provisional Application No. 62 / 243719 filed October 20, 2015, U.S. Provisional Application No. 62 / 309033 filed March 16, 2016, and U.S. Provisional Application No. 62 / 359254 filed July 7, 2016, the entirety of which is incorporated herein by reference.

[0002] Technology field

[0003] The present invention relates to the field of molecular biology, and in particular to a method for altering the genome of a cell.

[0004] Reference to the electronically submitted sequence list

[0005] An official copy of this sequence list was created on October 11, 2016, and is 185 kilobytes in size; it was submitted electronically via EFS-Web as a sequence list in ASCII format with the filename 20161011_BB2533PCT_SeqLst.txt, submitted concurrently with this specification. The sequence list contained in this ASCII format document is part of this specification, the entirety of which is incorporated herein by reference. Background Technology

[0006] Recombinant DNA technology has been able to alter the phenotype of organisms by enabling the insertion of DNA sequences at targeted genomic sites and / or the modification (editing) of specific endogenous chromosomal sequences. Site-specific integration technology using site-specific recombination systems, as well as other types of recombination technology, have been used to generate targeted insertions of genes of interest in various organisms. While genome editing technologies, such as designer zinc finger nucleases (ZFNs), transcriptional activator-like effector nucleases (TALENs), or homing meganucleases, can be used to generate targeted genomic perturbations, these systems tend to use designed nucleases with low specificity that must be redesigned for each target site, resulting in high costs and time for manufacturing.

[0007] Although various approaches have been developed to target specific regions in the biological genome for modification, there is still a need for new genome manipulation technologies that are inexpensive, easy to set up, scalable, and capable of targeting multiple locations within the genome.

[0008] Compositions and methods are provided for restoring the function of non-functional gene products within the genome of a cell. The methods and compositions provide an effective system for restoring the function of non-functional gene products using a guide polynucleotide / Cas endonuclease system and for modifying or altering target sites within the genome of a plant, plant cell, or seed. The present invention also describes a method for modifying nucleotide sequences within the genome of a cell using a restored functional selection marker, as well as a method for editing nucleotide sequences within the genome of a cell without introducing a polynucleotide modification template into the cell. Compositions and methods are also provided for delivering Cas endonuclease, guide RNA, and guide RNA / Cas complex into a cell without DNA by introducing components of the complex via mRNA molecules (guide RNA, Cas endonuclease) or protein molecules (Cas endonuclease), or by directly introducing the guide RNA / Cas ribonucleotide-protein complex (RGEN) itself.

[0009] In one embodiment of the present invention, the method is a method for restoring the function of a non-functional gene product within the genome of a cell, comprising the step of introducing a guide RNA / Cas endonuclease complex into a cell containing a disrupted gene within the genome, wherein the complex generates a double-strand break, the disrupted gene does not encode a functional gene product, and the disrupted gene is restored to a non-disrupted gene capable of encoding the functional gene product without using a polynucleotide modified template. The disrupted gene comprises a base pair deletion at the fourth nucleotide upstream (5') of the PAM sequence relative to the non-disrupted gene, and the base pair deletion renders the gene product of the disrupted gene non-functional by generating an amino acid frame shift in the gene product of the disrupted gene. The base pair deletion may be located at the first, second, or third nucleotide of the codon sequence. Restoration can be achieved by non-homologous end junction (NHEJ) inserting a single base at the double-strand break site, or by inserting a single base at the double-strand break site without using homologous recombination or homology-induced repair.

[0010] In one embodiment of the present invention, the method comprises the steps of: introducing a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using a polynucleotide modification template, and the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and selecting a cell having the modified nucleotide sequence by the functional selection marker protein. The introduction and selection steps do not include the introduction of the selection marker gene, such as a recombinant DNA construct comprising the selection marker gene. The disrupted selection marker gene may be any disrupted marker gene, including the disrupted visual marker gene. The modification of the target nucleotide sequence may be selected from the group consisting of the insertion of at least one nucleotide, the deletion of at least one nucleotide, or the substitution of at least one nucleotide at the target site. The method may further include the step of introducing a polynucleotide modification template or donor DNA into the cell, wherein the polynucleotide modification template comprises at least one nucleotide modification of the nucleotide sequence, and the donor DNA comprises at least one polynucleotide of interest to be inserted into the target site.

[0011] In one embodiment of the present invention, the method comprises a method for editing a nucleotide sequence within the genome of a cell without using a polynucleotide modified template, the method comprising: a) introducing at least one guide RNA and at least one Cas endonuclease into at least one cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence; b) selecting from (a) a cell having at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; and c) introducing at least one guide RNA and at least one Cas endonuclease into the cell of (b), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence and can insert a single nucleotide at the same position as the nucleotide deletion of (b) without using a polynucleotide modified template.

[0012] In one embodiment of the present invention, the method is a method for editing a nucleotide sequence within a plant genome without using a polynucleotide modified template or donor DNA, comprising: a) introducing at least one guide RNA and at least one Cas endonuclease into at least one plant cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence; b) selecting from (a) a plant cell comprising at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; c) regenerating a plant from the plant cell of (b); and d) introducing at least one guide RNA and at least one Cas endonuclease into a cell from the plant of (c), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence and inserting a single nucleotide at the same position as the nucleotide deletion of (b) without using a polynucleotide modified template. and e) optimally, a method comprising the step of selecting a cell containing the nucleotide insertion of (d).

[0013] The guide RNA and Cas endonuclease protein forming the guide RNA / Cas endonuclease complex can be introduced directly into the cell as RNA and protein, respectively, or as a ribonucleotide-protein complex. The components of the guide RNA / Cas endonuclease complex can be introduced as mRNA molecules encoding the Cas endonuclease protein and as RNA containing the guide RNA, or as recombinant DNA molecules encoding the guide RNA and the Cas endonuclease protein.

[0014] In one embodiment of the present invention, the method is a DNA-free method for delivering a guide RNA / Cas endonuclease complex into a cell, comprising the steps of: combining at least one guide RNA molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein; combining the ribonucleotide-protein with a particle delivery matrix to allow the ribonucleotide-protein to be combined with the matrix to form a ribonucleotide-protein-matrix complex; and introducing the ribonucleotide-protein-matrix complex into the cell.

[0015] In one embodiment of the present invention, the method is a DNA-free method for delivering a guide RNA / Cas endonuclease component into a cell, comprising the steps of introducing at least one guide RNA molecule and at least one Cas endonuclease protein into a cell, and growing the cell under appropriate conditions so that the guide RNA and the Cas endonuclease protein can form a complex within the cell.

[0016] The DNA-free method may further include the step of introducing a polynucleotide template, wherein the polynucleotide modified template comprises at least one nucleotide modification of a nucleotide sequence within the genome of the cell, and the at least one nucleotide modification of the polynucleotide modified template is selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, and (iv) any combination of (i) to (iii). The DNA-free method may also further include the step of introducing donor DNA, wherein the donor DNA comprises at least one polynucleotide of interest. Introduction into the cell may be achieved through a delivery system selected from the group consisting of particle-mediated delivery, whisker-mediated delivery, cell-penetrating peptide-mediated delivery, electroporation, PEP-mediated transfection, and nanoparticle-mediated delivery.

[0017] Cells include human, non-human, animal, archaea, bacteria, fungi, insects, yeast, unusual yeast, and plant cells.

[0018] Additionally, nucleic acid constructs, cells, plants, offspring plants, microorganisms, explants, seeds, and grains produced by the method described herein are provided. Further embodiments of the method and composition of the present invention are presented herein. Brief explanation of the drawing

[0019] Brief description of the drawings and sequence list The present invention may be more fully understood from the accompanying drawings and sequence list constituting part of this application and the following detailed description. The sequence descriptions and sequence list attached herein follow the rules governing the disclosure of nucleotide and amino acid sequences in patent applications as set forth in 37 CFR §§ 1.821-1.825. The sequence descriptions include three-letter codes for amino acids defined in 37 CFR §§ 1.821-1.825, which are incorporated herein by reference. floor plan Figure 1 shows the array and number of the top 10 most frequent NHEJ mutations induced by the maize optimized guide RNA / Cas endonuclease system described herein. The mutations were identified by deep sequencing. The reference sequence (SEQ ID NO: 48) indicates the unaltered locus, with each target site indicated in bold. The PAM sequence (gray) and the expected cleavage site (arrow) are also indicated. Deletions or insertions resulting from incomplete NHEJ are indicated by "-" or underlined italic nucleotides, respectively. Mutations 1 through 10 of the reference and target sites correspond to SEQ ID NO: 49 through 58, respectively. In maize, for most target sites, the most common type of mutation generated by the Cas9-gRNA system is a single nucleotide insertion (more than 60%) (numbered as 16,861). Figure 2 shows partial nucleotide sequences (SEQ ID NO: 59, 61, 63) and partial amino acid sequences (SEQ ID NO: 60, 62, 64) of the ALS2 gene and two edit repair templates (Oligo1 and Oligo2); modified nucleotides are underlined and the gene edit target codon sequence (from Pro to Ser) is boxed. Figure 3 shows a corn plant (left) and a wild-type plant (right) with an ALS2 allele edited for resistance to chlorsulfuron. Chlorsulfuron (100 mg / L) was sprayed on 4-week-old plants. Plants after 3 weeks of treatment are shown. Figures 4a through 4c show schematic diagrams of the ALS2 gene fragments (SEQ ID NO: 65, 67, 69) selected for modification and the use of ALS2 as a selection marker. The encoding amino acid sequences are indicated below the respective nucleotide sequences (SEQ ID NO: 66, 68). Figure 4a: Single nucleotide at position 165 ( G )(underlined in bold) can be removed to generate a specific knockout version of the ALS2 gene edited for chlorsulfuron resistance. Figure 4b shows a new nucleotide sequence in which the translation frame is shifted and the ALS2 gene is knocked out due to a single nucleotide deletion (G removal). Figure 4c: ALS2 gene function and chlorsulfuron resistance during the DSB repair process via the NHEJ pathway a single nucleotide ( N It is restored through the insertion of , underlined bold). FIGS. 5a and 5b. Reactivation of inactivated ALS2P165S as a selection marker. FIG. 5a (SEQ ID NO: 70). Design of the ALS2P165S gene containing an out-of-frame translation start codon located upstream of the 5' 3 nucleotides of PAM. Initiation of translation at the first AUG (indicated by the arrow below the sequence) encodes a 4-amino acid polypeptide that prevents the initiation of the translation start codon of ALS2 (gray text). FIG. 5b (SEQ ID NO: 71). A single nucleotide insertion (C, A, or T) or deletion (or any combination) resulting in the loss of the upstream AUG enables the initiation of translation at the ALS2 start codon (indicated by the arrow below the sequence), thereby restoring the translation of the full length of the ALS2P165S herbicide resistance gene. Figures 6a through 6c show schematic diagrams of the polynucleotide fragment of interest (SEQ ID NO: 72) containing the endogenous target site selected for modification. The encoded amino acid sequences are indicated below the respective nucleotide sequences (SEQ ID NO: 73, 75, 77). Figure 6a shows the single nucleotide located following the endonuclease cleavage site (indicated by the arrow) (in this example, indicated in underlined bold). C ) indicates that it can be removed via NHEJ. Fig. 6b shows the resulting polynucleotide of interest (SEQ ID NO: 74) in which a new cleavage site is created (indicated by the arrow) and the translation frame is shifted due to the deletion of a single base. Fig. 4c: The single nucleotide located following the endonuclease cleavage site (indicated in underlined bold in this example T ) is inserted via NHEJ without using a polynucleotide modification (repair) template, which can result in a single nucleotide edit of the polynucleotide of interest (SEQ ID NO: 76). The PAM sequence is highlighted in gray. Fig. 7. Top: Agrobacterium vector for the stable integration of UBI:Cas9 into the maize genome. Bottom: Agrobacterium vector for the stable integration of MDH:Cas9 into the maize genome. MDH is a thermoregulated promoter that controls the expression of Cas9. These vectors also contain a visual marker gene (END2:AmCYAN), which was used for the selection of stably transformed callus sectors. The sequence of the included red fluorescent protein (DsRED) was replicated into a forward 369 bp fragment separated by a 343-bp spacer, which contained sequences for recognition and targeting by two gRNAs and LIG3:4 meganuclease. H2B refers to the histone H2B gene promoter. Specific details for implementing the invention

[0020] order

[0021] Summary of Nucleic Acid and Protein Sequence Numbers explanation Nucleic Acid SEQ ID NO. Protein SEQ ID NO. Cas9 coding sequence 1 Potato ST-LS1 Intron 2 SV40 NLS 3 VirD2 NLS 4 Corn-optimized Cas9 expression cassette 5 Lig-CR3 Guide RNA Expression Vector 6 Corn genome target site MS26Cas-1 and PAM sequences 7 Corn genome target site MS26Cas-2 and PAM sequences 8 Corn genome target site MS26Cas-3 and PAM sequences 9 Corn genome target site LIGCas-1 and PAM sequences 10 Corn genome target site LIGCas-2 and PAM sequences 11 Corn genome target site LIGCas-3 and PAM sequences 12 Corn genome target site MS45Cas-1 and PAM sequences 13 Corn genome target site MS45Cas-2 and PAM sequences 14 Corn genome target site MS45Cas-3 and PAM sequences 15 Corn genome target site ALSCas-1 and PAM sequences 16 Corn genome target site ALSCas-2 and PAM sequences 17 Corn genome target site ALSCas-3 and PAM sequences 18 Primer sequence 19~38 ALS1-DNA sequence 39 ALS2-DNA sequence 40 Total length Zm-ALS2 protein 41 Corn genome target site ALSCas-4 and PAM sequences 42 794 bp polynucleotide modified template 43 127 bp polynucleotide modified template, oligo1 44 127 bp polynucleotide modified template, oligo2 45 Agrobacterium vector containing corn codon-optimized Cas9 and corn UBI promoters 46 Agrobacterium vector containing corn codon-optimized Cas9 and corn MDH promoters 47 The sequence shown in Fig. 1 48~58 The sequence shown in Fig. 2 59, 61, 63 60, 62, 64 The sequences shown in FIGS. 4a to 4c 65, 67, 69 66,68 The sequences shown in FIGS. 5a and 5b 70~71 The sequences shown in FIGS. 6a to 6c 72, 74, 76 73, 75,77 IN2 Promoter 78 ALSCas7 target site 79 ALSCas7-1 target site, a modified ALSCas7 target site 80 Corn target deviation point 81

[0022] Compositions and methods are provided for restoring the function of non-functional gene products within the genome of a cell. The methods and compositions provide an effective system for restoring the function of non-functional gene products using a guide RNA / Cas endonuclease system and for modifying or altering target sites within the genome of a plant, plant cell, or seed. The present invention also describes a method for modifying nucleotide sequences within the genome of a cell using restored functional selection markers, as well as a method for editing nucleotide sequences within the genome of a cell without introducing a polynucleotide modification template into the cell. Compositions and methods are also provided for delivering Cas9 endonuclease, sgRNA, and a guide RNA / Cas complex into a cell without DNA by introducing components of the complex (guide RNA and Cas endonuclease) through mRNA molecules (guide RNA, Cas endonuclease) or protein molecules (Cas endonuclease), or by directly introducing the nucleotide-protein complex (RGEN) itself.

[0023] CRISPR loci (short, regularly spaced palindromic repeat sequences) (also known as SPIDR (SPacer Interspersed Direct Repeat)) constitute a group of DNA loci. CRISPR loci consist of short, highly conserved DNA repeat sequences that are partially palindromic (typically 24 to 40 bp, repeated 1 to 140 times, also called CRISPR repeat sequences). Repeat sequences (typically species-specific) are spaced apart by variable sequences of constant length (typically 20 to 58 depending on the CRISPR loci) (WO2007 / 025097 published March 1, 2007). Bacteria and archaea have evolved an adaptive immune defense called a regularly spaced short palindromic repeat sequence (CRISPR) / CRISPR-binding (Cas) system that uses short RNA to induce the degradation of foreign nucleic acids (WO2007 / 025097 published March 1, 2007). Several CRISPR-Cas systems have been described, including Class 1 systems with multisubunit effector complexes and Class 2 systems with single protein effectors (e.g., but not limited to Cas9, Cpf1, C2c1, C2c2, C2c3) (Zetsche et al., 2015, Cell 163, 1-13; Shmakov et al., 2015, Molecular_Cell 60, 1-13; Makarova et al., 2015, Nature Reviews Microbiology Vol. 13:1-15, WO 2013 / 176772 A1, published November 23, 2013, the whole of which is incorporated herein by reference).

[0024] Type II CRISPR / Cas systems from bacteria utilize crRNA (CRISPR RNA) and tracrRNA (trans-activated CRISPR RNA) to induce Cas endonucleases to DNA targets. The crRNA contains a spacer region complementary to one strand of the double-stranded DNA target and a region that base-pairs with the tracrRNA (trans-activated CRISPR RNA), which forms an RNA duplex that induces Cas endonucleases to cleave the DNA target. The spacer is acquired through a process involving Cas1 and Cas2 proteins that is not fully understood. All Type II CRISPR-Cas loci contain the Cas1 and Cas2 genes in addition to the Cas9 gene (Makarova et al. 2015, Nature Reviews Microbiology Vol. 13:1-15). Cas genes generally include genes that are coupled to, bound to, close to, or in the vicinity of the flanking CRISPR locus. The terms "Cas gene" and "CRISPR-linked (Cas) gene" are used interchangeably herein. A comprehensive review of the Cas protein family is provided in the literature [Haft et al. (2005) Computational Biology, PLoS Comput Biol 1(6): e60. doi:10.1371 / journal.pcbi.0010060]. As described therein, 41 CRISPR-linked (Cas) gene families are described in addition to four previously known gene families. This indicates that CRISPR systems belong to different classes with different repetitive patterns, gene sets, and species ranges. The number of Cas genes at a given CRISPR locus may vary between species (Haft et al., 2005, Computational Biology, PLoS Comput Biol 1(6): e60. doi:10.1371 / journal.pcbi.0010060; Makarova et al.2015, Nature Reviews Microbiology Vol. 13:1-15; WO 2013 / 176772 A1, published November 23, 2013, the entirety of which is incorporated herein by reference).

[0025] The term "Cas endonuclease" in this application refers to a protein encoded by a Cas(CRISPR-binding) gene. Cas endonucleases, when complexed with a suitable polynucleotide component, can recognize all or part of a specific DNA target sequence, bind thereto, and selectively nick or cleave it. The Cas endonucleases described herein comprise one or more nuclease domains. The Cas endonucleases of the present invention include those having an HNH or HNH-like nuclease domain and / or a RuvC or RuvC-like nuclease domain (Makarova et al. 2015, Nature Reviews Microbiology Vol. 13:1-15). Cas comprises the Cas9 protein, Cpf1 protein, C2c1 protein, C2c2 protein, C2c3 protein, Cas3, Cas3-HD, Cas5, Cas7, Cas8, Cas10, or a complex thereof.

[0026] The terms “guide polynucleotide / Cas endonuclease complex,” “guide polynucleotide / Cas endonuclease system,” “guide polynucleotide / Cas complex,” “guide polynucleotide / Cas system,” “induction Cas system,” and “PGEN” as used herein are used interchangeably and refer to at least one guide polynucleotide and at least one Cas endonuclease protein capable of forming a polynucleotide-protein complex, said guide polynucleotide / Cas endonuclease complex may guide Cas endonuclease to a DNA target site so that Cas endonuclease may recognize the DNA target site, bind to it, and selectively nick or cleave (introduce a single or double strand break). The guide polynucleotide / Cas endonuclease complex of the present invention may comprise suitable polynucleotide component(s) and Cas protein(s) of any of the four known CRISPR systems (Horvath and Barrangou, Science 327:167-170), e.g., Type I, Type II, or Type III CRISPR systems. The Cas endonuclease unwinds the DNA duplex at the target sequence and selectively cleaves at least one DNA strand, as mediated by recognition of the target sequence by the polynucleotide complex with the Cas protein (e.g., crRNA or guide RNA, but not limited thereto). Generally, such recognition and cleavage of the target sequence by the Cas endonuclease occurs when the correct protospacer-adjacent motif (PAM) is located at or adjacent to the 3' end of the DNA target sequence.Alternatively, the Cas protein herein may lack DNA cleavage or nicking activity but can still specifically bind to a DNA target sequence when complexed with a suitable RNA component (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015 and U.S. Patent Application US 2015-0059010 A1 published February 26, 2015, the whole of which is incorporated herein by reference).

[0027] A guide polynucleotide / Cas endonuclease complex can cleave one or two strands of a DNA target sequence. A guide polynucleotide / Cas endonuclease complex capable of cleaving two strands of a DNA target sequence generally comprises a Cas protein having all of its endonuclease domains in a functional state (e.g., a wild-type endonuclease domain or a variant thereof possessing some or all activity in each endonuclease domain). Thus, a wild-type Cas protein (e.g., the Cas9 protein disclosed herein) or a variant thereof possessing some or all activity in each endonuclease domain of the Cas protein is a suitable example of a Cas endonuclease capable of cleaving two strands of a DNA target sequence. The Cas9 protein containing functional RuvC and HNH nuclease domains is an example of a Cas protein capable of cleaving two strands of a DNA target sequence. A guide polynucleotide / Cas endonuclease complex capable of cleaving one strand of a DNA target sequence may be characterized herein by having nikase activity (e.g., partial cleavage ability). Cas nikase generally comprises a single functional endonuclease domain that causes Cas to cleave only one strand of the DNA target sequence (i.e., to form a nik). For example, Cas9 nikase may comprise (i) a mutant dysfunctional RuvC domain and (ii) a functional HNH domain (e.g., a wild-type HNH domain). As another example, Cas9 nikase may comprise (i) a functional RuvC domain (e.g., a wild-type RuvC domain) and (ii) a mutant dysfunctional HNH domain. Non-limiting examples of Cas9 nikase suitable for use herein are Gasiunas et al., incorporated herein by reference. (Proc. Natl. Acad. Sci. USA 109:E2579-E2586), Jinek et al.(Science 337:816-821), Sapranauskas et al. (Nucleic Acids Res. 39:9275-9282) and U.S. Patent Application Publication No. 2014 / 0189896 are disclosed.

[0028] To increase the specificity of DNA targeting, a pair of Cas9 nickases may be used. Generally, this can be accomplished by introducing two Cas9 nickases that target nearby DNA sequences on opposite strands in the region for desired targeting and form nicks, as they are bound to RNA components having different guide sequences. These nearby cuts in each DNA strand produce double-strand breaks (i.e., DSBs with single-strand protrusions), which are subsequently recognized as substrates for non-homologous end junctions, NHEJs (which have a tendency toward incomplete repair leading to mutations), or homologous recombination, HR. In such embodiments, each nick may be spaced apart from each other by, for example, at least about 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, or 100 bases (or any integer between 5 and 100). One or two Cas9 nikcasase proteins of the present invention may be used in a pair of Cas9 nikcasases. For example, a Cas9 nikcasase having a mutant RuvC domain or an operating HNH domain (i.e., Cas9 HNH+ / RuvC-) (e.g., Streptococcus pyogenes Cas9 HNH+ / RuvC-) may be used. Each Cas9 nikcasase (e.g., Cas9 HNH+ / RuvC-) will be guided to specific DNA sites that are close to each other (separated by 100 base pairs or less) using suitable RNA components of the present invention having guide RNA sequences that target each nikcasase to a specific DNA site.

[0029] The Cas protein may be part of a fusion protein comprising one or more heterogeneous protein domains (e.g., one, two, three or more domains in addition to the Cas protein). This fusion protein may include any additional protein sequence and optionally a linker sequence between any two domains, e.g., between Cas and the first heterogeneous domain. Examples of protein domains that can be fused to the Cas protein of the present invention include epitope tags (e.g., histidine [His], V5, FLAG, influenza hemagglutinin [HA], myc, VSV-G, thioredoxin [Trx]), reporters (e.g., glutathione-5-transferase [GST], horseradish peroxidase [HRP], chloramphenicol acetyltransferase [CAT], beta-galactosidase, beta-glucuronidase [GUS], luciferase, green fluorescent protein [GFP], HcRed, DsRed, cyan fluorescent protein [CFP], yellow fluorescent protein [YFP], blue fluorescent protein [BFP]), and methylase activity, dimethylase activity, transcriptional activation activity (e.g., VP16 or VP64), transcriptional repressive activity, transcriptional release factor activity, histone modification activity, RNA It includes, without limitation, a domain having one or more of cleavage activity and nucleic acid binding activity. The Cas protein may also be fused with a DNA molecule or other molecules, such as a maltose binding protein (MBP), an S-tag, a Lex A DNA binding domain (DBD), a GAL4A DNA binding domain, and a protein that binds to the herpes simplex virus (HSV) VP16.

[0030] The Cas proteins of this invention may be derived from any of the following genera: Aerophyrum ( Aeropyrum ), Pirobakulum( Pyrobaculum ), Sulpolobus( Sulfolobus ), Archaeoglobus( Archaeoglobus ), Haloarcula( Haloarcula ), Methanobacterium( Methanobacterium ), Metanococcus( Methanococcus), Metanosarcina( Methanosarcina ), Metanophirus( Methanopyrus ), Pyrococcus( Pyrococcus ), picropillus( Picrophilus ), Sunnyoplasmia( Thernioplastia ), Corynebacterium( Corynebacterium ), Mycobacterium( Mycobacterium ), Streptomyces( Streptomyces ), Aquifex( Waterman ), Porphyromonas ( Porphyromonas ), Chlorobium( Chlorobium ), Summers( Thermae ), Bacillus( Bacillus ), Listeria( Listeria ), Staphylococcus( Staphylococcus ), Clostridium( Clostridium ), Thermoanaerobacter ( Thermoanaerobacter ), Mycoplasma( Mycoplasma ), Fusobacterium( Fusobacterium ), Azakus( Azarcus ), Chromobacterium( Chromobacterium ), Neiceria( Neisseria ), Nitrosomonas( Nitrosomonas ), Disulfovibrio( Desulfovibrio ), Geobacter( Geobacter ), Myrococcus( Myrococcus ), Campylobacter( Campylobacter ), Bolinella( Woolly ), Ashinetobakter( Acinetobacter ), Erwinia( Erwinia ), Eskerichya( Escherichia ), Legionella( Legionella ), Methylococcus( Methylococcus ), Pasteurella( Pasteurella ), Photobacterium( Photobacterium ), Salmonella( Salmonella ), Xanthomonas ( Xanthomonas ), Yeshnia( Yersinia ), Streptococcus( Streptococcus ), Treponema ( Treponema ), Francisela( Francisella ) or thermomotor( Thermotoga ). Alternatively, the Cas protein of the present invention may be encoded by any of SEQ ID NO: 462 to 465, 467 to 472, 474 to 477, 479 to 487, 489 to 492, 494 to 497, 499 to 503, 505 to 508, 510 to 516, or 517 to 521, as disclosed in U.S. Application Publication No. 2010 / 0093617 incorporated herein by reference.

[0031] In certain embodiments, the guide polynucleotide / Cas endonuclease complex may bind to a DNA target site sequence but does not cleave any strand of the target site sequence. Such complexes may comprise a Cas protein in which all nuclease domains are mutagenic and nonfunctional. For example, the Cas9 protein of the present invention, which may bind to a DNA target site sequence but does not cleave any strand of the target site sequence, may comprise both a mutagenic RuvC domain and a mutagenic HNH domain. The Cas protein of the present invention, which binds to but does not cleave a target DNA sequence, may be used to regulate gene expression, for example, in which case the Cas protein may be fused with a transcription factor (or part thereof) (e.g., a repressor or an activator, any of which disclosed herein).

[0032] The Cas endonuclease gene may be a type II Cas9 endonuclease, for example, the Cas9 genes listed in SEQ ID NOs: 462, 474, 489, 494, 499, 505, and 518 of WO2007 / 025097, published March 1, 2007 and incorporated herein by reference, but is not limited thereto. In other embodiments, the Cas endonuclease gene is a plant, maize, or soybean-optimized Cas9 endonuclease gene. The Cas endonuclease gene of the present invention may be a plant or microbial codon-optimized Cas9 endonuclease gene. The Cas endonuclease gene can be operably linked to the SV40 nuclear targeting signal upstream of the Cas codon region and the two-part VirD2 nuclear localization signal downstream of the Cas codon region (Tinland et al. (1992) Proc. Natl. Acad. Sci. USA 89:7442-6).

[0033] "Cas9" (formerly referred to as Cas5, Csn1, or Csx12) in this application refers to a Cas endonuclease of the Type II CRISPR system that forms a complex with cr nucleotides and tracr nucleotides, or with a single guide polynucleotide, to specifically recognize and cleave all or part of a DNA target sequence. The Cas9 protein comprises a RuvC nuclease domain and an HNH (HNH) nuclease domain, each of which can cleave a single DNA strand in the target sequence (co-action of the two domains induces a DNA double-strand break, whereas the activity of one domain induces nick). Generally, the RuvC domain comprises subdomains I, II, and III, wherein domain I is located near the N-terminus of Cas9, and subdomains II and III are located in the middle of the protein flanked to the HNH domain (Hsu et al, Cell 157:1262-1278). A Type II CIRSPR system comprises a DNA cutting system that utilizes the Cas9 endonuclease as a complex with at least one polynucleotide component. For example, Cas9 may be a complex with CRISPR RNA (crRNA) and trans-activated CRISPR RNA (tracrRNA). In other examples, Cas9 may be a complex with a single guide RNA.

[0034] The amino acid sequences of the Cas9 protein described herein as well as other specific Cas proteins of the present invention are, for example, Streptococcus (e.g., S. pyogenes ( pyogenic ), S. Nummoniae( pneumonia ), S. thermophilus( thermophilic ), S. Agalactia( agalactia ), S. Parasanguinis( blood-borne ), S. Oralis( oral ), S. Salivarius( salivary ), S. Macaca( macaques ), S. disgalactiae( dysgalactia ), S. Anginosus( angina ), S. Constellatus( starry ), S. Pseudoporcinus( pseudo-porcine ), S. Mutans( changing )), Listeria (e.g., L. innoqua ( harmless )), Spiroplasma( Spiroplasma ) (e.g., S. Apis( bee ), S. Sirpidicola( syrphid )), Peptostreptococcus ( Peptostreptococcaceae ), atopobium( Atopobium ), Porphyromonas ( Porphyromonas ) (e.g., P. Cartonia( Catonia )), Prevotella( Prevotella ) (for example, P. Intermedia( intermediate )), Veilonella( Veillonella ), Treponema ( Treponema )(for example, T. Sokransky( sister-in-law ), T. Denticolla( toothpick )), Capnocytophaga( Capnocytophaga ), Pinegoldia( Finegoldia )(e.g., F. Magna( great )), to Coriobacteriaceae( Coriobacteriaceae )(e.g., C. bacterium( bacteria )), Olsnella( Olsenella )(e.g., O. propusa( profuse )), Haemophilus( Haemophilus )(e.g., H. sputorum( spit ), H. At Pitmania ( pittmans )), Pasteurella( Pasteurella )(for example, to P. Betia( betty )), Olivebacter( Olive bacterium )(e.g., O. citiensis( thirsty )), Epilitonimonas( Epilithonimonas )(e.g., E. Tenax( tenacious )), Mesonia( Mesonia )(e.g., M. Mobilis( mobile )), Lactobacillus( Lactobacillus )(e.g., L. plantarum( plants)), Bacillus (e.g., B. cereus ( candle )), Aquimarina( Aquamarine )(for example, A. Muelleri( to be beaten )), Chryseobacterium( Chryseobacterium )(e.g., C. Parustre( marshy )), Bacteroides( Bacteroides )(e.g., B. graminisolvense( graminisolvens )), Neisseria (e.g., N. meningitidis ( meningitidis )), Francisela( Francisella )(For example, F. Nobishida( novicida )) or Flavobacterium( Flavobacterium )(e.g., F. Frigidarium( frigidarium ), F. Solly( soli It can originate from species. As another example, the Cas9 protein is referenced in the literature [Chylinski et al. ( RNA Biology It may be any of the Cas9 proteins disclosed in [10:726-737 and U.S. Patent Application 62 / 162377 filed May 15, 2015].

[0035] Accordingly, the sequences of the Cas9 proteins of the present invention are, for example, GenBank registry number G3ECR1 (S. thermophilus), WP_026709422, WP_027202655, WP_027318179, WP_027347504, WP_027376815, WP_027414302, WP_027821588, WP_027886314, WP_027963583, WP_028123848, WP_028298935, Q03JI6 (S. thermophilus), EGP66723, EGS38969, EGV05092, EHI65578 (S. pseudoporsinus), incorporated by reference EIC75614 (S. oralis), EID22027 (S. constellatus), EIJ69711, EJP22331 (S. oralis), EJP26004 (S. anginosus), EJP30321, EPZ44001 (S. phyogenes), EPZ46028 (S. phyogenes), EQL78043 (S. phyogenes), EQL78548 (S. phyogenes), ERL10511, ERL12345, ERL19088 (S. phyogenes), ESA57807 (S. phyogenes), ESA59254 (S. phyogenes), ESU85303 (S. phyogenes), ETS96804, UC75522, EGR87316 (S. (Disgalactiae), EGS33732, EGV01468 (S. oralis), EHJ52063 (S. macaca), EID26207 (S. oralis), EID33364, EIG27013 (S. parasanguinis), EJF37476, EJO19166 (Streptococcus species BS35b), EJU16049, EJU32481, YP_006298249, ERF61304, ERK04546, ETJ95568 (S.It may include any of the Cas9 amino acid sequences disclosed in Agalactia), TS89875, ETS90967 (Streptococcus species SR4), ETS92439, EUB27844 (Streptococcus species BS21), AFJ08616, EUC82735 (Streptococcus species CM6), EWC92088, EWC94390, EJP25691, YP_008027038, YP_008868573, AGM26527, AHK22391, AHB36273, Q927P4, G3ECR1, or Q99ZW2 (S. phyogenes). Any variant of any of these Cas9 protein sequences may be used, but must have specific binding activity to DNA and selectively endonucleotic activity when combined with the RNA component of the present invention. Such variants may include an amino acid sequence that is at least about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to the amino acid sequence of the reference Cas9.

[0036] Alternatively, the Cas9 protein of the present invention may be encoded by any of SEQ ID NO: 462 (S. thermophilus), 474 (S. thermophilus), 489 (S. agalactia), 494 (S. agalactia), 499 (S. mutans), 505 (S. phyogenes), or 518 (S. phyogenes), as disclosed in U.S. Application Publication No. 2010 / 0093617 (incorporated herein by reference). Alternatively, the Cas9 protein may comprise, for example, an amino acid sequence that is at least about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to any of the aforementioned amino acid sequences. Such variant Cas9 proteins must have specific binding activity to DNA and selectively cleavage or nicking activity when bound to the RNA component of the present invention.

[0037] The Cas protein of the present invention, e.g., Cas9, may include a heterogeneous nuclear localization sequence (NLS). The heterogeneous NLS amino acid sequence of the present invention may exhibit sufficient strength to induce the accumulation of the Cas protein in detectable amounts in the nucleus of, for example, the yeast cell of the present invention. The NLS may include a short sequence (e.g., 2 to 20 residues) of one (monopartite) or more (bipartite) of basic, positively charged residues (e.g., lysine and / or arginine), which may be located anywhere in the Cas amino acid sequence but must be exposed on the protein surface. The NLS may be operably linked, for example, to the N-terminus or C-terminus of the Cas protein of the present invention. Two or more NLS sequences may be linked, for example, to the Cas protein, for example, to both the N-terminus and the C-terminus of the Cas protein. Non-limiting examples of suitable NLS sequences of the present invention include those disclosed in U.S. Patents 6660830 and 7309576 (e.g., Table 1 of the said documents), which are incorporated herein by reference.

[0038] Cas endonucleases may comprise modified forms of the Cas9 polypeptide. Modified forms of the Cas9 polypeptide may comprise amino acid changes (e.g., deletions, insertions, or substitutions) that reduce the natural nuclease activity of the Cas9 protein. For example, in some cases, modified forms of the Cas9 protein have less than 50%, less than 40%, less than 30%, less than 20%, less than 10%, less than 5%, or less than 1% of the nuclease activity of the corresponding wild-type Cas9 polypeptide (U.S. Patent Application US20140068797 A1 published March 6, 2014). In some cases, modified forms of the Cas9 polypeptide do not have substantial nuclease activity and are referred to as catalytically "inactive Cas9" or "inactive cas9 (dCas9)". Catalytically inactivated Cas9 variants include Cas9 variants containing mutations in the HNH and RuvC nuclease domains. These catalytically inactivated Cas9 variants can interact with sgRNA and bind to target sites in vivo, but cannot cleave either strand of target DNA.

[0039] Catalytically inactive Cas9 can be fused to heterogeneous sequences (U.S. patent application US20140068797 A1 published March 6, 2014). Suitable fusion partners include, but are not limited to, polypeptides that provide activity to indirectly increase transcription by acting directly on target DNA or on polypeptides bound to target DNA (e.g., histones or other DNA-binding proteins). Additional suitable fusion partners include, but are not limited to, polypeptides that provide methyltransferase activity, dimethylase activity, acetyltransferase activity, diacetylase activity, kinase activity, phosphatase activity, ubiquitin ligase activity, diubiquitination activity, adenylation activity, didenylation activity, SUMOation activity, diSUMOation activity, ribosylation activity, diribosylation activity, myristoylation activity, or dimyristoylation activity. In addition, suitable fusion partners include, but are not limited to, polypeptides that directly provide increased transcription of the target nucleic acid (e.g., transcription activators or fragments thereof, proteins or fragments thereof constituting transcription activators, small molecules / drug-responsive transcription regulators, etc.). Catalytically inactive Cas9 may also be fused to FokI nucleases to produce double-strand breaks (Guilinger et al. Nature biotechnology, Vol. 32, No. 6, June 2014).

[0040] The terms “functional fragment,” “functionally equivalent fragment,” and “functionally equivalent fragment” of Cas endonuclease are used interchangeably herein and refer to a part or subsequence of a Cas endonuclease sequence that retains the ability to recognize a target site, bind thereto, and selectively nick or cleave (introduce a single or double strand cut).

[0041] The terms “functional variant,” “functionally equivalent variant,” and “functionally equivalent variant” of Cas endonuclease are used interchangeably herein and refer to variants of Cas endonuclease that retain the ability to recognize a target site, bind thereto, and selectively nick or cleave (introduce a single or double strand cleave). Fragments and variants can be obtained through methods such as site-specific mutagenesis and synthetic preparation.

[0042] The Cas endonuclease gene is, in principle, a plant codon-optimized Streptococcus pyogenes Cas9 gene capable of recognizing any genomic sequence of the N(12–30)NGG form that can be targeted, or selected from the group consisting of Brevivacillus laterosporus, Lactobacillus reuteri Mlc3, Lactobacillus rosiae DSM 15814, Pediococcus pentosaceus SL4, Lactobacillus nodensis JCM 14932, Sulfurospirillum species SCADC, Bifidobacterium thermophilum DSM 20210, Loctanella bestpoldensis, Sphingomonas sanjanigenens NX02, Epilitonimonas tenax DSM 16811, Sporocytophaga myxococcoides, and Cycloplexus torquis ATCC 700755 It comprises a Cas9 endonuclease derived from a living organism, said Cas9 endonuclease being able to form a guide RNA / Cas endonuclease complex capable of recognizing all or part of a DNA target sequence, binding thereto, and selectively nicking or cleaving it. Other Cas endonuclease systems are described in U.S. Patent Application 62 / 162,377 filed May 15, 2015 and 62 / 162,353 filed May 15, 2015, both of which are incorporated herein by reference.

[0043] Cas9 endonucleases can be utilized for targeted genome editing (through single- and complex double-strand cleavage and nicking) and targeted genome regulation (through tethering of epigenetic effector domains to Cas9 or sgRNA). Cas9 can also be genetically engineered to function as an RNA-induced recombinase and can serve as a scaffold for the assembly of multiple protein-nucleic acid complexes via RNA tethering (Mali et al. 2013 Nature Methods Vol. 10: 957-963).

[0044] As used herein, the term "guide polynucleotide" relates to a polynucleotide sequence capable of forming a complex with Cas endonuclease, enabling Cas endonuclease to recognize a DNA target site, bind thereto, and selectively cleave it. The guide polynucleotide may be a single molecule or a double molecule. The guide polynucleotide sequence may be an RNA sequence (referred to as guide RNA, gRNA), a DNA sequence, or a combination thereof (RNA-DNA combination sequence). Optionally, the guide polynucleotide may comprise at least one nucleotide, a phosphodiester bond or linkage modification, e.g., fixed nucleic acid (LNA), 5-methyl dC, 2,6-diaminopurine, 2'-fluoro A, 2'-fluoro U, 2'-O-methyl RNA, a phosphorothioate bond, a linkage to a cholesterol molecule, a linkage to a polyethylene glycol molecule, a linkage to a spacer 18 (hexaethylene glycol chain) molecule, or a 5' to 3' covalent linkage resulting in cyclization, but is not limited thereto. Guide polynucleotides comprising ribonucleic acid alone are also referred to as “guide RNA” or “gRNA” (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015 and U.S. Patent Application US 2015-0059010 A1 published February 26, 2015, the whole of which is incorporated herein by reference).

[0045] The guide polynucleotide may be a dual molecule (also referred to as a duplex guide polynucleotide) comprising a cr nucleotide sequence and a tracr nucleotide sequence. The cr nucleotide comprises a first nucleotide sequence domain (referred to as a variable targeting domain or VT domain) that can hybridize to a nucleotide sequence of target DNA, and a second nucleotide sequence (also referred to as a tracr mate sequence) that is part of a Cas endonuclease recognition (CER) domain. The tracr mate sequence can hybridize to the tracr nucleotide along a complementary region and together form a Cas endonuclease recognition domain or a CER domain. The CER domain may interact with the Cas endonuclease polypeptide. The cr nucleotide and tracr nucleotide of the duplex guide polynucleotide may be RNA, DNA, and / or RNA-DNA-combined sequences. In some embodiments, the crnucleotide molecule of the duplex guide polynucleotide is referred to as "crDNA" (where it consists of consecutive DNA nucleotides), "crRNA" (where it consists of consecutive RNA nucleotides), or "crDNA-RNA" (where it consists of a combination of DNA and RNA nucleotides). The crnucleotide may comprise a fragment of crRNA that occurs naturally in bacteria and archaea. The size of the crRNA fragment that occurs naturally in bacteria and archaea and may be present in the crnucleotide disclosed herein may have a range of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more nucleotides, but is not limited to these ranges.In some embodiments, the tracr nucleotide is referred to as "tracrRNA" (where it consists of consecutive RNA nucleotides), "tracrDNA" (where it consists of consecutive DNA nucleotides), or "tracrDNA-RNA" (where it consists of a combination of DNA and RNA nucleotides). In one embodiment, the RNA guiding the RNA / Cas9 endonuclease complex is a duplex RNA comprising a duplex crRNA-tracrRNA. The tracrRNA (trans-activated CRISPR RNA) comprises, in the 5' to 3' direction, (i) a sequence that anneales with a repeat region of CRISPR type II crRNA and (ii) a stem loop acceptor (Deltcheva et al., Nature 471:602-607). A duplex guide polynucleotide can form a complex with a Cas endonuclease, and said guide polynucleotide / Cas endonuclease complex (also referred to as a guide polynucleotide / Cas endonuclease system) can guide the Cas endonuclease to a genomic target site so that the Cas endonuclease recognizes the target site, binds to it, and selectively nicks or cleaves (introduces a single or double strand break) (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015, and U.S. Patent Application US 2015-0059010 A1 published February 26, 2015, the whole of which is incorporated herein by reference).

[0046] The guide polynucleotide may be a single molecule (also referred to as a single guide polynucleotide) comprising a cr nucleotide sequence linked to a tracr nucleotide sequence. The single guide polynucleotide comprises a first nucleotide sequence domain (referred to as a variable targeting domain or VT domain) capable of hybridizing to a nucleotide sequence of target DNA, and a Cas endonuclease recognition domain (CER domain) that interacts with the Cas endonuclease polypeptide. "Domain" means a sequence of nucleotides that may be RNA, DNA, and / or RNA-DNA combination sequences. The VT domain and / or CER domain of the single guide polynucleotide may comprise an RNA sequence, a DNA sequence, or an RNA-DNA combination sequence. A single guide polynucleotide consisting of sequences from cr nucleotides and tracr nucleotides may be referred to as "single guide RNA" (when consisting of consecutive RNA nucleotides) or "single guide DNA" (when consisting of consecutive DNA nucleotides) or "single guide RNA-DNA" (when consisting of a combination of RNA and DNA nucleotides). A single guide polynucleotide can form a complex with a Cas endonuclease, and said guide polynucleotide / Cas endonuclease complex (also referred to as a guide polynucleotide / Cas endonuclease system) can guide the Cas endonuclease to a genomic target site, thereby enabling the Cas endonuclease to recognize the target site, bind thereto, and selectively nick or cleave (introduce a single or double strand break) (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015, and U.S. Patent Application US 2015-0059010 A1 published February 26, 2015, the whole of which is incorporated herein by reference).

[0047] The terms “variable targeting domain” or “VT domain” are used interchangeably herein and include a nucleotide sequence that can hybridize (complementary) to one strand (nucleotide sequence) of a double-stranded DNA target site. The percentage complementarity between the first nucleotide sequence domain (VT domain) and the target sequence is at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 63%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, It may be 95%, 96%, 97%, 98%, 99%, or 100%. The variable targeting domain may be at least 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 nucleotides in length. In some embodiments, such variable targeting domain comprises 12 to 30 consecutive nucleotides. The variable targeting domain may consist of a DNA sequence, an RNA sequence, a modified DNA sequence, a modified RNA sequence, or any combination thereof.

[0048] The terms “Cas endonuclease recognition domain” or “CER domain” (of the guide polynucleotide) are used interchangeably herein and comprise a nucleotide sequence that interacts with the Cas endonuclease polypeptide. The CER domain comprises a tracr nucleotide sequence followed by a tracr nucleotide mate sequence. The CER domain may consist of a DNA sequence, an RNA sequence, a modified DNA sequence, a modified RNA sequence (e.g., see US 2015-0059010 A1 published February 26, 2015, the entirety of which is incorporated herein by reference), or any combination thereof.

[0049] The nucleotide sequence linking the cr nucleotide and tracr nucleotide of a single guide polynucleotide may include an RNA sequence, a DNA sequence, or an RNA-DNA combination sequence. In one embodiment, the nucleotide sequence connecting the cr nucleotide and the tracr nucleotide of the single guide polynucleotide is at least 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, The length may be 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100 nucleotides. In another embodiment, the nucleotide sequence connecting the cr nucleotide and the tracr nucleotide of the single guide polynucleotide may include, but is not limited to, a tetraloop sequence, e.g., a GAAA tetraloop sequence.

[0050] Nucleotide sequence modifications of the guide polynucleotide, VT domain and / or CER domain may be selected from, but are not limited to, the group consisting of a 5' cap, a 3' polyadenylated tail, a riboswitch sequence, a stability control sequence, a sequence forming a dsRNA duplex, a modification or sequence that targets the guide polynucleotide to an intracellular location, a modification or sequence that provides tracking, a modification or sequence that provides a binding site for a protein, a locked nucleic acid (LNA), 5-methyl dC nucleotide, 2,6-diaminopurine nucleotide, 2'-fluoro A nucleotide, 2'-fluoro U nucleotide; 2'-O-methyl RNA nucleotide, a phosphorothioate bond, a linkage to a cholesterol molecule, a linkage to a polyethylene glycol molecule, a linkage to a spacer 18 molecule, a covalent linkage from 5' to 3', or any combination thereof. These modifications may bring about at least one additional beneficial feature, wherein the additional beneficial feature is selected from the group of modified or regulated stability, intracellular targeting, tracking, fluorescent labeling, binding sites for proteins or protein complexes, modified binding affinity for complementary target sequences, modified resistance to cell degradation, and increased cell permeability.

[0051] The terms “functional fragment,” “functionally equivalent fragment,” and “functionally equivalent fragment” of guide RNA, crRNA, or tracrRNA are used interchangeably herein and each refers to a part or subsequence of guide RNA, crRNA, or tracrRNA that retains the ability to function as guide RNA, crRNA, or tracrRNA.

[0052] The terms “functional variant,” “functionally equivalent variant,” and “functionally equivalent variant” of guide RNA, crRNA, or tracrRNA are used interchangeably herein and refer to, respectively, a variant of guide RNA, crRNA, or tracrRNA that retains the ability to function as guide RNA, crRNA, or tracrRNA.

[0053] The terms “single guide RNA,” “gRNA,” and “sgRNA” are used interchangeably herein and relate to the synthetic fusion of two RNA molecules, which are crRNA (CRISPR RNA) containing a variable targeting domain (linked to a tracr mate sequence that hybridizes to tracrRNA) fused to tracrRNA (trans-activated CRISPR RNA). The single guide RNA may comprise a crRNA or crRNA fragment of a type II CRISPR / Cas system and a tracrRNA or tracrRNA fragment capable of forming a complex with a type II Cas endonuclease, and said guide RNA / Cas endonuclease complex may guide the Cas endonuclease to a DNA target site, thereby enabling the Cas endonuclease to recognize and bind to the DNA target site and selectively nick or cleave (introduce a single or double strand break).

[0054] The terms “guide RNA / Cas endonuclease complex,” “guide RNA / Cas endonuclease system,” “guide RNA / Cas complex,” “guide RNA / Cas system,” “gRNA / Cas complex,” “gRNA / Cas system,” “RNA-induced endonuclease,” and “RGEN” are used interchangeably herein and refer to at least one RNA component and at least one Cas endonuclease protein capable of forming a complex, said guide RNA / Cas endonuclease complex may guide Cas endonuclease to a DNA target site so that Cas endonuclease may recognize the DNA target site, bind to it, and selectively nick or cleave (introduce a single or double strand break). The guide RNA / Cas endonuclease complex of the present invention may include suitable RNA component(s) and Cas protein(s) of any of the known CRISPR systems (Zetsche et al., 2015, Cell 163, 1-13; Shmakov et al., 2015, Molecular_Cell 60, 1-13; Makarova et al. 2015, Nature Reviews Microbiology Vol. 13:1-15; Horvath and Barrangou, Science 327:167-170), such as type I, type II, or type III CRISPR systems. The guide RNA / Cas endonuclease complex may comprise a type II Cas9 endonuclease and at least one RNA component (e.g., crRNA and tracrRNA, or gRNA) (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015, and U.S. Patent Application US 2015-0059010 A1 published February 26, 2015, the whole of which is incorporated herein by reference).

[0055] Cas endonucleases may be introduced (delivered) into cells by any method known in the art, e.g., but not limited to, transient introduction methods, transfection, microinjection, and / or local treatment methods, or indirectly via recombinant enzymes. Plant cells differ from human and animal cells in that they contain a plant cell wall, which can act as a barrier to the direct delivery of Cas9 endonucleases into plant cells. Recombinant DNA constructs encoding Cas9 endonucleases have been successfully introduced into plant cells (Svitashev et al ., Plant Physiology, 2015, Vol. 169, pp. 931-945) enabled genome editing at target sites. One possible disadvantage in stably introducing recombinant DNA constructs into plant cells is that the persistent presence of Cas9 endonuclease can increase off-target effects.

[0056] As described herein, direct delivery of Cas endonuclease into plant cells can be achieved through particle-mediated delivery. Based on the experiments described herein, those skilled in the art can now envision that any other direct delivery method, such as but not limited to polyethylene glycol (PEG)-mediated transfection into protoplasts, whisker-mediated delivery, electroporation, gene gun, cell-penetrating peptide, or mesoporous silica nanoparticle (MSN)-mediated direct protein delivery, can be successfully utilized to deliver Cas9 endonuclease into plant cells.

[0057] Direct delivery of Cas endonuclease (also referred to as DNA-free delivery of Cas endonuclease) can be achieved by introducing Cas protein, mRNA encoding Cas endonuclease, and / or the RNA-induced endonuclease ribonucleotide-protein complex (RGEN) itself (as a ribonucleotide-protein complex) into a cell using any method known in the art. Direct delivery of Cas endonuclease via mRNA encoding Cas endonuclease or via polypeptide molecules is also referred to herein as DNA-free delivery of Cas endonuclease because no DNA molecule is involved in the production of the Cas endonuclease protein. Likewise, direct delivery of guide RNA as an RNA molecule is also referred to herein as DNA-free delivery of guide RNA. Likewise, direct delivery of the guide RNA / endonuclease complex itself (RGEN) as a ribonucleotide-protein complex is also referred to herein as DNA-free delivery of RGEN.

[0058] Direct introduction of Cas endonuclease as a protein, as an mRNA molecule with gRNA, or as the RGEN ribonucleotide-protein itself causes the RGEN complex to degrade rapidly after genome editing at the target site, allowing the complex to exist only transiently in the cell, which leads to a reduction in off-target effects (as described in Example 12).

[0059] Direct delivery of these components can be achieved by direct delivery (co-delivery) of other mRNAs that can promote the reinforcement and / or visualization of cells receiving the RGEN components. For example, delivery of mRNA encoding selectable visual markers, such as fluorescent proteins (e.g., red, green, yellow, blue, or combinations thereof, but not limited to), may be used instead of, or in combination with, the direct selection of repair products of disrupted non-functional genes.

[0060] A method for restoring the function of a non-functional gene product by restoring the nucleotide sequence of a destroyed gene so that the restored nucleotide sequence encodes a functional gene product is described herein.

[0061] A disrupted gene refers to a gene that has been modified (disrupted) so that its gene product loses its function (called a non-functional gene product) or has reduced function compared to the product of the corresponding gene that has not been disrupted (also called a non-disrupted gene). For example, a gene encoding for a functional polypeptide or protein may be disrupted (disrupted) so that the translation product of the disrupted gene loses its function or produces a polypeptide with reduced function.

[0062] Functional gene products include functional proteins or polypeptides having biological or non-biological functions.

[0063] Non-functional gene products include references to the gene products of the disrupted gene. Non-functional gene products include polypeptides that have lost their function (absence of function) or have reduced function compared to the gene products of the corresponding non-disrupted gene.

[0064] In one embodiment of the present invention, the method is a method for restoring the function of a non-functional gene product within the genome of a cell, comprising the step of introducing a guide RNA / Cas endonuclease complex into a cell containing a disrupted gene within the genome, wherein the complex generates a double-strand break, the disrupted gene does not encode a functional gene product, and the disrupted gene is restored to a non-disrupted gene capable of encoding the functional gene product without using a polynucleotide modified template. The disrupted gene comprises a base pair deletion of the fourth nucleotide upstream (5') of the PAM sequence relative to the non-disrupted gene, and the base pair deletion renders the gene product of the disrupted gene non-functional by generating an amino acid frame shift in the gene product of the disrupted gene. The base pair deletion may be the first, second, or third nucleotide of the codon sequence. Restoration can be achieved by non-homologous end junction (NHEJ) inserting a single base at the double-strand break site, or by inserting a single base at the double-strand break site without using homologous recombination or homology-induced repair.

[0065] Modification of other targets can be achieved by simultaneously adding another guide-polynucleotide while restoring gene function by NHEJ (e.g., by delivering the RGEN component or the RGEN complex itself to the cell). (In addition to the target for restoring gene function by NHEJ) these other targets can be any target within the genome, including the gene transfer locus. If one gRNA targets and activates a selection marker via NHEJ (e.g., conferring herbicide resistance, but not limited to this), and other gRNA(s) can facilitate targeted mutagenesis, deletion, gene editing, or site-specific phenotypic gene insertion and promote DSB(s) at the selection marker and other target sites, a simultaneous delivery approach of two or more gRNAs can enable completely transient targeted genome modifications because all other necessary components (Cas9, gRNA) can be delivered in the form of proteins and / or in vitro transcribed RNA molecules.

[0066] The term "destructed gene" includes references to modified (destructed) marker genes (e.g., but not limited to, phenotypic marker genes and selection marker genes) such that the gene product loses its function (e.g., in the case of herbicide destruction selection marker genes, the destroyed gene no longer confers herbicide resistance).

[0067] The terms "selection marker" or "selection marker" are used interchangeably herein and often refer to a DNA segment (e.g., a selection marker gene) that, under certain conditions, enables the identification of a molecule or cell containing it, the selection of such molecule or cell, or selection for such molecule or cell. These markers may encode an activity, e.g., the production of RNA, peptide, or protein (but not limited thereto), or may provide a binding site for RNA, peptide, protein, inorganic and organic compounds or compositions, etc. A selection marker further comprises a gene that, when the gene is modified or knocked out, generates an attribute in a cell, thereby enabling the identification of a cell containing such attribute or selection for such cell (or for such cell).

[0068] In one embodiment, the selection of cells is made possible by applying a selection design in which a selective agent (e.g., antibiotics or herbicides, but not limited thereto) is used to inhibit or kill cells or tissues that do not contain the selection marker, and cells or tissues containing the selection marker gene continue to grow due to the expression of the selection marker gene.

[0069] In one embodiment, the selection marker enables the visual selection of cells by applying a selection design in which a visual marker (e.g., a fluorescent molecule) is used to select cells containing a visual marker, for example.

[0070] Selection marker genes include DNA segments containing chlorsulfuron resistance genes, phosphomannose isomerase genes (PMI), non-alphaphos resistance genes (BAR), phosphinothricin acetyltransferase (PAT) genes, hygromycin resistance genes (NPTII), glyphosate resistance genes, and restriction enzyme sites; DNA segments encoding products that confer resistance to toxic compounds, including antibiotics such as spectinomycin, ampicillin, kanamycin, tetracycline, VASTA, neomycin phosphotransferase II (NEO), and hygromycin phosphotransferase (HPT); and DNA segments encoding products deficient in recipient cells (e.g., tRNA genes, trophication markers); DNA segments encoding products that can be easily identified (referred to as visual marker genes; visual marker genes include references to fluorescent marker genes, e.g., red fluorescent marker genes, blue fluorescent marker genes, green fluorescent marker genes, yellow fluorescent marker genes), genes encoding DsRED, RFP, red fluorescent protein, CFP, GFP, green fluorescent protein, and phenotypic markers such as β-galactosidase, GUS; genes encoding fluorescent proteins such as green fluorescent protein (GFP), cyan (CFP), yellow (YFP), red (RFP), and cell surface proteins, but are not limited thereto. Selection marker genes further include the creation of new primer sites for PCR (e.g., juxtaposition of two DNA sequences that were not previously placed side by side), the inclusion of DNA sequences that are not or are affected by restriction endonucleases or other DNA modifying enzymes, chemicals, etc., and the inclusion of DNA sequences required for specific modifications (e.g., methylation) that enable identification.

[0071] Additional selection markers include genes conferring resistance to herbicide compounds, e.g., glufosinate ammonium, bromoxinyl, imidazolinone, and 2,4-dichlorophenoxyacetate (2,4-D). For example, Yarranton, (1992) Curr Opin Biotech 3:506-11; Christopherson et al., (1992) Proc. Natl. Acad. Sci. USA 89:6314-8; Yao et al., (1992) Cell 71:63-72; Reznikoff, (1992) Mol Microbiol 6:2419-22; Hu et al., (1987) Cell 48:555-66; Brown et al., (1987) Cell 49:603-12; Figge et al., (1988) Cell 52:713-22; Deuschle et al., (1989) Proc. Natl. Acad. Sci. USA 86:5400-4; Fuerst et al., (1989) Proc. Natl. Acad. Sci. USA 86:2549-53; Deuschle et al., (1990) Science 248:480-3; Gossen, (1993) Ph.D. Thesis, University of Heidelberg; Reines et al., (1993) Proc. Natl. Acad. Sci. USA 90:1917-21; Labow et al., (1990) Mol Cell Biol 10:3343-56; Zambretti et al., (1992) Proc. Natl. Acad. Sci. USA 89:3952-6; Baim et al., (1991) Proc. Natl. Acad. Sci. USA 88:5072-6; Wyborski et al., (1991) Nucleic Acids Res 19:4647-53; Hillen and Wissman, (1989) Topics Mol Struc Biol 10:143-62; Degenkolb et al., (1991) Antimicrob Agents Chemother 35:1591-5; Kleinschnidt et al., (1988) Biochemistry 27:1094-104; Bonin, (1993) Ph.D. Thesis, University of Heidelberg; Gossen et al., (1992) Proc. Natl. Acad. Sci. USA 89:5547-51; Oliva et al., (1992) Antimicrob Agents Chemother 36:913-9; Hlavka et al., (1985) Handbook of Experimental Pharmacology, Vol. 78 (Springer-Verlag, Berlin); See Gill et al., (1988) Nature 334:721-4.

[0072] Phenotype marker genes include genes encoding screening or selection markers, including visual markers, whether positive or negative selection markers. Any phenotypic marker may be used.

[0073] As described herein, phenotype and selection marker genes can be modified to be introduced into plant cells as disrupted genes encoding non-functional gene products, and can be used as targets by double-strand breaks that induce endonucleases to restore them to non-disrupted genes encoding functional gene products through the introduction of guide RNA and DNA repair.

[0074] The phenotype or selection marker gene to be destroyed may be a marker gene that has previously been introduced into a cell and stably integrated into the cell's genome. Such pre-integrated selection marker genes may be supplemented by other genes, for example, cell growth enhancement genes (e.g., ZmODP2 and ZmWUS, e.g., PCT / US16 / 49144 filed August 26, 2016 and PCT / US16 / 49128 filed August 26, 2016, incorporated herein by reference).

[0075] As described herein, phenotype and selection marker genes can be modified to be introduced into plant cells as disrupted genes (inactive forms) and can be used as targets by double-strand breaks that introduce endonucleases for restoration (reactivation) by guide RNA introduction and repair.

[0076] Expression marker genes (e.g., but not limited to ALS, EPSPS, BAR) that can confer resistance to a compound or allow endogenous or previously integrated marker genes or their gene products to be used as markers are described herein, and these can be modified into an inactive form as described herein and then used as targets for reactivation by introduction and repair of guide RNA.

[0077] In one embodiment of the present invention, the method comprises the steps of: introducing a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using a polynucleotide modification template, and the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and selecting a cell having the modification of the nucleotide sequence by or based thereon with the functional selection marker protein. Selection may include providing a chemical to cells (e.g., plant cells, or plants derived from said plant cells) expressing the functional selection marker protein, wherein the functional selection marker protein causes the cells (e.g., plant cells, or plants derived from said plant cells) to be resistant to said chemical. To select cells or organisms containing a desired modification within the genome, the chemical may be provided during any stage of cell development (in the case of plant cells, during any stage of development of the plant cell or plant). Additionally, selection includes screening of cells (e.g., plant cells, or plants derived from said plant cells) for the presence of a visual marker derived from the expression of the functional selection marker protein.

[0078] For example, as described herein, the method is a method for modifying a nucleotide sequence within the genome of a cell, comprising the steps of introducing a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a disrupted resistant ALS marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the disrupted resistant ALS marker gene, and the disrupted resistant ALS marker gene is restored to a non-disrupted resistant ALS marker gene capable of encoding a functional resistant ALS protein conferring resistance to chlorsulfuron without using a polynucleotide modification template, and the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; The method may include the step of selecting cells having a modification of the above nucleotide sequence by or based on the resistance ALS protein that confers resistance to chlorsulfuron. To select a plant cell or plant containing a desired modification within the genome, the selection step may include the step of providing chlorsulfuron to the plant cell or the plant derived from the plant cell at any stage of development of the plant cell or the plant.

[0079] The introduction and selection steps do not involve the introduction of a selection marker gene, such as a recombinant DNA construct containing a selection marker gene. The disrupted selection marker gene may be any disrupted marker gene, including a disrupted visual marker gene. The modification of the target nucleotide sequence may be selected from the group consisting of the insertion of at least one nucleotide, the deletion of at least one nucleotide, or the substitution of at least one nucleotide at the target site. The method may further include the step of introducing a polynucleotide modification template or donor DNA into the cell, wherein the polynucleotide modification template comprises at least one nucleotide modification of the nucleotide sequence, and the donor DNA comprises at least one polynucleotide of interest to be inserted into the target site.

[0080] Any inducible endonuclease may be used in the method disclosed herein. Such endonucleases include, but are not limited to, Cas and Cpf1 endonucleases. Many endonucleases have been described so far that can recognize specific PAM sequences (e.g., see U.S. Patent Application 62 / 162377 filed May 15, 2015 and 62 / 162353 filed May 15, 2015 and Zetsche B et al. 2015. Cell 163, 1013) and cleave target DNA at specific sites. Based on the methods and embodiments described herein utilizing an inducible Cas system, it is understood that these methods can now be adapted to utilize any inducible endonuclease system. For example, the method for restoring the function of non-functional gene products within the genome of a cell described herein can be envisioned to be applied to a method comprising the steps of restoring a disrupted gene and generating a functional gene product by introducing an inductive Cpf1 endonuclease complex instead of an inductive Cas endonuclease complex. Other inductive endonucleases and nucleotide-protein complexes used in the method disclosed herein include those described in WO 2013 / 088446.

[0081] Endonucleases are enzymes that cleave phosphodiester bonds within polynucleotide chains and include restriction endonucleases that cleave DNA at specific sites without damaging bases. Restriction endonucleases include Type I, Type II, Type III, and Type IV endonucleases, which further include subtypes. In Type I and Type III systems, both methylase activity and restriction activity are contained in a single complex. Endonucleases also include meganucleases, also known as homing endonucleases (HEases), which bind to and cleave at specific recognition sites like restriction endonucleases, but the recognition sites for meganucleases are generally longer, typically about 18 bp or longer (Patent application WO-PCT PCT / US12 / 30061 filed March 22, 2012). Meganucleases have been classified into four families based on conserved sequence motifs: the LAGLIDADG, GIY-YIG, HNH, and His-Cys box families. These motifs are involved in the coordination of metal ions and the hydrolysis of phosphodiester bonds. HEases are known for their long recognition sites and resistance to certain sequence polymorphisms in DNA substrates. The naming conventions for meganucleases are similar to those for other restriction endonucleases. Meganucleases are also characterized by the prefixes F-, I-, or PI- for enzymes encoded by a standalone ORF, intron, and entain, respectively. One step in the recombination process involves the cleavage of a polynucleotide at or near the recognition site. This cleavage activity can be utilized to generate double-strand breaks. For a review of site-specific recombinases and their recognition sites, see Sauer (1994) Curr Op Biotechnol 5:521-7; and see Sadowski (1993) FASEB 7:760-7. In some examples, recombinases belong to the integrase or resorbase family.

[0082] TAL effector nucleases are a new class of sequence-specific nucleases that can be used to create double-strand breaks at specific target sequences within the genomes of plants or other organisms (Miller et al. (2011) Nature Biotechnology 29:143-148). Zinc finger nucleases (ZFNs) are genetically engineered double-strand break inducers composed of a zinc finger DNA binding domain and a double-strand break inducer domain. Recognition site specificity is conferred by the zinc finger domain, which typically contains two, three, or four zinc fingers and has, for example, a C2H2 structure, but other zinc finger structures are known and genetically engineered. The zinc finger domain can design polypeptides that specifically bind to selected polynucleotide recognition sequences. ZFNs include a genetically engineered DNA-binding zinc finger domain linked to a nuclease domain from a non-specific endonuclease domain, for example, a type II endonuclease such as FokI. Additional functions, including transcription activator domains, transcription repressor domains, and methylases, may be fused to the zinc finger binding domain. In some cases, dimerization of the nuclease domain is required for cleavage activity. Each zinc finger recognizes three consecutive base pairs in target DNA. For example, under the nuclease dimerization requirement, the 3-finger domain recognizes a sequence of nine consecutive nucleotides, and two sets of zinc finger triplets are used to combine an 18-nucleotide recognition sequence.

[0083] DNA double-strand break (DSB) technologies (ZFN, TALEN, and CRISPR-Cas) are widely applied in academic research, gene therapy, and animal and plant breeding programs. These technologies have been successfully used to introduce genomic modifications in various plant species, including major crops such as maize, wheat, soybeans, and rice. Plant genome editing is limited by current transformation and modification methods, DNA delivery efficiency, and low plant regeneration rates. Unlike human and animal systems, the presence of thick walls surrounding all plant cells fundamentally impacts plant transformation and genetic modification protocols. These cell walls prevent the use of transfection or electroporation, which are widely used for nucleic acid and / or protein delivery in mammalian genome editing experiments. For this reason, plant transformation and genetic modification rely primarily on Agrobacterium-mediated delivery and biolial delivery (ballistic delivery) of guide RNA / Cas endonuclease reagents on DNA vectors. As a result, gRNA and Cas9 expression cassettes are often incorporated into the genome, potentially leading to gene disruption, plant mosaicism, and potential out-of-site cleavage. These unwanted secondary changes can be isolated by several backcrossings of wild-type parent plants, but this process can be time-consuming, particularly for crops with complex polyploid genomes and long reproductive cycles, such as soybeans and wheat, though not limited to these. As described herein, delivering Cas endonuclease and gRNA into plant cells in the form of an RGEN complex can significantly mitigate these side effects (Examples 11 to 12). Unexpectedly high frequency NHEJ-mediated mutagenesis promoted by the delivery of the RGEN complex in plants is described in Example 10.Given the high frequency of mutagenesis using RGEN complexes, DNA-free and selection marker-free gene modification can be a practical approach for generating gene knockouts. However, due to the low frequency HDR pathway in plant somatic cells, these DNA-free and selection marker-free approaches may be less practical for gene editing and insertion (compared to gene mutations induced by NHEJ). Furthermore, DNA molecules often integrate into target DSB sites, reducing the efficiency of gene editing, particularly gene insertion. DNA vectors encoding genes delivered into plant cells (e.g., Cas9, gRNA, selection marker genes, and trait genes) tend to co-integrate into the same DSB site, which has been shown to drastically reduce the frequency of available events with site-specific trait gene insertion. Restricting the delivery DNA molecule to donor DNA (e.g., trait genes with homologous cancer) can increase the probability of events with a desired genotype. Therefore, the concept described herein of a disrupted (inactive) endogenous or pre-integrated selection marker gene that can be activated upon RGEN delivery can make DNA-free and selection marker-free approaches for gene editing and gene insertion very practical.

[0084] Guide polynucleotides may be introduced directly into cells as single-stranded or double-stranded polynucleotides by any method known in the art, e.g., but not limited to, a gene gun, whisker-mediated transformation, Agrobacterium transformation, or local treatment methods. Guide RNA may also be introduced indirectly into cells by introducing (but not limited to, via methods such as a gene gun or Agrobacterium transformation) a recombinant DNA molecule containing a heterologous nucleic acid fragment encoding guide RNA, which is operably linked to a specific promoter capable of transcribing guide RNA in the cell. The specific promoter may be, but is not limited to, an RNA polymerase III promoter that enables the transcription of RNA having precisely defined, unmodified 5'-terminus and 3'-terminus (DiCarlo et al., Nucleic Acids Res. 41: 4336-4343; Ma et al., Mol. Ther. Nucleic Acids 3:e161). As described herein, direct delivery of sgRNA into plant cells can be achieved through particle-mediated delivery. Based on the experiments described herein, those skilled in the art may now envision that any other direct delivery method, such as but not limited to polyethylene glycol (PEG)-mediated transfection into protoplasts, whisker-mediated transformation, electroporation, gene gun, cell-penetrating peptide, or mesoporous silica nanoparticle (MSN)-mediated direct protein delivery, can be successfully utilized to deliver gRNA into plant cells.

[0085] Guide polynucleotides can be produced by any method known in the art, including the chemical synthesis of guide polynucleotides (e.g., but not limited to Hendel et al. 2015, Nature Biotechnology 33, 985-989), guide polynucleotides produced in vitro, and / or self-splicing guide RNA (e.g., but not limited to Xie et al. 2015, PNAS 112:3570-3575).

[0086] The terms “target site,” “target sequence,” “target site sequence,” “target DNA,” “target locus,” “genome target site,” “genome target sequence,” “genome target locus,” and “protospacer” are used interchangeably herein and refer to a polynucleotide sequence within the cell genome that a guide polynucleotide / Cas endonuclease complex can recognize, bind to, and selectively nick or cleave, such as, but not limited to, a chromosome, an episome, a transfer locus, or any other DNA molecule (including chromosomal DNA, chloroplast DNA, mitochondrial DNA, and plasmid DNA). The target site may be an endogenous site within the cell genome, or alternatively, the target site may be heterogeneous to the cell and may not occur naturally in the cell genome, or the target site may be found at a heterogeneous genomic location compared to where it occurs naturally. As used herein, the terms “endogenous target sequence” and “inherent target sequence” are used interchangeably to refer to a target sequence that is endogenous or intrinsic to the cell genome, specifically a target sequence located at an endogenous or intrinsic position within the cell genome. Cells include, but are not limited to, cells of humans, non-humans, animals, bacteria, fungi, insects, yeasts, non-conventional yeasts, and plants, as well as plants and seeds produced by the methods described herein. “Artificial target site” or “artificial target sequence” are used interchangeably herein to refer to a target sequence introduced into the cell genome. Such artificial target sequence may be identical to the endogenous or intrinsic target sequence within the cell genome, but may be located at a different position within the cell genome (i.e., a non-endogenous or non-inherent position).

[0087] “Changed target site,” “Changed target sequence,” “Modified target site,” and “Modified target sequence” are used interchangeably herein and refer to a target sequence as disclosed herein comprising at least one change compared to an unchanged target sequence. Such “change” includes, for example, (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, or (iv) any combination of (i) to (iii).

[0088] The length of the target DNA sequence (target site) may vary and, for example, include a target site of at least 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 nucleotides. The target site may be palindromic; that is, a sequence on one strand is deciphered identically in the opposite direction on the complementary strand. The nick / cleavage site may be located within the target sequence or the nick / cleavage site may be located outside the target sequence. In other variations, the cleavage may occur at nucleotide positions directly opposite each other to produce a blunt end cut, or, in other cases, the cleavage may be skewed to produce a single-strand overhang, also called a "sticky end," which may be a 5' overhang or a 3' overhang. An active variant of a genomic target site may be used. Such active variants may possess at least 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more of sequence identity with a given target site, and the active variants may be recognized and cleaved by Cas endonucleases by possessing biological activity. Analytical methods for measuring single or double-strand breaks of a target site by endonucleases are known in the art and generally measure the total activity and specificity of the agent on a DNA substrate containing the recognition site.

[0089] The "protospacer adjacent motif (PAM)" of the present invention refers to a short nucleotide sequence adjacent to a target sequence (protospacer) recognized (targeted) by the guide polynucleotide / Cas endonuclease system described herein. If there is no PAM sequence following the target DNA sequence, the Cas endonuclease may not successfully recognize the target DNA sequence. The sequence and length of the PAM of the present invention may vary depending on the Cas protein or Cas protein complex used. The PAM sequence may be of any length, but is generally 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 nucleotides long.

[0090] The terms "targeting," "gene targeting," and "DNA targeting" are used interchangeably herein. DNA targeting herein may be the specific introduction of a knockout, edit, or knockin into a specific DNA sequence, such as in a cell's chromosome or plasmid. Generally, DNA targeting may be performed herein by cleaving one or two strands of a specific DNA sequence in a cell, where the Cas protein is combined with a suitable polynucleotide component. Such DNA cleaving may induce NHEJ or HDR processes, which can result in modifications at the target site in the case of a double-strand break (DSB).

[0091] The terms “knockout,” “gene knockout,” and “genetic knockout” are used interchangeably herein. A knockout refers to a DNA sequence of a cell that has become partially or completely inactive by targeting with a Cas protein, and prior to the knockout, such DNA sequence may have been able to encode, for example, an amino acid sequence or possessed a regulatory function (e.g., a promoter). A knockout may be produced by insertion-deletion (insertion or deletion of nucleotide bases in a target DNA sequence via an NHEJ) or by specific removal of a sequence that reduces or completely destroys the function of the sequence at or near the targeting site.

[0092] A guide polynucleotide / Cas endonuclease system is used in combination with a co-delivered polynucleotide modification template to enable editing (modification) of a genomic nucleotide sequence of interest (see also U.S. Patent Application US 2015-0082478 A1 published March 19, 2015, and WO2015 / 026886 A1 published February 26, 2015, the entirety of which is incorporated herein by reference).

[0093] "Modified nucleotide" or "edited nucleotide" refers to a nucleotide sequence of interest comprising at least one change compared to an unmodified nucleotide sequence. Such "changes" include, for example, (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, or (iv) any combination of (i) to (iii).

[0094] The term "polynucleotide modified template" comprises a polynucleotide containing at least one nucleotide modification relative to the nucleotide sequence to be edited. The nucleotide modification may be at least one nucleotide substitution, addition, or deletion. Optionally, the polynucleotide modified template may further comprise a homologous nucleotide sequence flanked to at least one nucleotide modification, and the flanked homologous nucleotide sequence provides sufficient homology to the desired nucleotide sequence to be edited.

[0095] Polynucleotide modified templates can be introduced into cells by any method known in the art, such as, but not limited to, transient introduction methods, transfection, electroporation, microinjection, particle-mediated delivery, topical treatment methods, whisker-mediated delivery, delivery via cell-penetrating peptides, or direct delivery via mesoporous silica nanoparticles (MSNs).

[0096] Polynucleotide modified templates can be introduced into cells as single-stranded polynucleotide molecules, double-stranded polynucleotide molecules, or as part of circular DNA (vector DNA). Polynucleotide modified templates can also be tethered to guide RNA and / or Cas endonucleases. Tethered DNA can enable the co-localization of target and template DNA, which is useful for genome editing and targeted genome regulation, and may also be useful for targeting post-mitotic cells where the function of the endogenous HR mechanism is expected to be significantly weakened (Mali et al. 2013 Nature Methods Vol. 10: 957-963). Polynucleotide modified templates can be transiently present in cells or introduced via viral replicons.

[0097] The nucleotide to be edited may be located within or outside the target site recognized and cleaved by Cas endonuclease. In one embodiment, at least one nucleotide modification is not a modification at the target site recognized and cleaved by Cas endonuclease. In another embodiment, there are at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 30, 40, 50, 100, 200, 300, 400, 500, 600, 700, 900, or 1000 nucleotides between the at least one nucleotide to be edited and the genomic target site.

[0098] Genome editing can be performed using any available gene editing method. For example, gene editing can be performed by introducing a polynucleotide modification template (sometimes called a gene repair oligonucleotide) containing a modification targeted to a gene within the host cell's genome into the host cell. The polynucleotide modification template for use in this method may be single-stranded or double-stranded. Examples of such methods are generally described, for example, in US Publication 2013 / 0019349.

[0099] In one embodiment of the present invention, the method comprises the steps of: introducing at least one polynucleotide modification template, a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using the polynucleotide modification template, wherein the polynucleotide modification template comprises at least one nucleotide modification of the nucleotide sequence, and wherein the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and selecting a cell having the modification of the nucleotide sequence by the functional selection marker protein. The introduction and selection steps do not involve the introduction of a selection marker gene, such as a recombinant DNA construct containing the selection marker gene. The disrupted selection marker gene may be any disrupted marker gene, including a disrupted visual marker gene.

[0100] Based on the experiments described herein, those skilled in the art can now envision that any other direct delivery method, such as but not limited to polyethylene glycol (PEG)-mediated transfection into protoplasts, whisker-mediated transformation, electroporation, gene gun, cell-penetrating peptide, or mesoporous silica nanoparticle (MSN)-mediated direct protein delivery, can be successfully used to deliver polynucleotide modified templates in plant cells.

[0101] In some embodiments, gene editing may be facilitated by inducing a double-strand break (DSB) at a defined location within the genome close to the desired alteration. The DSB may be induced using any available DSB inducer, including, but not limited to, TALEN, meganuclease, zinc finger nuclease, nucleic acid-induced-endonuclease systems, e.g., Cas9-gRNA systems (based on the bacterial CRISPR-Cas system), etc. In some embodiments, the introduction of the DSB may be combined with the introduction of a polynucleotide modification template.

[0102] A genome sequence editing method combining a DSB and a modification template generally comprises the step of introducing into a host cell a DSB inducer capable of recognizing a target sequence within a chromosomal sequence and inducing a DSB in the genomic sequence, or a nucleic acid encoding the DSB inducer, and at least one polynucleotide modification template comprising at least one nucleotide change relative to the nucleotide sequence to be edited. The polynucleotide modification template may further comprise a nucleotide sequence flanked to the at least one nucleotide change, and the flanked sequence is substantially homologous to the chromosomal region flanked to the DSB. Genome editing using DSB inducers such as Cas9-gRNA complexes is described, for example, in U.S. patent application US 2015-0082478 A1 published March 19, 2015; WO2015 / 026886 A1 published February 26, 2015; U.S. application 62 / 023246 filed July 7, 2014; and U.S. application 62 / 036,652 filed August 13, 2014, all of which are incorporated herein by reference.

[0103] A method for editing nucleotide sequences within the genome of a cell without using a polynucleotide modified template is described herein.

[0104] Gene editing that modifies a target sequence or a nucleotide of interest near the target sequence using an inducible Cas endonuclease system and a polynucleotide modification template relies on homologous recombination / homologous induced repair (HDR) mechanisms, which occur at a lower frequency in plant cells compared to the frequency of non-homologous end junctions (NHEJ). It would be desirable to increase the frequency of gene editing without relying on HDR-type mechanisms. As a method that enables gene editing without using a polynucleotide modification template by relying on the restoration of a destroyed gene, the restoration is achieved by a non-homologous end junction (NHEJ) that inserts at least a single base into a double-strand break site, or by inserting at least a single base into a double-strand break site without using homologous recombination or homologous induced repair.

[0105] In one embodiment of the present invention, the method comprises a method for editing a nucleotide sequence within the genome of a cell without using a polynucleotide modified template, the method comprising: a) introducing at least one guide RNA and at least one Cas endonuclease into at least one cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence; b) selecting from (a) a cell having at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; and c) introducing at least one guide RNA and at least one Cas endonuclease into the cell of (b), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence and can insert a single nucleotide at the same position as the nucleotide deletion of (b) without using a polynucleotide modified template.

[0106] In one embodiment of the present invention, the method is a method for editing a nucleotide sequence within a plant genome without using a polynucleotide modified template or donor DNA, comprising: a) introducing at least one guide RNA and at least one Cas endonuclease into at least one plant cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence; b) selecting from (a) a plant cell comprising at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; c) regenerating a plant from the plant cell of (b); and d) introducing at least one guide RNA and at least one Cas endonuclease into a cell from the plant of (c), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence and inserting a single nucleotide at the same position as the nucleotide deletion of (b) without using a polynucleotide modified template. and e) optimally, a method comprising the step of selecting a cell containing the nucleotide insertion of (d).

[0107] The terms "knock-in," "gene knock-in," "genetic insertion," and "genetic knock-in" are used interchangeably herein. A knock-in refers to the substitution or insertion of a DNA sequence in a specific DNA sequence of a cell by targeting it with a Cas protein (by HR, where an appropriate donor DNA polynucleotide is also used). Examples of knock-ins are the specific insertion of a heterologous amino acid-coding sequence into the coding region of a gene, or the specific insertion of a transcriptional regulatory element into a locus.

[0108] Various methods and compositions may be used to obtain cells or organisms having a polynucleotide of interest that inserts into a target site for Cas endonuclease. These methods may provide the incorporation of the polynucleotide of interest at the target site using homologous recombination. In one method provided, the polynucleotide of interest is provided to the biological cell as a donor DNA construct.

[0109] As used herein, “donor DNA” refers to a DNA construct comprising a polynucleotide of interest to be inserted into a target site of a Cas endonuclease. The donor DNA construct may further comprise a first homologous region and a second homologous region flanked to the polynucleotide of interest. The first homologous region and the second homologous region of the donor DNA share homology with the first genomic region and the second genomic region, respectively, that are present at or flanked therein to the target site of the cell or biological genome. The donor DNA may be tethered to a guide polynucleotide and / or a Cas endonuclease. The tethered donor DNA may enable co-localization of the target and donor DNA, which is useful for genome editing and targeted genome regulation, and may also be useful for targeting postmitotic cells where the function of the endogenous HR mechanism is expected to be significantly weakened (Mali et al. 2013 Nature Methods Vol. 10 : 957-963).

[0110] "Homology" refers to similar DNA sequences. For example, a "homologous region to a genomic region" found in donor DNA is a DNA region that has a sequence similar to a given "genomic region" of a cell or biological genome. The homologous region can be of any length sufficient to facilitate homologous recombination at the truncated target site. For example, so that the homologous region has sufficient homology to undergo homologous recombination with the corresponding genomic region, the homologous region is at least 5~10, 5~15, 5~20, 5~25, 5~30, 5~35, 5~40, 5~45, 5~50, 5~55, 5~60, 5~65, 5~70, 5~75, 5~80, 5~85, 5~90, 5~95, 5~100, 5~200, 5~300, 5~400, 5~500, 5~600, 5~700, 5~800, 5~900, 5~1000, 5~1100, 5~1200, 5~1300, 5~1400, Lengths of 5–1500, 5–1600, 5–1700, 5–1800, 5–1900, 5–2000, 5–2100, 5–2200, 5–2300, 5–2400, 5–2500, 5–2600, 5–2700, 5–2800, 5–2900, 5–3000, 5–3100 or more bases may be included. “Sufficient homology” indicates that two polynucleotide sequences have sufficient structural similarity to act as substrates for a homologous recombination reaction. Structural similarity includes the sequence similarity of the polynucleotides as well as the total length of each polynucleotide fragment. Sequence similarity can be described by percentage sequence identity over the entire length of the sequence, and / or by conserved regions containing local similarities such as consecutive nucleotides having 100% sequence identity, and percentage sequence identity over a portion of the length of the sequence.

[0111] The amount of homology or sequence identity shared by the target and donor polynucleotides may vary and is approximately 1–20 bp, 20–50 bp, 50–100 bp, 75–150 bp, 100–250 bp, 150–300 bp, 200–400 bp, 250–500 bp, 300–600 bp, 350–750 bp, 400–800 bp, 450–900 bp, 500–1000 bp, 600–1250 bp, 700–1500 bp, 800–1750 bp, 900–2000 bp, 1–2.5 kb, 1.5–3 kb, 2–4 kb, 2.5–5 kb, It includes a total length and / or region having unit integral values ​​in a range including 3 to 6 kb, 3.5 to 7 kb, 4 to 8 kb, 5 to 10 kb, or up to the entire length of the target area. This range includes all integers within the range, for example, the range 1 to 20 bp includes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20 bp. The amount of homology may be described by percentage sequence identity over the entire alignment length of the two polynucleotides, which includes at least 50%, 55%, 60%, 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% percentage sequence identity. Sufficient homology includes any combination of polynucleotide length, total percentage sequence identity, and optionally, a conserved region of consecutive nucleotides or a local percentage sequence identity, for example, sufficient homology can be described as a region of 75 to 150 bp having at least 80% sequence identity with a region of the target locus.Sufficient homology may also be explained by the prediction of the specific hybridization ability of two polynucleotides under very strict conditions (e.g., Sambrook. et al. , (1989) Molecular Cloning: A Laboratory Manual , (Cold Spring Harbor Laboratory Press, NY); Current Protocols in Molecular Biology Ausubel et al. , Eds (1994) Current Protocols, (Greene Publishing Associates, Inc. and John Wiley & Sons, Inc.); and Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology--Hybridization with Nucleic Acid Probes , (see Elsevier, New York).

[0112] The term "genome region" as used herein is a segment of a chromosome within a cell genome that exists on one side of a target site or, alternatively, includes part of the target site. To ensure that a genomic region has sufficient homology to undergo homologous recombination with its corresponding homologous region, the genomic region is at least 5~10, 5~15, 5~20, 5~25, 5~30, 5~35, 5~40, 5~45, 5~50, 5~55, 5~60, 5~65, 5~70, 5~75, 5~80, 5~85, 5~90, 5~95, 5~100, 5~200, 5~300, 5~400, 5~500, 5~600, 5~700, 5~800, 5~900, 5~1000, 5~1100, 5~1200, 5~1300, 5~1400, 5~1500, It may include bases of 5~1600, 5~1700, 5~1800, 5~1900, 5~2000, 5~2100, 5~2200, 5~2300, 5~2400, 5~2500, 5~2600, 5~2700, 5~2800, 5~2900, 5~3000, 5~3100 or more.

[0113] The polynucleotide of interest and / or traits may be stacked together at a complex trait locus as described in US-2013-0263324-A1 published October 3, 2013 and PCT / US13 / 22891 published January 24, 2013, which are incorporated herein by reference. The guide polynucleotide / Cas9 endonuclease system described herein provides an efficient system for generating double-strand breaks and can enable the traits to be stacked at a complex trait locus.

[0114] A guide polynucleotide / Cas endonuclease system may be used to introduce one or more polynucleotides of interest or one or more traits of interest to one or more target sites by introducing one or more guide polynucleotides, one Cas endonuclease, and optionally one or more donor DNA into a plant cell (as described in U.S. Patent Application US-2015-0082478-A1 published March 19, 2015, incorporated herein by reference). A fertile plant may be produced from a plant cell comprising a modification at one or more target sites, the modification being selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, and (iv) any combination of (i) to (iii). Plants containing such modified target sites may further accumulate traits at said complex trait loci by crossing them with plants containing at least one gene or trait of interest at the same complex trait locus (see also US-2013-0263324-A1 published October 3, 2013 and PCT / US13 / 22891 published January 24, 2013, incorporated herein by reference).

[0115] Structural similarity between a given genomic region and a corresponding homologous region found in donor DNA can be any degree of sequence identity that allows homologous recombination to occur. For example, the amount of homology or sequence identity shared by the "homologous region" of donor DNA and the "genomic region" of the biological genome can have at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity for the sequence to undergo homologous recombination.

[0116] Homologous regions on the donor DNA may have homology with any sequence flanked at the target site. In some embodiments, homologous regions share substantial sequence homology with the genomic sequence immediately adjacent to the target site, but it is acknowledged that homologous regions may be designed to have sufficient homology to a region that may additionally be 5' or 3' at the target site. In another embodiment, homologous regions may have homology with a fragment of the target site together with a downstream genomic region. In one embodiment, the first homologous region further comprises a first fragment of the target site, and the second homologous region comprises a second fragment of the target site, and the first fragment and the second fragment are different.

[0117] When a double-strand break is induced in DNA, the cell's DNA repair mechanisms are activated to repair the break. The non-homologous end ligation (NHEJ) pathway is the most common repair mechanism for merging break ends (Bleuyard et al., (2006) DNA Repair 5:1-12). While the structural integrity of chromosomes is generally preserved by repair, deletions, insertions, or other rearrangements may occur. Although the two ends of a single double-strand break are the most common substrate for NHEJ (Kirik et al., (2000) EMBO J 19:5562-6), if two different double-strand breaks occur, the free ends of the different breaks may ligate, leading to chromosomal deletions (Siebert and Puchta, (2002) Plant Cell 14:1121-31) or chromosomal translocations between different chromosomes (Pacher et al., (2007) Genetics 175:21-9). Error-prone DNA repair mechanisms can cause mutations at double-strand break sites. The non-homologous end junction (NHEJ) pathway is the most common repair mechanism for merging break ends (Bleuyard et al., (2006) DNA Repair 5:1-12).

[0118] Alternatively, double-strand breaks can be repaired by homologous recombination (HR) between homologous DNA sequences. For example, once the sequence surrounding the double-strand break is altered by exonuclease activity associated with the maturation of the double-strand break, a gene conversion pathway can restore the original structure if homologous sequences, such as homologous chromosomes in non-dividing somatic cells or sister chromatids after DNA replication, are available (Molinier et al., (2004) Plant Cell 16:342-52). Ectopic and / or epigenetic DNA sequences may also serve as DNA repair templates for homologous recombination (Puchta, (1999) Genetics 152:1173-81). Episomal DNA molecules may also be linked to double-strand breaks (e.g., integration of T-DNA into chromosomal double-strand breaks) (Chilton and Que, (2003) Plant Physiol 133:956-65; Salomon and Puchta, (1998) EMBO J 17:6086-95).

[0119] As used herein, "homologous recombination (HR)" refers to the exchange of DNA fragments between two DNA molecules at homologous sites. The frequency of homologous recombination is influenced by several factors. Different organisms differ in the amount of homologous recombination and the relative ratio of homologous to non-homologous recombination. In general, the length of the homologous region affects the frequency of homologous recombination events: the longer the homologous region, the higher the frequency. The length of the homologous region required to observe homologous recombination also varies by species. In many cases, at least 5 kb of homology has been utilized, but homologous recombination has been observed with as little homology as 25–50 bp. For example, Singer et al., (1982) Cell 31:25–33; Shen and Huang, (1986) Genetics 112:441–57; Watt et al., (1985) Proc. Natl. Acad. Sci. USA 82:4768-72, Sugawara and Haber, (1992) Mol Cell Biol 12:563-75, Rubnitz and Subramani, (1984) Mol Cell Biol 4:2253-8; Ayares et al., (1986) Proc. Natl. Acad. Sci. USA 83:5199-203; See Liskay et al., (1987) Genetics 115:161-7.

[0120] Homology-directed repair (HDR) is a cellular mechanism for repairing double-stranded and single-stranded DNA breaks. Homology-directed repair includes homologous recombination (HR) and single-strand annealing (SSA) (Lieber. 2010 Annu. Rev. Biochem. 79:181-211). The most common form of HDR is called homologous recombination (HR), which requires the longest sequence homology between the donor DNA and the recipient DNA. Other forms of HDR include single-strand annealing (SSA) and break-induced duplication, which require shorter sequence homology compared to HR. Homology-directed repair in nicks (single-strand breaks) can occur through mechanisms distinct from HDR in double-stranded breaks (Davis and Maizels. PNAS (0027-8424), 111 (10), p. E924-E932).

[0121] For example, altering the plant cell genome through homology-induced repair (HDR) is a powerful tool for genetic engineering. Although the frequency of homologous recombination in higher plants is low, there are several examples of successful homologous recombination of plant endogenous genes. Parameters for homologous recombination in plants were primarily investigated by constructing introduced, truncated selection marker genes. In these experiments, homologous DNA fragments were generally 0.3 kb to 2 kb. The observed homologous recombination frequency was 10 -4 to 10 -5It was to that extent. For example, see Halfter et al., (1992) Mol Gen Genet 231:186-93; Offringa et al., (1990) EMBO J 9:3077-84; Offringa et al., (1993) Proc. Natl. Acad. Sci. USA 90:7346-50; Paszkowski et al., (1988) EMBO J 7:4021-6; Hourda and Paszkowski, (1994) Mol Gen Genet 243:106-11; and Risseeuw et al., (1995) Plant J 7:109-19.

[0122] DNA double-strand breaks appear to be an effective factor in activating homologous recombination pathways (Puchta et al., (1995) Plant Mol Biol 28:281-92; Tzfira and White, (2005) Trends Biotechnol 23:567-9; Puchta, (2005) J Exp Bot 56:1-14). Using DNA cleavage agents, a 2 to 9-fold increase in homologous recombination was observed among artificially engineered homologous DNA repeat sequences in plants (Puchta et al., (1995) Plant Mol Biol 28:281-92). In maize protoplasts, enhanced homologous recombination between plasmids was demonstrated through experiments using linear DNA molecules (Lyznik et al., (1991) Mol Gen Genet 230:209-18).

[0123] Donor DNA may be introduced by any means known in the art. For example, a plant having a target site is provided. Donor DNA may be provided by any delivery method known in the art, including, for example, Agrobacterium-mediated transformation, whisker-mediated transformation, or a bio-genoline gun. Donor DNA may be transiently present in the cell or may be introduced via a viral replicon. In the presence of Cas endonuclease and the target site, the donor DNA is inserted into the plant genome.

[0124] As described herein, direct delivery of donor DNA into plant cells can be achieved through particle-mediated delivery. Based on the experiments described herein, those skilled in the art may now envision that any other direct delivery method, such as but not limited to polyethylene glycol (PEG)-mediated transfection into protoplasts, electroporation, gene gun, whisker-mediated delivery, cell-penetrating peptides, or mesoporous silica nanoparticle (MSN)-mediated direct protein delivery, can be successfully utilized to deliver donor DNA into plant cells.

[0125] In one embodiment of the present invention, the method comprises the steps of: introducing at least one donor DNA, a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using a polynucleotide modification template, wherein the donor DNA comprises at least one polynucleotide of interest to be inserted into the target site, and the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and selecting a cell having the modification of the nucleotide sequence by the functional selection marker protein. The introduction and selection steps do not involve the introduction of a selection marker gene, such as a recombinant DNA construct containing the selection marker gene. The disrupted selection marker gene may be any disrupted marker gene, including a disrupted visual marker gene.

[0126] Further uses for guide RNA / Cas endonuclease systems are described (see U.S. Patent Application US 2015-0082478 A1 published March 19, 2015, WO2015 / 026886 A1 published February 26, 2015, U.S. Application 2015-0059010 A1 published February 26, 2015, U.S. Application 62 / 023246 filed July 7, 2014, and U.S. Application 62 / 036,652 filed August 13, 2014, incorporated herein by reference), modification or substitution of a nucleotide sequence of interest (e.g., regulatory element), insertion of a polynucleotide of interest, gene knockout, gene knock-in, modification of a splicing site and / or introduction of an alternative splicing site, nucleotides encoding a protein of interest, amino acid and / or protein fusion. Gene silencing by modification of the sequence and expression of inversion repeat sequences within the gene of interest is included, but not limited to.

[0127] Polynucleotides of interest are further described herein and include polynucleotides that reflect the interests of those involved in commercial markets and crop development. Crops and markets of interest are changing, and as developing countries open to global markets, new crops and technologies will also emerge. Furthermore, as the understanding of agronomic traits and characteristics such as yield and hybrid vigor increases, the selection of genes for genetic engineering will change accordingly.

[0128] Additionally, a method is provided for identifying one or more plant cells containing a polynucleotide of interest incorporated at a target site in the genome. Various methods may be used to identify plant cells having a genomic insertion at or near the target site without using a screening marker phenotype. Such methods may include, but are not limited to, PCR methods, sequencing methods, nuclease digestion, Southern blot, and any combination thereof, directly analyzing the target sequence to detect any change in the target sequence. For example, see U.S. Patent Application 12 / 147,834 incorporated herein by reference to the extent necessary for the methods described herein. The method also includes the step of restoring a plant from a plant cell containing a polynucleotide of interest incorporated in the genome. The plant may be sterile or fertile. It is acknowledged that any polynucleotide of interest incorporated into the plant genome at the target site and expressed in the plant may be provided.

[0129] Polynucleotides / polypeptides of interest include, but are not limited to, sequences coding for herbicide resistance, insecticidal coding sequences, nematode coding sequences, antimicrobial coding sequences, antifungal coding sequences, antiviral coding sequences, coding sequences coding for tolerance to abiotic and biotic stress, or sequences modifying plant traits such as yield, grain quality, nutrient content, starch quality and quantity, nitrogen fixation and / or utilization, fatty acids, and oil content and / or composition. More specific polynucleotides of interest include, but are not limited to, genes that improve crop yield, polypeptides that improve crop desirability, genes encoding proteins that confer resistance to abiotic stresses such as drought, nitrogen, temperature, salinity, toxic metals, or trace elements, resistance to toxins such as insecticides and herbicides, or genes encoding proteins that confer resistance to biotic stresses such as attacks by fungi, viruses, bacteria, insects, and nematodes, and the development of diseases associated with these organisms. General categories of genes of interest include, for example, information-related genes such as zinc fingers, transfer-related genes such as kinases, and housekeeping-related genes such as heat shock proteins. More specific categories of transplant genes include, for example, genes encoding traits important for agronomic characteristics, insect resistance, disease resistance, herbicide resistance, fertility or sterility, grain characteristics, and commercial products. Genes of interest generally include genes related to oil, starch, carbohydrate, or nutrient metabolism, as well as genes affecting other traits described herein, such as kernel size, sucrose loading, etc., which may be stacked or used in combination with herbicide resistance, but are not limited thereto.

[0130] Crop-important traits such as oil, starch, and protein content can be genetically modified in addition to using traditional breeding methods. Modifications include increasing oleic acid, saturated and unsaturated oil content, increasing lysine and sulfur levels, introducing essential amino acids, and modifying starch. Modification of hordothionine protein is described in U.S. Patents 5,703,049, 5,885,801, 5,885,802, and 5,990,389, which are incorporated herein by reference.

[0131] The polynucleotide sequence of interest may encode proteins involved in the introduction of disease resistance or pest resistance. "Disease resistance" or "pest resistance" means that a plant avoids harmful symptoms resulting from interactions with plant pathogens. Pest resistance genes may encode resistance to pests that significantly impede yield, such as root worms, cutworms, and European corn borers. Disease resistance and insect resistance genes, such as proteins like lysozyme or cecropin for antimicrobial protection, or defensin, glucanase, or chitinase for antifungal protection, or Bacillus thuringiensis endotoxin, protease inhibitors, collagenase, lectin, or glycosidase for nematode or insect control, are all examples of useful gene products. Genes encoding disease resistance traits include, for example, a detoxification gene for fumonisin (U.S. Patent No. 5,792,931); These include genes for low toxicity (avr) and disease resistance (R) (Jones et al. (1994) Science 266:789; Martin et al. (1993) Science 262:1432; and Mindrinos et al. (1994) Cell 78:1089), etc. Insect resistance genes can encode resistance to pests that significantly impede yield, such as root mites, cutworms, and European corn borers. These genes include, for example, Bacillus thuringiensis toxicity protein genes (U.S. Patents 5,366,892; 5,747,450; 5,736,514; 5,723,756; 5,593,881; and Geiser et al . (1986) Gene Includes 48:109) etc.

[0132] Proteins produced by the expression of “herbicide resistance proteins” or “herbicide resistance encoding nucleic acid molecules” include proteins that confer to cells the ability to withstand higher concentrations of herbicides than cells that do not express these proteins, or the ability to withstand specific concentrations of herbicides for a longer period than cells that do not express these proteins. These may be introduced into plants by genes encoding resistance to herbicides that inhibit the action of acetolactate synthase (also called AHAS), particularly sulfonylurea herbicides, genes encoding resistance to herbicides that inhibit the action of glutamine synthase, e.g., phosphinothricin or vasta (e.g., vasa gene), glyphosate (e.g., EPSP synthase gene and GAT gene), HPPD inhibitors (e.g., HPPD gene), or other such genes known in the art. For example, see U.S. Patents 7,626,077, 5,310,667, 5,866,775, 6,225,114, 6,248,876, 7,169,970, 6,867,293 and U.S. Provisional Application 61 / 401,456, respectively incorporated herein by reference. The BA gene encodes resistance to the herbicide BASTA, and nptII The gene encodes resistance to the antibiotics kanamycin and geneticin, and the ALS gene mutation encodes resistance to the herbicide chlorsulfuron.

[0133] The "sulfonylurea-resistant polypeptide" as used herein comprises any polypeptide that confers resistance to at least one sulfonylurea when expressed in plants. Sulfonylurea herbicides inhibit the growth of higher plants by blocking acetolactate synthase (ALS), also known as acetohydroxy acid synthase (AHAS). Plants with specific mutations in ALS (e.g., S4 and / or HRA mutations) are resistant to sulfonylurea herbicides. The preparation of sulfonylurea-resistant plants is described in U.S. Patents 5,605,011; 5,013,659; 5,141,870; 5,767,361; 5,731,180; 5,304,732; and 4,761,373, the entirety of which is incorporated herein by reference for all purposes. It is described in more detail in Nos. 5,331,107; 5,928,937; and 5,378,824; and international publication WO 96 / 33270, and Tan et al. 2005. Imidazolinone-tolerant crops: history, current status and future. Pest Management Sci 61:246-257. Sulfonylurea-resistant polypeptides may be encoded, for example, by the SuRA or SuRB loci of ALS. In certain embodiments, ALS inhibitor-resistant polypeptides include C3 ALS mutations, HRA ALS mutations, S4 mutations, or S4 / HRA mutations, or any combination thereof. Different mutations in ALS are known to confer resistance to different herbicides and groups (and / or subgroups) of herbicides; see, for example, Tranel and Wright (2002) Weed Science 50:700-712. Also see U.S. Patents 5,605,011, 5,378,824, 5,141,870, and 5,013,659, each incorporated herein by reference in its entirety. HRA mutations in ALS have specific uses in one embodiment.The mutation causes the production of an acetolactate synthase polypeptide resistant to at least one sulfonylurea compound.

[0134] A gene encoding a sulfonylurea-resistant polypeptide is called a sulfonyl resistance gene or sulfonyl resistance gene. The terms sulfonyl resistance gene or sulfonyl resistance gene are used interchangeably herein.

[0135] A disrupted sulfonylurea resistance (ALS) gene refers to a disrupted gene in which the corresponding non-disrupted gene encodes a sulfonylurea resistance polypeptide, and which has been modified so that its gene product no longer encodes a functional sulfonylurea resistance polypeptide.

[0136] In one embodiment, the method is a method for producing a sulfonylurea-resistant plant having a modified target site, comprising: a) introducing a first guide RNA, a Cas9 endonuclease, and at least a second guide RNA into a plant cell having a disrupted sulfonylurea resistance (ALS) gene, wherein the first guide RNA and the Cas9 endonuclease can form a first complex capable of introducing a double strand into the disrupted sulfonylurea resistance (ALS) gene, and the second guide RNA and the Cas9 endonuclease can form a second complex capable of introducing a double strand cut into the target site; and b) a method comprising obtaining a sulfonylurea-resistant plant from the plant cell, wherein the sulfonylurea-resistant plant comprises a modification to the target, and the modification comprises a step selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, or (iv) any combination of (i) to (iii).

[0137] Components of a sulfonylurea-responsive inhibitor system (as described in US 8,257,956 published September 4, 2012) can also be introduced into a plant genome to create an inhibitor / operator / inducer system in which polypeptides within the plant can specifically bind to an operator, and specific binding is regulated by a sulfonylurea compound.

[0138] Sterility genes may be encoded in expression cassettes and provide an alternative to physical detachment. Examples of genes used in this manner include male fertility genes, such as MS26 (see, e.g., U.S. Patents 7,098,388, 7,517,975, 7,612,251), MS45 (see, e.g., U.S. Patents 5,478,369, 6,265,640), or MSCA1 (see, e.g., U.S. Patent 7,919,676). Corn plants (Zea mays L.) can be grown using self-pollination and cross-pollination techniques. Corn has male flowers located on the stamens and female flowers located on the ears within the same plant. Corn can self-pollinated ("self-reproducing") or cross-pollinated. In corn, natural pollination occurs when pollen from the stamens is blown by the wind to the silks protruding from the top of the early ears. Pollination can be easily controlled by techniques known to those skilled in the art. The development of corn hybrids requires the development of homozygous inbred lines, the crossing of these lines, and the evaluation of the crosses. Line breeding and recurrent selection are two breeding methods used to develop inbred lines from a population. A breeding program combines two or more inbred lines or desired traits from various broad sources into a breeding pool where new inbred lines are developed through self-reproduction and the selection of desired phenotypes. A hybrid corn variety is the cross of these two inbred lines, each of which may possess one or more desirable traits lacking in the other or complement one. The new inbred variety is crossed with other inbred lines, and the hybrids from these crosses are evaluated to determine which one is commercially viable. The offspring of the first generation of hybrids are designated as F1. F1 hybrids grow better than the inbred parents. This hybrid vigor or hybrid strength can be demonstrated in various ways, including increased plant growth and yield.

[0139] Hybrid corn seeds can be produced by a male sterile system including manual stamen removal. To produce hybrid seeds, male stamens are removed from growing female inbreeding mother plants and can be planted in various alternating row patterns with male inbreeding mother plants. Consequently, if sufficiently isolated from foreign corn pollen sources, the ears of the female inbreeding hybrid will be fertilized only by pollen from the male inbreeding hybrid. Thus, the resulting seeds are hybrids (F1) and will form hybrid plants.

[0140] Field changes affecting plant development can result in plant tasseling after the passive emasculation of the female parent is completed. Alternatively, the stamens of the female inbreeding plant may not be completely removed during the emasculation process. In either case, the female plants will successfully pollinate, and some female plants will self-pollinate. This will consequently result in the harvesting of seeds from the female inbreeding plant alongside normally produced hybrid seeds. Since female inbreeding seeds do not exhibit hybrid vigor, they are not as productive as F1 seeds. Furthermore, the presence of female inbreeding seeds can represent a germplasm security risk for the company producing the hybrid.

[0141] Alternatively, female inbred hybrids can be mechanically culled. Mechanical culling is approximately as reliable as manual culling but is faster and less expensive. However, most culling machines cause more damage to plants than manual culling. Therefore, no current form of culling is entirely satisfactory, and there remains a need to lower production costs and eliminate self-pollination of the female parent in the production of hybrid seeds.

[0142] Mutations causing male sterility in plants have the potential to be useful for hybrid seed production methods in cultivated plants such as maize, and can lower production costs by eliminating the need for labor-intensive male stasis removal (also known as emasculation) from maternal parent plants used as hybrids. Mutations causing male sterility in maize have been produced by various methods such as X-ray or UV irradiation, chemical treatment, or transposable element insertion (ms23, ms25, ms26, ms32) (Chaubal et al. (2000) Am J Bot 87:1193-1201). Conditional regulation of fertility genes through fertility / sterility "molecular switches" can enhance design options for new male sterility systems for crop improvement (Unger et al. (2002) Transgenic Res 11:455-465).

[0143] Additionally, the polynucleotide of interest is recognized as potentially containing an antisense sequence complementary to at least a portion of the messenger RNA (mRNA) for the targeted gene sequence of interest. The antisense nucleotide is configured to hybridize with the corresponding mRNA. Modification of the antisense sequence may be made insofar as the sequence hybridizes with the corresponding mRNA and interferes with its expression. In this way, an antisense construct having 70%, 80%, or 85% sequence identity with the corresponding antisense sequence may be used. Additionally, a portion of the antisense nucleotide may be used to interfere with the expression of the target gene. Generally, sequences of at least 50 nucleotides, 100 nucleotides, or 200 nucleotides or more may be used.

[0144] Additionally, the polynucleotide of interest may be used in a sense direction to suppress endogenous gene expression in plants. Methods for suppressing gene expression in plants using a polynucleotide in a sense direction are known in the art. These methods generally comprise the step of transforming a plant with a DNA construct comprising a promoter that is operably linked to at least a portion of a nucleotide sequence corresponding to the transcript of the endogenous gene to induce expression in the plant. Generally, such nucleotide sequences have substantial sequence identity with respect to the sequence of the transcript of the endogenous gene, generally about 65% sequence identity, greater than about 85% sequence identity, or greater than about 95% sequence identity. See U.S. Patents 5,283,184 and 5,034,323 incorporated herein by reference.

[0145] The polynucleotide of interest may also be a phenotypic marker.

[0146] The recombinant DNA molecule, the DNA sequence of interest, and the polynucleotide of interest may comprise one or more DNA sequences for gene silencing. Gene silencing methods involving the expression of DNA sequences in plants are known in the art and include, but are not limited to, co-inhibition, antisense inhibition, double-stranded RNA (dsRNA) interference, hairpin RNA (hpRNA) interference, intron-containing hairpin RNA (ihpRNA) interference, transcriptional gene silencing, and microRNA (miRNA) interference.

[0147] As used herein, “nucleic acid” means polynucleotide and includes single-stranded or double-stranded polymers of deoxyribonucleotide or ribonucleotide bases. Nucleic acids may also include fragments and modified nucleotides. Accordingly, the terms “polynucleotide,” “nucleic acid sequence,” “nucleotide sequence,” and “nucleic acid fragment” are used interchangeably to refer to polymers of RNA and / or DNA that are single or double-stranded and optionally include synthetic, non-natural, or modified nucleotide bases. Nucleotides (usually found in the form of 5'-monophosphate) are designated by a single letter notation as follows: "A" for adenosine or deoxyadenosine (for RNA or DNA, respectively), "C" for cytosine or deoxycytosine, "G" for guanosine or deoxyguanosine, "U" for uridine, "T" for deoxythymidine, "R" for purine (A or G), "Y" for pyrimidine (C or T), "K" for G or T, "H" for A, C, or T, "I" for inosine, and "N" for any nucleotide.

[0148] "Open Reading Frame" is abbreviated as ORF.

[0149] The terms “functionally equivalent subfragment” and “functionally equivalent subfragment” are used interchangeably herein. These terms refer to a portion or subsequence of an isolated nucleic acid fragment that retains the ability to alter gene expression or produce a specific phenotype, regardless of whether the fragment or subfragment encodes an active enzyme. For example, the fragment or subfragment may be used in gene design to produce a desired phenotype in a transgenic plant. The gene may be designed for repression by linking the nucleic acid fragment or subfragment to the plant promoter sequence in a sense direction or an antisense direction, regardless of whether the gene encodes an active enzyme.

[0150] The terms "conserved domain" or "motif" refer to a set of amino acids conserved at specific locations along the aligned sequences of evolutionarily related proteins. While amino acids at other locations may vary among homologous proteins, amino acids highly conserved at specific locations represent amino acids essential for the structure, stability, or activity of the protein. Because they are identified by a high degree of conservation in the aligned sequences of protein homologous groups, they can be used as identifiers, or "signatures," to determine whether a protein with a newly determined sequence belongs to a previously identified group of proteins.

[0151] Polynucleotide and polypeptide sequences, variants thereof, and structural relationships of these sequences may be described by the terms “homology,” “homology,” “substantially identical,” “substantially similar,” and “substantially corresponding,” as used interchangeably herein. These refer to polypeptides or nucleic acid fragments in which changes in one or more amino acids or nucleotide bases do not affect the function of the molecule, e.g., the ability to mediate gene expression or produce a specific phenotype. These terms also refer to modification(s) of a nucleic acid fragment that do not substantially alter the functional properties of the obtained nucleic acid fragment compared to an initial, unmodified fragment. These modifications include the deletion, substitution, and / or insertion of one or more nucleotides in the nucleic acid fragment.

[0152] A substantially similar nucleic acid sequence included may be defined by its ability to hybridize with the sequence exemplified herein (under moderately strict conditions, e.g., 0.5X SSC, 0.1% SDS, 60°C) or to any part of the nucleotide sequence disclosed herein, and is functionally equivalent to any nucleic acid sequence disclosed herein. Moderately similar fragments, such as homologous sequences from distantly-related organisms, may be adjusted to select very similar fragments, e.g., genes replicating functional enzymes from closely-related organisms. Washing after hybridization determines the strictness.

[0153] The term “selectively hybridize” includes references to hybridization of a specific nucleic acid target sequence and substantial exclusion of the non-target nucleic acid to a detectably greater degree (e.g., at least twice the background) than hybridization to a non-target nucleic acid sequence under strict hybridization conditions. The sequences selectively hybridize generally have at least 80% sequence identity with each other, or 90% sequence identity, and include up to 100% sequence identity (i.e., completely complementary).

[0154] The terms "strict conditions" or "strict hybridization conditions" refer to the conditions under which a probe selectively hybridizes to its target sequence in an in vitro hybridization assay. Strict conditions are sequence-dependent and will vary depending on the situation. By controlling the strictness of hybridization and / or washing conditions, a target sequence 100% complementary to the probe can be identified (homology probing). Alternatively, strict conditions can be adjusted to allow some discrepancy in the sequence to detect a lower degree of similarity (heterogeneous probing). Generally, probes are less than approximately 1,000 nucleotides in length, optionally less than 500 nucleotides.

[0155] Generally, strict conditions will be conditions at pH 7.0 to 8.3 and at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., more than 50 nucleotides) where the salt concentration is less than about 1.5 M Na ions, generally about 0.01 to 1.0 M Na ion concentration (or other salt(s)). Strict conditions may also be achieved by the addition of an destabilizing agent such as formamide. Exemplary low strict conditions include hybridization using a buffer of 30 to 35% formamide, 1 M NaCl, and 1% SDS (sodium dodecyl sulfate) at 37°C, and washing in 1X to 2X SSC (20X SSC = 3.0 M NaCl / 0.3 M trisodium citrate) at 50 to 55°C. Exemplary moderately severe conditions include hybridization in 40 to 45% formamide, 1 M NaCl, and 1% SDS at 37°C, and washing in 0.5X to 1X SSC at 55 to 60°C. Exemplary highly severe conditions include hybridization in 50% formamide, 1 M NaCl, and 1% SDS at 37°C, and washing in 0.1X SSC at 60 to 65°C.

[0156] In the context of nucleic acid or polypeptide sequences, "sequence identity" or "identity" refers to nucleic acid bases or amino acid residues within two identical sequences when aligned for maximum match across a specific comparison window.

[0157] The term “percentage of sequence identity” refers to a value determined by comparing two optimally aligned sequences in a comparison window, wherein a portion of the polynucleotide or polypeptide sequence in the comparison window may contain insertions or deletions (i.e., gaps) when compared to a reference sequence (which does not contain insertions or deletions) for the optimal alignment of the two sequences. The percentage is calculated by determining the number of positions in the two sequences where the same nucleic acid base or amino acid residue appears, calculating the number of matching positions, dividing the number of matching positions by the total number of positions in the comparison window, and multiplying the result by 100 to calculate the percentage of sequence identity. Useful examples of percentage sequence identity include, but are not limited to, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95%, or any integer percentage from 50% to 100%. These identities may be determined using any of the programs described herein.

[0158] Sequence alignment and percentage identity or similarity calculations were performed using MegAlign on the LASERGENE bioinformatics computing set (DNASTAR Inc., Madison, WI). TM It may be determined using various comparison methods designed to detect homologous sequences that include the program without limitation. Within the context of this application, it will be understood that when sequence analysis software is used for analysis, the analysis results will be based on the "default values" of the mentioned program unless otherwise specified. As used herein, "default values" will mean any set of values ​​or parameters loaded with the original software when it is first initialized.

[0159] The "cluster V alignment method" is cluster V (Higgins and Sharp, (1989) CABIOS 5:151-153; Higgins et al. , (1992) Comput Appl Biosci Named as (listed in 8:189-191) and MegAlign of the LASERGENE bioinformatics computing set (DNASTAR Inc., Madison, WI) TM This corresponds to the alignment method found in the program. For multiple alignments, the default values ​​correspond to GAP PENALTY=10 and GAP LENGTH PENALTY=10. The default parameters for calculating percentage identity and pair alignment of protein sequences using the Clustal method are KTUPLE=1, GAP PENALTY=3, WINDOW=5, and DIAGONALS SAVED=5. For nucleic acids, these parameters are KTUPLE=2, GAP PENALTY=5, WINDOW=4, and DIAGONALS SAVED=4. After aligning sequences using the Clustal V program, you can obtain "percentage identity" by viewing the "Sequence Distance" table in the same program.

[0160] The "Cluster W alignment method" is named Cluster W (described in Higgins and Sharp, (1989) CABIOS 5: 151-153; Higgins et al., (1992) Comput Appl Biosci 8: 189-191) and MegAlign of the LASERGENE bioinformatics computing set (DNASTAR Inc., Madison, WI). TM This corresponds to the alignment method found in the v6.1 program. Default parameters for multiple alignment (GAP PENALTY=10, GAP LENGTH PENALTY=0.2, Delayed Divergence Sequence(%)=30, DNA Transition Weight=0.5, Protein Weight Matrix=Gonnet Series, DNA Weight Matrix=IUB). After aligning sequences using the Clustal W program, you can obtain "Percentage Identity" by viewing the "Sequence Distance" table in the same program.

[0161] Unless otherwise specified, the sequence identity / similarity values ​​provided herein refer to values ​​obtained using GAP version 10 (GCG, Accelrys, San Diego, CA) with the following parameters: % identity and % similarity for nucleotide sequences using a gap generation penalty weight of 50 and a gap length extension penalty weight of 3, and the nwsgapdna.cmp scoring matrix; % identity and % similarity for amino acid sequences using a GAP generation penalty weight of 8 and a gap length extension penalty of 2, and the BLOSUM62 scoring matrix (Henikoff and Henikoff, (1989) Proc. Natl. Acad. Sci. USA 89:10915). GAP is defined by Needleman and Wunsch, (1970) J Mol Biol Algorithm 48:443-53 is used to find an alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. GAP considers all possible alignment and gap locations and generates an alignment with the most matches and the fewest gaps using a gap generation penalty and a gap extension penalty per match base.

[0162] "BLAST" is a search algorithm provided by the National Center for Biotechnology Information (NCBI) in the United States, used to find regions of similarity between biological sequences. This program compares nucleotide or protein sequences with sequence databases and calculates the statistical significance of matches to identify sequences with sufficient similarity to the query sequence so that similarities are not predicted to have occurred randomly. BLAST reports the identified sequences and their local alignment with the query sequence.

[0163] It is well understood by those skilled in the art that multiple levels of sequence identity are useful for identifying polypeptides from different species or from naturally or synthetically modified species, and that such polypeptides have the same or similar function or activity. Useful examples of percentage identity include, but are not limited to, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%, or any integer percentage from 50% to 100%. Actually, 50% to 100%, for example, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, Amino acid identity of any integer of 97%, 98%, or 99% may be useful in describing the present invention.

[0164] "Gene" includes, but is not limited to, a nucleic acid fragment that expresses a functional molecule, such as a specific protein, including but not limited to a regulatory sequence (5' non-coding sequence) preceding the coding sequence and a coding sequence (3' non-coding sequence) following it. "Natural gene" refers to a gene found in nature along with its own regulatory sequence.

[0165] A “mutant gene” is a gene that has been altered through human intervention. Such “mutant genes” have a sequence different from that of the corresponding non-mutant gene by at least one nucleotide insertion, deletion, or substitution. In a specific embodiment of the present invention, the mutant gene comprises an alteration attributable to the guide polynucleotide / Cas endonuclease system disclosed herein. A mutant plant is a plant containing the mutant gene.

[0166] The "target mutation" as used herein is a mutation of an endogenous gene created by altering a target sequence within the endogenous gene using a method comprising a double-strand break inducer capable of inducing a double-strand break in the DNA of the target sequence, as disclosed herein or known in the art.

[0167] Guide RNA / Cas endonuclease-induced target mutations can occur in nucleotide sequences located within or outside genomic target sites that are recognized and cleaved by Cas endonuclease.

[0168] When applied to plant cells, the term "genome" includes not only chromosomal DNA found within the nucleus but also organelle DNA found within the cell's intracellular components (e.g., mitochondria or chloroplasts).

[0169] "Codon modification genes," "codon preference genes," or "codon optimization genes" are genes that have a frequency of codon usage designed to mimic the frequency of codon usage preferred by the host cell.

[0170] An "allele" is one of several different forms of a gene that occupies a given locus on a chromosome. If all alleles present at a given locus on a chromosome are identical, the plant is homozygous at that locus. If the alleles present at a given locus on a chromosome are different, the plant is heterozygous at that locus.

[0171] "Coding sequence" refers to a polynucleotide sequence that codes for a specific amino acid sequence. "Regulatory sequence" refers to a nucleotide sequence located upstream (5' non-coding sequence), within, or downstream (3' non-coding sequence) of a coding sequence that affects the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include, but are not limited to, promoters, translation leader sequences, 5' untranslated sequences, 3' untranslated sequences, introns, polyadenylation target sequences, RNA processing sites, effector binding sites, and stem-loop structures.

[0172] "Plant-optimized nucleotide sequences" are nucleotide sequences optimized for increased expression in plants. For example, plant-optimized nucleotide sequences may be synthesized by modifying a nucleotide sequence encoding a protein, such as the double-strand break inducers (e.g., endonucleases) disclosed herein, using one or more plant-preferred codons for improved expression. For example, for a discussion of the use of host-preferred codons, see Campbell and Gowri (1990). Plant Physiol See 92:1-11.

[0173] Methods for synthesizing plant preference genes are available in the art. For example, U.S. Patents 5,380,831 and 5,436,391, and Murray, incorporated herein by reference. et al. (1989) Nucleic Acids Res See . 17:477-498. Additional sequence modifications are known to enhance gene expression in plant hosts. These include, for example, one or more sequences encoding spurious polyadenylation signals, one or more exon-intron splice site signals, one or more transposable-like repeat sequences, and the removal of other such well-characterized sequences that may be detrimental to gene expression. The GC content of the sequence can be adjusted to even out the average for a given plant host, calculated by referencing known genes expressed in host plant cells. Where possible, the sequence is modified to avoid one or more predicted hairpin secondary mRNA structures. Thus, the "plant-optimized nucleotide sequence" of the present invention comprises one or more such sequence modifications.

[0174] A promoter is a region of DNA involved in the recognition and binding of RNA polymerases and other transcription initiation proteins. A promoter sequence consists of a proximal upstream element and a distal upstream element, the latter often referred to as an enhancer. An "enhancer" is a DNA sequence capable of stimulating promoter activity and may be an element native to the promoter or a heterologous element inserted to enhance the promoter's level or tissue specificity. A promoter may be derived entirely from an intrinsic gene, may consist of different elements derived from different promoters found in nature and / or may include synthetic DNA fragments. Those skilled in the art understand that different promoters may induce gene expression in different tissues or cell types, at different stages of development, or in response to different environmental conditions. Furthermore, in most cases, because the precise boundaries of regulatory sequences are not fully defined, it is acknowledged that DNA fragments of some variants may possess the same promoter activity. The promoter that causes genes to be expressed in most cell types at most times is generally referred to as a "constitutive promoter."

[0175] Certain promoters have been found to be capable of inducing RNA synthesis at a faster rate than others. These are referred to as "powerful promoters." Some other promoters have been found to induce high levels of RNA synthesis only in specific types of cells or tissues; when a promoter not only induces RNA synthesis in a specific tissue but also induces reduced levels in other tissues, it is often called a "tissue-specific promoter" or "tissue-preferred promoter." Since the expression patterns of chimeric genes (or genes) introduced into plants are controlled using promoters, there is ongoing interest in isolating novel promoters capable of controlling the expression of chimeric genes (or genes) to specific levels in specific tissue types or at specific plant developmental stages.

[0176] Plant promoters may include promoters capable of initiating transcription in plant cells (a review of plant promoters is Potenza et al. , (2004) In Vitro Cell Dev Biol See 40:1-22). Constancy promoters are, for example, the core promoter of the Rsyn7 promoter and other constancy promoters disclosed in WO99 / 43838 and U.S. Patent 6,072,050; the core CaMV 35S promoter (Odell et al. , (1985) Nature 313:810-2); rice actin (McElroy et al. , (1990) Plant Cell 2:163-71); ubiquitin (Christensen et al. , (1989) Plant Mol Biol 12:619-32; Christensen et al., (1992) Plant Mol Biol 18:675-89); pEMU (Last et al., (1991) Theor Appl Genet 81:581-8); MAS (Velten et al., (1984) EMBO J 3:2723-30); includes the ALS promoter (U.S. Patent No. 5,659,026), etc. Other homeostatic promoters are described, for example, in U.S. Patents No. 5,608,149; No. 5,608,144; No. 5,604,121; No. 5,569,597; No. 5,466,785; No. 5,399,680; No. 5,268,463; No. 5,608,142 and No. 6,177,611. In some examples, inducible promoters may be used. Pathogen-inducible promoters induced after infection by a pathogen include, but are not limited to, those that regulate the expression of PR proteins, SAR proteins, beta-1,3-glucanase, chitinase, etc.

[0177] Chemically regulated promoters can be used to control gene expression in plants through the application of exogenous chemical regulators. These promoters may be chemically inducible promoters, where the application of a chemical induces gene expression, or chemically inhibiting promoters, where the application of a chemical inhibits gene expression. An example of a chemically inducible promoter is the corn In2-2 promoter activated by the benzene sulfonamide herbicide allergen (De Veylder et al. , (1997) Plant Cell Physiol 38:568-77), corn GST promoter activated by a hydrophobic electrophilic compound used as a herbicide before weed germination (GST-II-27, WO93 / 01294) and tobacco PR-1a promoter activated by salicylic acid (Ono et al. , (2004) Biosci Biotechnol Biochem Other chemically modified promoters include, but are not limited to, steroid-responsive promoters (e.g., glucocorticoid-derived promoters (Schena et al. , (1991) Proc. Natl. Acad. Sci. USA 88:10421-5; McNellis et al. , (1998) Plant J 14:247-257); Tetracycline-inducible and tetracycline-inhibitory promoters (Gatz et al. , (1991) Mol Gen Genet 227:229-37; includes U.S. Patents 5,814,618 and 5,789,156).

[0178] Tissue-preferring promoters can be utilized to aim at enhancing expression within specific plant tissues. Examples of tissue-preferring promoters include, for instance, Kawamata et al. , (1997) Plant Cell Physiol 38:792-803; Hansen et al. , (1997) Mol Gen Genet 254:337-43; Russell et al., (1997) Transgenic Res 6:157-68; Rinehart et al. , (1996) Plant Physiol 112:1331-41; Van Camp et al. , (1996) Plant Physiol 112:525-35; Canevascini et al. , (1996) Plant Physiol 112:513-524; Lam, (1994) Results Probl Cell Differ 20:181-96; and Guevara-Garcia et al. , (1993) Plant J Examples include 4:495-505. Leaf-preferring promoters include, for example, Yamamoto et al. , (1997) Plant J 12:255-65; Kwon et al. , (1994) Plant Physiol 105:357-67; Yamamoto et al. , (1994) Plant Cell Physiol 35:773-8; Gotor et al. , (1993) Plant J 3:509-18; Orozco et al. , (1993) Plant Mol Biol 23:1129-38; Matsuoka et al. , (1993) Proc. Natl. Acad. Sci. USA 90:9586-90; Simpson et al. , (1958) EMBO J 4:2723-9; Timko et al. , (1988) Nature 318:57-8 can be cited. Root-preferring promoters include, for example, Hire et al. , (1992) Plant Mol Biol 20:207-18(Soybean root-specific glutamine synthase gene); Miao et al. , (1991) Plant Cell 3:11-22 (Cytozole glutamine synthase (GS)); Keller and Baumgartner, (1991) Plant Cell 3:1051-61 (Root-specific regulatory elements of the GRP 1.8 gene in kidney beans); Sanger et al. , (1990) Plant Mol Biol 14:433-43(A. tumepaciens( tumefaciens ) Root-specific promoter of mannopine synthase (MAS); Bogusz et al. , (1990) Plant Cell 2:633-41 (Parasponia Andersoni( Parasponia andersonii ) and Trema Tomentosa( Trema tomentosa Root-specific promoter isolated from ); Leach and Aoyagi, (1991) Plant Sci 79:69-76 (A. Rhizogenes( rhizogenes ) rolC and rolD root-inducing genes); Teeri et al. , (1989) EMBO J 8:343-50(Agrobacterium( Agrobacterium ) Wound-inducing TR1' and TR2' genes); VfENOD-GRP3 gene promoter (Kuster et al. , (1995) Plant Mol Biol 29:759-72); and rolB promoter(Capana et al. , (1994) Plant Mol Biol 25:681-91; Phaseolin gene (Murai et al. , (1983) Science 23:476-82; Sengopta-Gopalen et al. , (1988) Proc. Natl. Acad. Sci. USA 82:3320-4) can be cited. Also see U.S. Patents 5,837,876; 5,750,386; 5,633,363; 5,459,252; 5,401,836; 5,110,732 and 5,023,179.

[0179] Seed-preferring promoters include not only seed-specific promoters that are active during seed development, but also seed germination promoters that are active during seed germination. Thompson et al. , (1989) BioEssays See 10:108. Seed-preferring promoters include, but are not limited to, Cim1 (cytokinin-inducing message); cZ19B1 (corn 19 kDa zein); and milps (myo-inositol-1-phosphate synthase); (WO00 / 11177; and U.S. Patent 6,225,529). For dicotyledonous plants, seed-preferring promoters include, but are not limited to, legume β-phaseolin, nafin, β-conglycinin, soybean lectin, cruciferin, etc. For monocotyledonous plants, seed-preferring promoters include, but are not limited to, corn 15 kDa zein, 22 kDa zein, 27 kDa gamma zein, waxy, shrunken 1, shrunken 2, globulin 1, oleosin, and nuc1. Also, END1 and END2 See WO00 / 12733, which discloses a seed preference promoter from a gene.

[0180] The term "inducible promoter" refers to a promoter that selectively expresses a coding sequence or functional RNA in response to the presence of endogenous or exogenous stimuli, for example, by a chemical compound (chemical inducer), or in response to the environment, hormones, chemicals, and / or developmental signals. Inducible or regulatory promoters include promoters induced or regulated by, for example, light, heat, stress, flood or drought, salt stress, osmotic stress, plant hormones, wounds, or chemicals, such as ethanol, abscisic acid (ABA), jasmonate, salicylic acid, or phytoreducers.

[0181] An example of stress-inducible is the RD29A promoter (Kasuga et al. (1999) Nature Biotechnol. 17:287-91). Those skilled in the art are well aware of protocols for simulating drought conditions and evaluating drought tolerance in plants exposed to simulated or naturally occurring drought conditions. For example, those skilled in the art may simulate drought conditions by providing plants with less water than normally required or by withholding water over a period of time, and may evaluate drought tolerance by examining differences in physiological and / or health status, including (but not limited to) vigor, growth, size, or root length, or, in particular, leaf color or leaf area. Other techniques for evaluating drought tolerance include the measurement of chlorophyll fluorescence, photosynthetic rate, and gas exchange rate. Furthermore, those skilled in the art are well aware of protocols for simulating stress conditions such as osmotic stress, salt stress, and temperature stress, and evaluating stress tolerance in plants exposed to simulated or naturally occurring stress conditions.

[0182] Other examples of inducible promoters useful for plant cells are described in U.S. Patent Application US 2013-0312137A1, published November 21, 2013, which is incorporated herein by reference. U.S. Patent Application US 2013-0312137A1 describes a mannitol dehydrogenase from corn encoding C BSU- A The ZmCAS1 promoter from the nther_Subtraction library (CAS1) gene and its functional fragment are described. The ZmCAS1 promoter (also referred to as the “CAS1 promoter”, “mannitol dehydrogenase promoter”, or “mdh promoter”) may be induced by chemical or stress treatment. Chemicals may be, but are not limited to, anaphylactic agents such as N-(aminocarbonyl)-2-chlorobenzenesulfonamide (2-CBSU). Stress treatment may be a heat treatment such as heat shock treatment, but is not limited to (see also U.S. provisional patent application 62 / 120421 filed February 25, 2015, incorporated herein by reference).

[0183] Many types of new promoters useful to plant cells are continuously being discovered; and many examples The Biochemistry of Plants It can be found in the edits by Okamuro and Goldberg (1989) in Vol. 115, Stumpf and Conn, eds (New York, NY: Academic Press), pp. 1-82.

[0184] "Translation leader sequence" refers to a polynucleotide sequence located between the promoter sequence and the coding sequence of a gene. The translation leader sequence is present in the mRNA upstream of the translation start sequence. The translation leader sequence can affect the processing of the primary transcript for the mRNA, mRNA stability, or translation efficiency. Examples of translation leader sequences have been described (e.g., Turner and Foster, (1995) Mol Biotechnol 3:225-236).

[0185] "3' non-coding sequence," "transcription terminator," or "termination sequence" refers to a DNA sequence located downstream of a coding sequence and includes a polyadenylation recognition sequence and other sequences encoding regulatory signals that may affect mRNA processing or gene expression. Polyadenylation signals are generally characterized by influencing the addition of a polyadenylic acid region to the 3' end of an mRNA precursor. The use of other 3' non-coding sequences is Ingelbrecht et al. , (1989) Plant Cell It is exemplified in 1:671-680.

[0186] "RNA transcript" refers to the product produced from RNA polymerase-catalyzed transcription of a DNA sequence. If the RNA transcript is a complete complementary copy of the DNA sequence, it is called the primary transcript or pre-mRNA. If the RNA transcript is an RNA sequence derived from the post-transcriptional processing of the primary transcript pre-mRNA, it is called mature RNA or mRNA. "Messenger RNA" or "mRNA" refers to RNA that lacks introns and can be translated into protein by a cell. "crDNA" refers to DNA that is complementary to an mRNA template and synthesized from it using the enzyme reverse transcriptase. cDNA can be single-stranded or converted into a double-stranded form using the Klenow fragment of DNA polymerase I. "Sense" RNA refers to an RNA transcript containing mRNA that can be translated into protein in a cell or in vitro. “Antisense RNA” refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and blocks the expression of the target gene (see, for example, U.S. Patent 5,107,065). The complementarity of the antisense RNA may be with any part of the specific gene transcript, namely the 5’ non-coding sequence, the 3’ non-coding sequence, an intron, or a coding sequence. “Functional RNA” refers to antisense RNA, ribozyme RNA, or other RNA that may not be translated but influences cellular processes. The terms “complement” and “reverse complement” are used interchangeably herein with respect to mRNA transcripts and are intended to define the antisense RNA of the message.

[0187] The term “operably linked” refers to the combination of nucleic acid sequences on a single nucleic acid fragment such that one function is regulated by the other. For example, a promoter is operably linked to a coding sequence when it can regulate the expression of the coding sequence (i.e., when the coding sequence is under the transcriptional control of the promoter). The coding sequence may be operably linked to the regulatory sequence in a sense or antisense direction. In other examples, a complementary RNA region may be operably linked directly or indirectly to the 5' of the target mRNA, or to the 3' of the target mRNA, or within the target mRNA, or a first complementary region is the 5' of the target mRNA and its complement is the 3' of the target mRNA.

[0188] The standard recombinant DNA and molecular cloning techniques used herein are well known in the art, and Sambrook et al. , Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory : It is described in more detail in Cold Spring Harbor, NY (1989). The transformation method is well known to those skilled in the art and is described below.

[0189] "PCR," or "polymerase chain reaction," is a technique for synthesizing specific DNA segments and consists of a series of repetitive cycles of denaturation, annealing, and expansion. Typically, double-stranded DNA is heat-denatured, and two primers complementary to the 3' boundary of the target segment are annealed to the DNA at low temperatures and then expanded at intermediate temperatures. A set of these three consecutive steps is called a "cycle."

[0190] The term "recombination" refers to, for example, the manipulation of a nucleic acid segment isolated by genetic engineering technology, or the artificial combination of two sequence segments that would not otherwise be separated by chemical synthesis.

[0191] The terms “plasmid,” “vector,” and “cassette” refer to extrachromosomal elements, typically in the form of double-stranded DNA, that often carry genes that are not part of the cell’s central metabolism. These elements may be linear or circular forms of autonomous replication sequences, genome integration sequences, phages, or nucleotide sequences of single or double-stranded DNA or RNA derived from any source, and multiple nucleotide sequences are combined or recombined into a unique structure capable of introducing a polynucleotide of interest into a cell. A “transformation cassette” refers to a specific vector containing a gene and having elements other than the gene that promote the transformation of a specific host cell. An “expression cassette” refers to a specific vector containing a gene and having elements other than the gene that enable the expression of that gene in a host.

[0192] The terms “recombinant DNA molecule,” “recombinant construct,” “expression construct,” “construct,” “construct,” and “recombinant DNA construct” are used interchangeably herein. A recombinant construct comprises an artificial combination of nucleic acid fragments, for example, a regulatory sequence and a coding sequence that are not all found together in nature. For example, a construct may comprise a regulatory sequence and a coding sequence derived from different sources, or a regulatory sequence and a coding sequence derived from the same source but arranged in a manner different from that found in nature. Such constructs may be used alone or in combination with a vector. When a vector is used, the choice of the vector depends on the method to be used to transform the host cell, as is well known to those skilled in the art. For example, a plasmid vector may be used. Those skilled in the art are well aware of the genetic elements that must be present in the vector to successfully transform, select, and proliferate the host cell. Those skilled in the art also know that different independent transformation events can result in different expression levels and patterns (Jones et al. , (1985) EMBO J 4:2411-2418; De Almeida et al. , (1989) Mol Gen Genetics (218:78-86), it will be recognized that several events are generally screened to obtain a lineage exhibiting desired expression levels and patterns. These screenings can be achieved by standard molecular biological and biochemical analyses, and other analytical methods including Southern analysis of DNA, Northern analysis of mRNA expression, PCR, real-time quantitative PCR (qPCR), reverse transcription PCR (RT-PCR), immunoblotting analysis of protein expression, enzyme or activity analysis, and / or phenotypic analysis.

[0193] As used herein, the term "expression" refers to the production of a functional end product (e.g., mRNA, guide RNA, or protein) in a precursor or mature form.

[0194] The term “introduction” includes references to introducing, providing, or contacting compounds, such as but not limited to, nucleic acids (e.g., expression constructs) or peptides, polypeptides, or proteins into a cell. Introduction includes the direct delivery of polynucleotides (e.g., RNA, DNA, RNA-DNA hybrids, single or double-stranded oligonucleotides, linear or circular polynucleotides) and / or the direct delivery of proteins (polypeptides). Introduction includes references to the incorporation of nucleic acids or polypeptides into eukaryotic or prokaryotic cells in which the nucleic acids may be incorporated into the cell’s genome, and includes references to the transient introduction of nucleic acids or proteins into a cell. Introduction includes references to stable or transient transformation methods, transfection, transduction, microinjection, electroporation, viral methods, Agrobacterium-mediated transformation, ballistic particle acceleration, whisker-mediated transformation, as well as sexual mating. Accordingly, "introduction" in the context of inserting a nucleic acid fragment (e.g., recombinant DNA construct / expression construct, guide RNA, guide DNA, template DNA, donor DNA) into a cell includes "transfection," "transformation," or "transduction," and includes references to the incorporation of a nucleic acid fragment into a eukaryotic or prokaryotic cell in which the nucleic acid fragment may be incorporated into the cell's genome (e.g., chromosome, plasmid, chloroplast, or mitochondrial DNA), converted into an autonomous replicon, or transiently expressed (e.g., transfected mRNA).

[0195] Various methods of introducing, contacting, and / or providing a composition to an organism are known, including stable transformation methods, transient transformation methods, virus-mediated methods, sexual mating, and sexual reproduction. Stable transformation indicates that the introduced polynucleotide is incorporated into the organism's genome and can be inherited by its offspring. Transient transformation indicates that the introduced composition is expressed or present in the organism only transiently.

[0196] Protocols for contacting, delivering, and introducing polynucleotides and polypeptides into cells or organisms are known, and microinjection (Crossway et al. , (1986) Biotechniques 4:320-34 and U.S. Patent No. 6,300,543), meristematic transformation (U.S. Patent No. 5,736,369), electroporation (Riggs et al. , (1986) Proc. Natl. Acad. Sci. USA 83:5602-6, Agrobacterium-mediated transformation (U.S. Patents 5,563,055 and 5,981,840), Whisker-mediated transformation (Ainley et al. 2013, Plant Biotechnology Journal 11:1126-1134; Shaheen A. and M. Arshad 2011 Properties and Applications of Silicon Carbide (2011), 345-358 Editor(s): Gerhardt, Rosario. Publisher: InTech, Rijeka, Croatia. CODEN: 69PQBP; ISBN: 978-953-307-201-2), Direct gene transfer (Paszkowski) et al. , (1984) EMBO J 3:2717-22), and ballistic particle acceleration (U.S. Patents No. 4,945,050; 5,879,918; 5,886,244; 5,932,782; Tomes et al. , (1995) “Direct DNA Transfer into Intact Plant Cells via Microprojectile Bombardment” in Plant Cell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborg & Phillips (Springer-Verlag, Berlin); McCabe et al. , (1988) Biotechnology 6:923-6; Weissinger et al. , (1988) Ann Rev Genet 22:421-77; Sanford et al. , (1987) Particulate Science and Technology 5:27-37 (Onion); Christou et al. , (1988) Plant Physiol 87:671-4 (soybeans); Finer and McMullen, (1991) In Vitro Cell Dev Biol 27P:175-82 (Soybeans); Singh et al. , (1998) Theor Appl Genet 96:319-24 (Soybean); Datta et al. , (1990) Biotechnology 8:736-40 (Rice); Klein et al. , (1988) Proc. Natl. Acad. Sci. USA 85:4305-9 (Corn); Klein et al. , (1988) Biotechnology 6:559-63 (corn); U.S. Patent No. 5,240,855; Nos. 5,322,783 and 5,324,646; Klein et al. , (1988) Plant Physiol 91:440-4 (Corn); Fromm et al. , (1990) Biotechnology 8:833-9 (Corn); Hooykaas-Van Slogteren et al. , (1984) Nature 311:763-4; U.S. Patent No. 5,736,369 (Grain); Bytebier et al. , (1987) Proc. Natl. Acad. Sci. USA 84:5345-9 (Lily family); De Wet et al. , (1985) in The Experimental Manipulation of Ovule Tissues, ed. Chapman et al. , (Longman, New York), pp. 197-209 (Pollen); Kaeppler et al. , (1990) Plant Cell Rep 9:415-8) and Kaeppler et al. , (1992) Theor Appl Genet 84:560-6 (Whisker-mediated transformation); D'Halluin et al. , (1992) Plant Cell 4:1495-505 (Electroporation); Li et al. , (1993) Plant Cell Rep 12:250-5; Christou and Ford (1995) Annals Botany 75:407-13 (Rice) and Osjoda et al. , (1996) Nat Biotechnol 14:745-50 (corn via Agrobacterium tumefaciens) includes.

[0197] Alternatively, polynucleotides can be introduced into a cell or organism by bringing the cell or organism into contact with a virus or viral nucleic acid. Generally, such methods involve incorporating polynucleotides into viral DNA or RNA molecules. In some examples, the polypeptide of interest may initially be synthesized as part of a viral polyprotein and subsequently treated by proteolysis in vivo or in vitro to produce the desired recombinant protein. Methods for introducing polynucleotides containing viral DNA or RNA molecules into plants and expressing proteins encoded therein are known (see, for example, U.S. Patents 5,889,191, 5,889,190, 5,866,785, 5,589,367, and 5,316,931). Transient transformation methods include, but are not limited to, directly introducing polypeptides such as double-strand break inducers into an organism, introducing polynucleotides such as DNA and / or RNA polynucleotides into an organism, and introducing RNA transcripts such as mRNA encoding double-strand break inducers. Such methods include, for example, microinjection or a gene gun. For example, Crossway et al. , (1986) Mol Gen Genet 202:179-85; Nomura et al. , (1986) Plant Sci 44:53-8; Hepler et al. , (1994) Proc. Natl. Acad. Sci. USA 91:2176-80; and, Hush et al. , (1994) J Cell Sci See 107:775-84.

[0198] Nucleic acids and proteins may be provided to cells by any method, including methods utilizing molecules, such as cell-penetrating peptides and nanocarriers, to promote the uptake of any or all components (proteins and / or nucleic acids) of the inducing Cas system. Also, refer to US20110035836 Nanocarier based plant transfection and transduction and EP 2821486 A1 Method of introducing nucleic acid into plant cells, incorporated herein by reference.

[0199] Introducing a guide RNA / Cas endonuclease complex into a cell comprises introducing the individual components of said complex individually or combined into the cell, either directly (directly delivered as RNA for guide and protein for Cas endonuclease) or through a recombinant construct expressing said components (guide RNA, Cas endonuclease). Introducing a guide RNA / Cas endonuclease complex into a cell comprises introducing the guide RNA / Cas endonuclease complex into the cell as a ribonucleotide-protein. The ribonucleotide-protein may be assembled prior to introduction into the cell as described herein.

[0200] Plant cells differ from human and animal cells in that they contain a plant cell wall that can act as a barrier to the direct delivery of RGEN ribonucleic acid protein and / or the direct delivery of RGEN components.

[0201] As described herein, direct delivery of RGEN ribonucleoprotein into plant cells can be achieved through particle-mediated delivery (gene gun). Based on the experiments described herein, those skilled in the art may now envision that any other direct delivery method, such as but not limited to polyethylene glycol (PEG)-mediated transfection into protoplasts, electroporation, cell-penetrating peptides, or mesoporous silica nanoparticle (MSN)-mediated direct protein delivery, can be successfully utilized to deliver RGEN ribonucleoprotein into plant cells.

[0202] As described herein, direct delivery of RGEN ribonucleic acid proteins causes the complex to degrade rapidly after genome editing at target sites within the cell genome, allowing the complex to exist only transiently in the cell. This transient presence of the RGEN complex can lead to a reduction in off-target effects. On the other hand, delivery of RGEN components (guide RNA, Cas9 endonuclease) via plasmid DNA sequences can result in constant expression of RGEN from these plasmids, which can exacerbate off-target effects (Cradick, TJ et al (2013) Nucleic Acids Res 41:9584-9592; Fu, Y et al (2014) Nat. Biotechnol. 31:822-826).

[0203] Direct delivery can be achieved by combining any one component of an RNA-induced endonuclease (guide RNA, Cas protein, gRNA, or mRNA encoding Cas endonuclease) or the RGEN complex itself with a particle delivery matrix comprising, for example, but not limited to, gold particles, tungsten particles, and silicon carbide whisker particles. Examples of the binding methods described herein for binding the particles to plasmid DNA and DNA of interest may also be used to coat the particles with guide RNA molecules, mRNA molecules, Cas protein, and RGEN complexes.

[0204] These coated microparticles can be introduced into cells by any direct method known in the art, such as the gene gun method described in Example 8. To enable the coating of the RGEN component onto the microparticles, the microparticles and the RGEN component or RGEN complex may be combined (mixed) with any material. For example, the RGEN component may be deposited onto gold pellets having a diameter in the range of at least 0.1 µm, 0.2 µm, 0.3 µm, 0.4 µm, 0.5 µm, 0.6 µm, 0.7 µm, 0.8 µm, 0.9 µm, or 1.0 µm using any suitable buffer (e.g., but not limited to, water-soluble cationic lipids, e.g., but not limited to, TransIT-2020 transfection reagent (Cat# MIR 5404, Mirus, USA)). The RGEN component solution can be prepared on ice (or at any temperature suitable for enabling particulate binding) using at least 0.1 μg, 0.2 μg, 0.3 μg, 0.4 μg, 0.5 μg, 0.6 μg, 0.7 μg, 0.8 μg, 0.9 μg, 1.0 μg, 2.0 μg, 3.0 μg, 4.0 μg, 5.0 μg, 6.0 μg, 7.0 μg, 8.0 μg, 9.0 μg, or 10 μg of RNA (derived RNA or mRNA) or Cas endonuclease protein. At least 1 μg to 20 μg of the prepared particulates can be carefully added to and mixed with the pre-mixed RGEN component of the RGEN complex.

[0205] In one embodiment of the present invention, the method comprises a method for delivering a guide RNA / Cas endonuclease complex into a cell, the method comprising the steps of: combining at least one guide RNA molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein; combining the ribonucleotide-protein with a particle delivery matrix to allow the ribonucleotide-protein to be combined with the matrix to form a ribonucleotide-protein-matrix complex; and introducing the ribonucleotide-protein-matrix complex into the cell. The particle delivery matrix may comprise microparticles combined with cationic lipids.

[0206] The term “cationic lipid” includes references to water-soluble cationic lipids, e.g., but not limited to TransIT-2020, or cationic lipid solutions, e.g., but not limited to N,N,N',N'-tetramethyl-N,N'-bis(2-hydroxyethyl)-2,3-di(oleoyloxy)-1,4-butanediammonium iodide, and cationic lipid solutions comprising L-dioleoyl phosphatidylethanolamine (DOPE) (see also US2007 / 0178593 published August 2, 2007, incorporated herein by reference).

[0207] The particle transfer matrix may include fine particles selected from the group consisting of gold particles, tungsten particles, and silicon carbide whisker particles.

[0208] The particle delivery matrix may further comprise a compound selected from the group consisting of Tfx-10™, Tfx-20™, Tfx-50™, Lipofectin™, Lipofectamine™, Cellfectin™, Effectene™, Cytofectin GSV™, Perfect Lipids™, DOTAP™, DMRIE-C™, FuGENE-6™, Superfect™, Polyfeet™, polyethyleneimine, chitosan, protamine Cl, histone H1, histone CENH3, poly-L lysine, and DMSA (US2007 / 0178593 disclosed August 2, 2007, incorporated herein by reference).

[0209] The RGEN components are also, in a solution suitable for enabling complex formation (e.g., but not limited to, Cas9 buffer (NEB)) at any temperature capable of forming a complex, e.g., 1°C, 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C, 13°C, 14°C, 15°C, 16°C, 17°C, 18°C, 19°C, 20°C, 21°C, 22°C, 23.0°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33.0°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, and 40°C, At least 0.1 µg, 0.2 µg, 0.3 µg, 0.4 µg, 0.5 µg, 0.6 µg, 0.7 µg, 0.8 µg, 0.9 µg, 1.0 µg, 2.0 µg, 3.0 µg, 4.0 µg, 5.0 µg, 6.0 µg, 7.0 µg, 8.0 µg, 9.0 µg, or 10 µg of guide RNA, at least 0.1 µg, 0.2 µg, 0.3 µg, 0.4 µg, 0.5 µg, 0.6 µg, 0.7 µg, 0.8 µg, 0.9 µg, 1.0 µg, 2.0 µg, 3.0 µg, 4.0 µg, 5.0 µg, 6.0 µg, 7.0 It can be combined with µg, 8.0 µg, 9.0 µg, or 10 µg of Cas endonuclease before being coated on the microparticle.

[0210] In one embodiment of the present invention, the method comprises a method for delivering a guide RNA / Cas endonuclease component into a cell, the method comprising the steps of introducing at least one guide RNA molecule and at least one Cas endonuclease protein into a cell, and growing the cell under appropriate conditions so that the guide RNA and the Cas endonuclease protein can form a complex within the cell.

[0211] In one embodiment of the present invention, the method comprises a method for delivering a guide RNA / Cas endonuclease component into a cell, the method comprising the steps of introducing at least one guide RNA molecule and at least one mRNA encoding a Cas endonuclease protein into a cell, and growing the cell under appropriate conditions so that the mRNA can translate the Cas endonuclease protein and form a complex with the guide RNA.

[0212] In one embodiment of the present invention, the method comprises a method for delivering a guide RNA / Cas endonuclease complex into a cell, the method comprising the steps of: combining at least one guide RNA molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein, and combining the ribonucleotide-protein with a particle delivery matrix so that the ribonucleotide-protein and the matrix can be combined to form a ribonucleotide-protein-matrix complex; and introducing the ribonucleotide-protein-matrix complex into the cell together with at least one polynucleotide template, wherein the polynucleotide modified template comprises at least one nucleotide modification of a nucleotide sequence within the genome of the cell, and wherein the at least one nucleotide modification of the polynucleotide modified template comprises (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, and (iv) any combination of (i) to (iii).

[0213] In one embodiment of the present invention, the method comprises a method for delivering a guide RNA / Cas endonuclease complex into a cell, the method comprising the steps of: combining at least one guide RNA molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein, and combining the ribonucleotide-protein with a particle delivery matrix to form a ribonucleotide-protein-matrix complex so that the ribonucleotide-protein and the matrix can be combined; and introducing the ribonucleotide-protein-matrix complex into the cell together with a donor DNA, wherein the donor DNA comprises at least one polynucleotide of interest.

[0214] Conditions suitable for cell growth are well known in the art, and those skilled in the art may use any growth conditions (e.g., conditions suitable for plant cells) based on the type of cell. As described in Example 8, a plant embryo or cell may be cultured for 12 to 48 hours at a temperature ranging from 26°C to 37°C in any plant maintenance medium known in the art (e.g., but not limited to 560P, Example 8), and then placed at 26°C. After 5 to 7 days, the embryo / cell is transferred to any selective medium known in the art (e.g., but not limited to 560R, Example 8), and then subcultured.

[0215] The RGEN component (including guide RNA and Cas endonuclease protein) is a solution suitable for enabling complex formation at any temperature capable of forming the complex, e.g., 1°C, 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C, 13°C, 14°C, 15°C, 16°C, 17°C, 18°C, 19°C, 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, and 40°C (e.g., but not limited to Cas9 In a buffer (NEB), at least 0.1 µg, 0.2 µg, 0.3 µg, 0.4 µg, 0.5 µg, 0.6 µg, 0.7 µg, 0.8 µg, 0.9 µg, 1.0 µg, 2.0 µg, 3.0 µg, 4.0 µg, 5.0 µg, 6.0 µg, 7.0 µg, 8.0 µg, 9.0 µg, or 10 µg of guide RNA is used in at least 0.1 µg, 0.2 µg, 0.3 µg, 0.4 µg, 0.5 µg, 0.6 µg, 0.7 µg, 0.8 µg, 0.9 µg, 1.0 µg, 2.0 µg, 3.0 µg, 4.0 µg, 5.0 µg, By binding to 6.0 μg, 7.0 μg, 8.0 μg, 9.0 μg, or 10 μg of Cas endonuclease, it can bind before being coated on the microparticle (before binding to the microparticle) to form a ribonucleotide-protein complex (RNP).

[0216] "Mature" proteins refer to polypeptides that have been processed after translation (i.e., from which any prepeptide or propeptide present in the primary translation product has been removed). "Precursor" proteins refer to the primary product of mRNA translation (i.e., in which prepeptides and propeptides are still present). Prepeptides and propeptides may be, but are not limited to, intracellular localization signals.

[0217] "Stable transformation" refers to the delivery of a nucleic acid fragment into the host organism's genome, including the nucleus and organelle genomes, resulting in genetically stable inheritance. Meanwhile, "transient transformation" refers to the delivery of a nucleic acid fragment into the host organism's nucleus or other DNA-containing organelles, resulting in gene expression without integration or stable inheritance. A host organism containing the transformed nucleic acid fragment is referred to as a "transplanted organism."

[0218] The commercial development of genetically enhanced germplasm has also advanced to the stage of introducing various traits into cultivated plants, often referred to as the gene stacking approach. In this approach, various genes conferring different traits of interest can be introduced into plants. Gene stacking can be achieved by many means, including, but not limited to, simultaneous transformation, retransformation, and crossing cell lines with different genes of interest.

[0219] Cells include, but are not limited to, cells of humans, non-humans, animals, bacteria, fungi, insects, yeasts, and plants, as well as plants and seeds produced by the method described herein. Plant cells include cells selected from the group consisting of corn, rice, sorghum, rye, barley, wheat, millet, oats, sugarcane, grass, or switchgrass, soybeans, canola, alfalfa, sunflowers, cotton, tobacco, peanuts, potatoes, tobacco, Arabidopsis, and safflower cells.

[0220] “Plant” includes references to whole plants, plant organs, plant tissues, seeds, and plant cells, and their offspring. Plant cells include, without limitation, cells from seeds, suspension cultures, embryos, dividing parts, callus tissues, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores. Plant parts include roots, stems, shoots, leaves, pollen, seeds, tumor tissues, and differentiated and undifferentiated tissues, including, without limitation, various forms of cells and cultures (e.g., single cells, protoplasts, embryos, and callus tissues). Plant tissues may be in plants, or in plant organs, tissues, or cell cultures. The term “plant organ” refers to a plant tissue or a set of tissues constituting a part of a plant that is morphologically and functionally distinct. The term “genome” refers to the entire complement of genetic material (genes and non-coding sequences) present in each cell or organelle of an organism or virus; and / or a complete set of chromosomes inherited as (haploid) units from one parent. "Offspring" includes any subsequent generation of plants.

[0221] Transplanted plants include, for example, plants containing a heterologous polynucleotide introduced by a transformation step within their genome. The heterologous polynucleotide can be stably incorporated into the genome so that the polynucleotide is passed down through generations. The heterologous polynucleotide can be incorporated into the genome alone or as part of a recombinant DNA construct. Transplanted plants may contain more than one heterologous polynucleotide within their genome. Each heterologous polynucleotide may confer a different trait to the transplanted plant. The heterologous polynucleotide may contain a sequence derived from an alien species, or, if derived from the same species, a sequence that may be substantially modified from its native form. Transplants may include any cell, cell line, callus, tissue, plant part, or plant whose genotype has been altered by the presence of the heterologous nucleic acid, including the transplant that was initially modified in this way, as well as those produced by sexual crosses or asexual reproduction from the initial transplant. Conventional plant breeding methods, genome editing procedures described herein that do not result in the insertion of foreign polynucleotides, or naturally occurring events, such as random cross-fertilization, non-recombinant viral infection, non-recombinant bacterial transformation, non-recombinant translocation, or changes in the genome (chromosomal or extrachromosomal) caused by natural mutations are not considered to be transplants.

[0222] In a specific embodiment of the present invention, a fertile plant is a plant that produces viable male and female germ cells and self-fertilizes. Such a self-fertilizing plant can produce offspring plants without the contribution of any other germ cell plant and the genetic material contained therein. Another embodiment of the present invention may include the use of a plant that does not self-fertilize because the plant does not produce viable or otherwise fertilizable male germ cells, or female germ cells, or both. As used herein, "male sterile plant" is a plant that does not produce viable or otherwise fertilizable male germ cells. As used herein, "female sterile plant" is a plant that does not produce viable or otherwise fertilizable female germ cells. Male sterile and female sterile plants are recognized as being female fertile and male fertile, respectively. In addition, male fertile (but female sterile) plants can produce viable offspring when crossed with female fertile plants, and female fertile (but male sterile) plants can produce viable offspring when crossed with male fertile plants.

[0223] In this document, “non-conventional yeast” refers to any yeast that is not a Saccharomyces (e.g., S. cerevisiae) or Schizochoromyces yeast species. Non-conventional yeast is described in Non-Conventional Yeasts in Genetics, Biochemistry and Biotechnology: Practical Protocols (K. Wolf, KD Breunig, G. Barth, Eds., Springer-Verlag, Berlin, Germany, 2003), incorporated herein by reference. In certain embodiments, non-conventional yeast may additionally (or alternatively) be yeast that prefers the non-homologous end junction (NHEJ) DNA repair process over the repair process mediated by homologous recombination (HR). In this context (preferring NHEJ over HR), the definition of non-conventional yeast is provided by Chen et al. (incorporated herein by reference. PLoS ONE Further disclosed in 8:e57952). Preferred non-conventional yeasts herein are those of the genus Yarrowia (e.g., Yarrowia repolitica). The term “yeast” herein refers to fungal species existing primarily in a unicellular form. Yeast may optionally be referred to as “yeast cell” herein (see also U.S. Provisional Application 62 / 036,652 filed August 13, 2014, incorporated herein by reference).

[0224] A "centimorgan" (cM) or "map unit" is the distance between two linked genes, markers, target sites, loci, or any pair thereof, and 1% of meiotic products are recombinations. Therefore, a centimorgan corresponds to the distance equal to the 1% average recombination frequency between two linked genes, markers, target sites, loci, or any pair thereof.

[0225] The present invention is useful for the breeding of plants containing one or more introduced traits. Most commonly, the transplanted trait is randomly inserted throughout the plant genome as a result of a transformation system based on Agrobacterium, biolysics, or other commonly used procedures. Recently, gene targeting protocols capable of induced transplant insertion have been developed. One important technique, site-specific integration (SSI), can target the transplanted gene to the same chromosomal location as a previously inserted transplanted gene. Custom-designed meganucleases and custom-designed zinc finger meganucleases allow researchers to design nucleases to target specific chromosomal locations, and these reagents enable the targeting of the transplanted gene to the chromosomal location cut by these nucleases.

[0226] Systems currently used for the precise genetic manipulation of eukaryotic genomes, such as plant genomes, rely on homing endonucleases, meganucleases, zinc finger nucleases, and transcriptional activator-like effector nucleases (TALENs), which require new protein manipulation for every new target locus. The highly specific, RNA-guided DNA nuclease, guide RNA / Cas9 endonuclease system described herein can be more easily customized, making it more useful when modification of many different target sequences is the goal.

[0227] The guide RNA / Cas system described herein is particularly useful for genomic manipulation, especially plant genomic manipulation, in environments where nuclease off-target cleavage may be toxic to target cells. In one embodiment of the guide RNA / Cas system described herein, the expression-optimized Cas9 gene is stably incorporated into a target genome, e.g., a plant genome. The expression of the Cas9 gene is under the control of a promoter, e.g., a homeostatic promoter, a tissue-specific promoter, or a plant promoter, e.g., a temperature-inducible, stress-inducible, developmental stage-inducible, or chemical-inducible promoter. In the absence of the guide RNA or crRNA, the Cas9 protein cannot cleave DNA, so its presence in the plant cell will have little to no effect. Thus, the main advantage of the guide RNA / Cas system described herein is the ability to generate and maintain cell lines or genetically modified organisms capable of efficiently expressing the Cas9 protein with little to no effect on cell viability. To achieve targeted gene modification by inducing cleavage at a desired genomic region, guide RNA or crRNA can be introduced into cells containing a stably integrated and expressed cas9 gene by various methods. For example, guide RNA or crRNA can be synthesized chemically or enzymatically and introduced into Cas9-expressing cells via direct delivery methods such as a gene gun or electroporation. Alternatively, a gene capable of efficiently expressing guide RNA or crRNA in target cells can be synthesized chemically, enzymatically, or in a biological system, and such a gene can be introduced into Cas9-expressing cells via direct delivery methods such as a gene gun or electroporation, or biological delivery methods such as Agrobacterium-mediated DNA delivery.

[0228] Guide RNA / Cas system-mediated gene targeting may be used in a method for inducing transplant gene insertion in a manner similar to that disclosed in WO2013 / 0198888 (published August 1, 2013) using a guide RNA / Cas system as disclosed herein, instead of using a double-strand break inducer to introduce a gene of interest, and / or in a method for generating a complex transgenic locus containing multiple transplant genes. A complex transgenic locus comprises a genomic locus having multiple transplant genes that are genetically linked to one another. By inserting independent transplant genes within 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, 2, or even 5 centimorgans (cM) from each other, the transplant genes may be amplified as a single locus (see, e.g., U.S. Patent Application 13 / 427,138 or PCT Application PCT / US2012 / 030061). After selecting plants containing transplant genes, plants containing (at least) one transplant gene can be crossed to form F1 containing both transplant genes. In the offspring (F2 or BC1) from this F1, 1 / 500 of the offspring will have two different transplant genes recombined on the same chromosome. Subsequently, the complex locus can be multiplied into a single locus possessing both transplant gene traits. This process can be repeated to accumulate as many traits as desired.

[0229] Chromosomal intervals correlated with a phenotype or trait of interest can be identified. Various methods well known in the art can be used to identify chromosomal intervals. The boundaries of these chromosomal intervals are defined to include markers that link to genes controlling the trait of interest. In other words, chromosomal intervals are defined so that any marker within the interval (including terminal markers defining the boundaries of the interval) can be used as a marker for Northern blight resistance. In one embodiment, the chromosomal interval contains at least one QTL and may actually contain more than one QTL. Since one marker can link to more than one QTL, the proximity of multiple QTLs within the same interval can obscure the correlation between a specific marker and a specific QTL. Conversely, for example, if two adjacent markers show co-segregation with the desired phenotypic trait, it is sometimes unclear whether each of these markers identifies the same QTL or two different QTLs. The term “quantitative trait locus” or “QTL” refers to a region of DNA associated with the differential expression of a quantitative phenotypic trait in at least one genetic background, for example, in at least one breeding population. The region of the QTL contains or is closely linked to genes or genes that influence the trait in question. “Alleles of the QTL” may include multiple genes or other genetic factors within a continuous genomic region, such as a haplotype, or a linkage group. Alleles of the QTL may represent a haplotype within a specific window, said window being a continuous genomic region that can be defined and traced by a set of one or more polymorphic markers. A haplotype may be defined by the unique fingerprint of the alleles at each marker within the specific window.

[0230] Various methods can be utilized to identify cells with altered genomes at or near the target site without using screening marker phenotypes. These methods include, but are not limited to, PCR methods, sequencing methods, nuclease digestion, Southern blot, and any combination thereof, and can be viewed as detecting any changes in the target sequence by directly analyzing the target sequence.

[0231] Proteins can be modified in various ways, including amino acid substitution, deletion, cleavage, and insertion. These manipulation methods are generally known. For example, amino acid sequence variants of protein(s) can be produced by mutations in DNA. Methods for mutagenesis and nucleotide sequence alteration include, for example, Kunkel, (1985) Proc. Natl. Acad. Sci. USA 82:488-92; Kunkel et al. , (1987) Meth Enzymol 154:367-82; U.S. Patent No. 4,873,192; Walker and Gaastra, eds. (1983) Techniques in Molecular Biology (MacMillan Publishing Company, New York) and the references cited therein can be cited. Guidelines regarding amino acid substitutions that are unlikely to affect the biological activity of proteins are, for example, Dayhoff et al. , (1978) Atlas of Protein Sequence and StructureThis can be found in the model of Natl Biomed Res Found (Washington, DC). Conservative substitutions, such as exchanging one amino acid for another with similar properties, may be desirable. Conservative deletions, insertions, and amino acid substitutions are not expected to cause fundamental changes in protein properties, and the effects of any substitution, deletion, insertion, or combination thereof can be evaluated by conventional screening assays. Assays for double-strand break-inducing activity are known and generally measure the total activity and specificity of the agent on a DNA substrate containing the target site.

[0232] The term “dicot” refers to a subclass of angiosperms also known as “dicotyledoneae” and includes references to whole plants, plant organs (e.g., leaves, stems, roots, etc.), seeds, plant cells, and their offspring. Plant cells, as used herein, include, without limitation, seeds, suspension cultures, embryos, dividing parts, callus tissues, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores.

[0233] In the context of this specification, the term “crossed” (cross, cross, or crossing) means the fusion of gametes through pollination to produce offspring (i.e., cells, seeds, or plants). This term includes both sexual cross (pollination of a plant by another plant) and self-pollination (self-pollination, i.e., where pollen and ovules (or microspores and megaspores) originate from the same plant or genetically identical plants).

[0234] The term "introgression" refers to the inheritance of a desired allele at a locus from one genetic background to another. For example, the introgression of a desired allele at a specific locus may be inherited by at least one offspring plant through sexual crosses between two parent plants that possess the desired allele within their genomes. Alternatively, for example, the inheritance of the allele may occur through recombination between two donor genomes, for example, in a fused protoplast in which at least one donor protoplast possesses the desired allele within its genome. The desired allele may be, for example, a transplanted gene, a modified (mutated or edited) native allele, or a selected allele of a marker or QTL.

[0235] Standard methods for DNA isolation, purification, molecular replication, vector construction, and validation / characterization are well established (e.g., Sambrook et al. , (1989) Molecular Cloning: A Laboratory Manual (See , (Cold Spring Harbor Laboratory Press, NY) ). The vector and construct comprise a circular plasmid and a linear polynucleotide containing the polynucleotide of interest and optionally other components including a linker, adapter, regulator, or assay. In some examples, the recognition site and / or target site may be contained within an intron, coding sequence, 5' UTR, 3' UTR, and / or regulator region.

[0236] The present invention also provides an expression construct for expressing a guide RNA / Cas system capable of binding to and generating a double-strand cleavage within a target site in a plant, plant cell, or plant part. In one embodiment, the expression construct of the present invention comprises a promoter operably linked to a nucleotide sequence encoding a Cas gene and a promoter operably linked to the guide RNA of the present invention. The promoter can induce the expression of the operably linked nucleotide sequence in a plant cell.

[0237] Any plants, including monocotyledonous and dicots, may be used. Examples of monocotyledonous plants that may be used include corn (zea mace ( Zea mays )), rice (Oryza sativa( Oryza sativa )), rye(Secale Cereale( Secale cereale )), Susu(Sorgeom Bikala( Sorghum bicolor ), Sorgem Bulgar ( Sorghum vulgare )), Millet (e.g., pearl millet (Penisetum glacum ( Pennisetum glaucum )), Proso Millet (Panicum Milliaseum ( Panicum miliaceum )), Jo (Cetaria Italica( Setaria italica )), finger group (Elyucine Coracana ( Eleusine coracana ))), Mill (Triticum astibum( Triticum aestivum ), sugarcane (saccharum ( Saccharum ) species), oats (Avena ( Avena )), barley(hordeum( Hordeum )), Switchgrass(Panicum virgatum( Panicum virgatum ), pineapple (Ananas comosus ( Ananas comosus )), banana(musa( Musa Includes, but is not limited to, species), palms, ornamental plants, lawns, and other grasses. Examples of dicotyledonous plants that may be used include soybeans (glycine max ( Glycine max )), canola(Brassica naphus( Brassica napus ) and Brassica Campestris( B. campestris )), alfalfa(Medicago Sativa( Medicago sativa)), tobacco (Nicotiana tabacum ( Nicotiana tabacum )), Arabidopsis (Arabidopsis thaliana ( Arabidopsis thaliana )), sunflower(Helianthus Annus( Helianthus annuus )), cotton (Gossypium arboreum( Gossypium arboreum )), peanut(arakis hypogaea( Arachis hypogaea )), tomato(Solanum lycopersicum( Solanum lycopersicum )) and potato (Solanum tuberosum ( Solanum tuberosum Includes, but is not limited to, )) etc.

[0238] The meanings of the abbreviations are as follows: "sec" means second, "min" means minute, "h" means hour, "d" means day, "μL" means microliter, "mL" means milliliter, "L" means liter, "μM" means micromolar, "mM" means millimole, "M" means mole, "mmol" means millimole, "μmole" means micromolar, "g" means gram, "㎍" means microgram, "ng" means nanogram, "U" means unit, "bp" means base pair, and "kb" means kilobase.

[0239] Non-limiting examples of the compositions and methods disclosed herein are as follows:

[0240] 1. A method for restoring the function of a non-functional gene product within a cell genome, comprising the step of introducing a guide RNA / Cas endonuclease complex into a cell containing a disrupted gene within the genome, wherein the complex generates a double-strand break, the disrupted gene does not encode a functional gene product, and the disrupted gene is restored to a non-disrupted gene capable of encoding the functional gene product without using a polynucleotide modified template.

[0241] 2. A method in which, in Embodiment 1, the destroyed gene comprises a base pair deletion of the fourth nucleotide upstream (5') of the PAM sequence when compared to the corresponding non-destructive gene, and the base pair deletion causes an amino acid frame shift in the gene product of the destroyed gene, thereby making the gene product of the destroyed gene non-functional.

[0242] 3. In Embodiment 2, the base pair deletion is the first nucleotide of the codon sequence.

[0243] 4. In paragraph 2, the method in which the base pair deletion is the second nucleotide of the codon sequence.

[0244] 5. In Embodiment 2, the method wherein the base pair deletion is the third nucleotide of the codon sequence.

[0245] 6. A method in which, in Embodiment 1, restoration is achieved by non-homologous end junction (NHEJ) that inserts a single base into the double-strand break site.

[0246] 7. A method in Embodiment 1 in which restoration is achieved by inserting a single base into the double-strand break site without using homologous recombination or homologous induction repair.

[0247] 8. As a method of modifying nucleotide sequences within a cell genome,

[0248] A step of introducing a first guide RNA, a Cas endonuclease, and at least a second guide RNA into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double strand into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using a polynucleotide modified template, and the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and

[0249] A method comprising the step of selecting cells having a modification of the above nucleotide sequence by the above functional selection protein.

[0250] 9. In Embodiment 8, the modification is selected from the group consisting of the insertion of at least one nucleotide, the deletion of at least one nucleotide, or the substitution of at least one nucleotide at the target site.

[0251] 10. A method according to Embodiment 8, further comprising the step of introducing a polynucleotide modified template into the cell, wherein the polynucleotide modified template comprises at least one nucleotide modification of the nucleotide sequence.

[0252] 11. In Embodiment 8, the method wherein at least one nucleotide modification of the polynucleotide modified template is selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, and (iv) any combination of (i) to (iii).

[0253] 12. A method according to Embodiment 8, further comprising the step of introducing donor DNA into a cell, wherein the donor DNA comprises at least one polynucleotide of interest to be inserted into the target site.

[0254] 13. In Embodiment 8, the cell is selected from the group consisting of human, non-human, animal, archaea, bacteria, fungi, insects, yeast, non-conventional yeast, and plant cells.

[0255] 14. In Embodiment 13, the method wherein the plant cell is selected from the group consisting of monocot and dicot cells.

[0256] 15. In Embodiment 14, the plant cell is selected from the group consisting of corn, rice, sorghum, rye, barley, wheat, millet, oats, sugarcane, grass, or switchgrass, soybeans, canola, alfalfa, sunflower, cotton, tobacco, peanuts, potatoes, tomatoes, tobacco, Arabidopsis thaliana, and safflower cells.

[0257] 16. A method according to Embodiment 13, further comprising the step of producing a plant or a progeny plant from the plant cell.

[0258] 17. A plant or offspring plant produced by the method of Embodiment 16, lacking any one guide RNA and Cas endonuclease.

[0259] 18. In Embodiment 8, the destroyed selection marker gene is a destroyed ALS-resistance gene.

[0260] 19. A method for editing nucleotide sequences within a cell genome without using a polynucleotide modified template, wherein

[0261] a) introducing at least one guide RNA and at least one Cas endonuclease into at least one cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence;

[0262] b) selecting a cell from (a) that has at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; and

[0263] c) a method comprising the step of introducing at least one guide RNA and at least one Cas endonuclease into the cell of (b), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand cut into the nucleotide sequence and inserting a single nucleotide at the same location as the nucleotide deletion of (b) without using a polynucleotide modified template.

[0264] 20. A method for editing nucleotide sequences within a plant genome without using a polynucleotide modified template or donor DNA, comprising:

[0265] a) introducing at least one guide RNA and at least one Cas endonuclease into at least one plant cell, wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand cut into the nucleotide sequence;

[0266] b) selecting a plant cell from (a) that has at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited;

[0267] c) A step of regenerating a plant from the plant cells of (b);

[0268] d) introducing at least one guide RNA and at least one Cas endonuclease into a cell from the plant of (c), wherein the guide RNA and Cas endonuclease can form a complex capable of introducing a double-strand break into the nucleotide sequence and inserting a single nucleotide at the same position as the nucleotide deletion of (b) without using a polynucleotide modified template; and

[0269] e) Optimally, a method comprising the step of selecting a cell containing the nucleotide insertion of (d).

[0270] 21. A method in any one of embodiments 1, 8, 18 to 20, wherein the guide RNA and Cas endonuclease protein forming the guide RNA / Cas endonuclease complex are introduced into a cell as RNA and protein, respectively.

[0271] 22. A method in any one of embodiments 1, 8, 18 to 20, wherein the guide RNA / Cas endonuclease complex is assembled in vitro before being introduced into a plant cell and introduced into the cell as a ribonucleotide-protein complex.

[0272] 23. A method in any one of embodiments 1, 8, 18 to 20, wherein the component of the guide RNA / Cas endonuclease complex is introduced as mRNA encoding a Cas endonuclease protein and as RNA containing the guide RNA.

[0273] 24. A method in any one of embodiments 1, 8, 18 to 19, wherein the component of the guide RNA / Cas endonuclease complex is introduced as a recombinant DNA molecule encoding a guide molecule and a Cas endonuclease protein.

[0274] 25. A method in which the guide RNA / Cas endonuclease complex is assembled in a cell in any one of embodiments 1, 8, 18 to 19.

[0275] 26. A method for delivering a guide RNA / Cas endonuclease complex into a cell, comprising the steps of: combining at least one guide RNA molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein; combining the ribonucleotide-protein with a particle delivery matrix to allow the ribonucleotide-protein to be combined with the matrix to form a ribonucleotide-protein-matrix complex; and introducing the ribonucleotide-protein-matrix complex into the cell.

[0276] 27. A method for delivering a guide RNA / Cas endonuclease complex into a cell, comprising the steps of introducing at least one guide RNA molecule and at least one Cas endonuclease protein into a cell, and growing the cell under appropriate conditions so that the guide RNA and the Cas endonuclease protein can form a complex within the cell.

[0277] 28. A method for delivering a guide RNA / Cas endonuclease complex into a cell, comprising the steps of introducing at least one guide RNA molecule and at least one mRNA encoding a Cas endonuclease protein into a cell, and growing the cell under appropriate conditions so that the mRNA can translate the Cas endonuclease protein and form a complex with the guide RNA.

[0278] 29. A method according to embodiments 26 to 28, further comprising the step of introducing a polynucleotide template, wherein the polynucleotide modified template comprises at least one nucleotide modification of a nucleotide sequence within the genome of the cell, and the at least one nucleotide modification of the polynucleotide modified template is selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, and (iv) any combination of (i) to (iii).

[0279] 30. A method according to embodiments 26 to 28, further comprising the step of introducing donor DNA, wherein the donor DNA comprises at least one polynucleotide of interest.

[0280] 31. A method in which the guide RNA / Cas endonuclease complex of embodiments 26 to 28 introduces a double-strand cleavage to a target site within the genome of the cell.

[0281] 32. A method in which, in Embodiments 1 to 31, the Cas endonuclease is selected from the group consisting of Cas9 protein, Cpf1 protein, C2c1 protein, C2c2 protein, C2c3 protein, Cas3, Cas3-H, Cas5, Cas7, Cas8, Cas10, or a complex thereof.

[0282] 33. A method in which, in Embodiments 26 to 28, the introduction is carried out through a delivery system selected from the group consisting of particle-mediated delivery, whisker-mediated delivery, cell-penetrating peptide-mediated delivery, electroporation, PEP-mediated transfection, and nanoparticle-mediated delivery.

[0283] 34. In Embodiment 29, the polynucleotide modified template is a single-stranded or double-stranded molecule.

[0284] 35. In Embodiment 30, the donor DNA is a single-stranded or double-stranded molecule.

[0285] 36. A method according to embodiments 26 to 28, wherein the cell is a plant cell comprising a pre-integrated growth gene capable of stimulating cell growth.

[0286] 37. In embodiments 26 to 28, the cell is selected from the group consisting of human, non-human, animal, archaea, bacteria, fungi, insects, yeast, non-conventional yeast, and plant cells.

[0287] 38. In the embodiment 37, the plant cell is selected from the group consisting of monocot and dicot cells.

[0288] 39. In Embodiment 38, the plant cell is selected from the group consisting of corn, rice, sorghum, rye, barley, wheat, millet, oats, sugarcane, grass, or switchgrass, soybeans, canola, alfalfa, sunflower, cotton, tobacco, peanuts, potatoes, tomatoes, tobacco, Arabidopsis thaliana, and safflower cells.

[0289] 40. A method according to Embodiment 36, wherein the plant comprises at least one nucleotide modification within the genome of the plant cell, and the plant does not comprise the guide RNA / Cas endonuclease complex or any combination thereof.

[0290] 41. A plant produced from the plant cell of Embodiment 37, comprising at least one polynucleotide of interest integrated into its genome.

[0291] 42. In Embodiment 26, the particle transfer matrix comprises a fine particle.

[0292] 43. A method in which, in Embodiment 42, the fine particles are selected from the group consisting of gold particles, tungsten particles, and silicon carbide whisker particles.

[0293] 44. A method according to Embodiment 26, wherein the particle delivery matrix comprises microparticles combined with cationic lipids.

[0294] 45. In Embodiment 44, the cationic lipid is a water-soluble cationic lipid.

[0295] 46. ​​In Embodiment 45, the water-soluble cationic lipid is TransIT-2020.

[0296] 47. A method for producing a sulfonylurea-resistant plant having a modified target site, comprising: a) introducing a first guide RNA, a Cas9 endonuclease, and at least a second guide RNA into a plant cell having a destroyed sulfonylurea resistance (ALS) gene, wherein the first guide RNA and the Cas9 endonuclease can form a first complex capable of introducing a double-strand break immediately downstream (3') of a second nucleotide of a codon sequence located in the destroyed sulfonylurea resistance (ALS) gene, and the second guide RNA and the Cas9 endonuclease can form a second complex capable of introducing a double-strand break at the target site; and b) a method comprising obtaining a sulfonylurea-resistant plant from the plant cell, wherein the sulfonylurea-resistant plant comprises a modification to the target, and the modification comprises a step selected from the group consisting of (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, or (iv) any combination of (i) to (iii).

[0297] 48. A method for restoring the function of a non-functional gene product within a cell genome, comprising the step of introducing a guide polynucleotide / Cas endonuclease complex into a cell containing a disrupted gene within the genome, wherein the complex generates a double-strand break, the disrupted gene does not encode a functional gene product, and the disrupted gene is restored to a non-disrupted gene capable of encoding the functional gene product without using a polynucleotide modification template.

[0298] 49. A method in which, in Embodiment 46, the destroyed gene comprises a base pair deletion of the fourth nucleotide upstream (5') of the PAM sequence compared with the corresponding non-destructive gene, and the base pair deletion causes an amino acid frame shift in the gene product of the destroyed gene, thereby making the gene product of the destroyed gene non-functional.

[0299] 48. As a method of modifying nucleotide sequences within the genome of plant cells,

[0300] A step of introducing a first guide polynucleotide, a Cas endonuclease, and at least a second guide polynucleotide into at least one cell comprising a target site and a destroyed selection marker gene, wherein the first guide polynucleotide and the Cas endonuclease can form a first complex capable of introducing a double-strand break into the destroyed selection marker gene, and the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein without using a polynucleotide modification template, and the second guide polynucleotide and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and

[0301] A method comprising the step of selecting cells having a modification of the above nucleotide sequence by the above functional selection marker protein.

[0302] 50. A method for editing nucleotide sequences within a cell genome without using a polynucleotide modified template, wherein

[0303] a) introducing at least one guide polynucleotide and at least one Cas endonuclease into at least one cell, wherein the guide polynucleotide and the Cas endonuclease can form a complex capable of introducing a double-strand cut into the nucleotide sequence;

[0304] b) selecting a cell from (a) that has at least one single nucleotide deletion in the nucleotide sequence, wherein the nucleotide deletion is located at a position to be edited; and

[0305] c) a method comprising the step of introducing at least one guide polynucleotide and at least one Cas endonuclease into the cell of (b), wherein the guide polynucleotide and Cas endonuclease can form a complex capable of introducing a double-strand cut into the nucleotide sequence and inserting a single nucleotide at the same location as the nucleotide deletion of (b) without using a polynucleotide modification template.

[0306] 51. A method for delivering a guide polynucleotide / Cas endonuclease complex into a cell, comprising the steps of: combining at least one guide polynucleotide molecule with at least one Cas endonuclease protein to form a ribonucleotide-protein; combining the ribonucleotide-protein with a particle delivery matrix to allow the ribonucleotide-protein to be combined with the matrix to form a ribonucleotide-protein-matrix complex; and introducing the ribonucleotide-protein-matrix complex into the cell.

[0307] Examples

[0308] In the following examples, unless otherwise noted, parts and percentages are by weight and degrees are in degrees Celsius. It should be understood that these examples are provided merely as examples to illustrate embodiments of the invention. From the foregoing discussion and these examples, those skilled in the art may modify and alter the invention in various ways to suit different uses and conditions. Such modifications are also intended to fall within the scope of the appended claims.

[0309] Example 1

[0310] Modification of target DNA sequences within the plant cell genome by delivery of Cas9 endonuclease and guide RNA expression cassette

[0311] The Cas9 gene (SEQ ID NO: 1) from Streptococcus pyogenes M1 GAS (SF370) was optimized for corn codons using standard techniques known in the art, and the potato ST-LS1 intron (SEQ ID NO: 2) was introduced to eliminate expression in E. coli and Agrobacterium. To facilitate the nuclear localization of the Cas9 protein in corn cells, the primate virus 40 (SV40) part-amino-terminal nuclear localization signal (MAPKKKRKV, SEQ ID NO: 3) and the Agrobacterium tumefaciens part-virD2 T-DNA boundary endonuclease carboxyl-terminal nuclear localization signal (KRPRDRHDGELGGRKRAR, SEQ ID NO: 4) were included at the amino-terminal and carboxyl-terminal ends of the Cas9 open reading frame, respectively. The maize optimized Cas9 gene was operably linked to the maize homeostatic promoter (ubiquitin) by standard molecular biology techniques. Transcription was terminated by the addition of the 3' sequence from the potato proteinase inhibitor II gene (PinII) to generate the UBI:Cas9:PinII vector. The sequence of the ubiquitin-induced maize optimized Cas9 expression cassette is shown in SEQ ID NO: 5.

[0312] Literature [Mali et al., 2013 ( Science A single guide RNA (gRNA) was designed using the method described in [Cong et al., 2013 (339:823-26)]. Corn U6 polymerase III promoters and terminators were isolated and used to direct the initiation and termination of the gRNA, respectively. Science As described in 339:819-23), two pieces in reverse tandem orientation with the cuts oriented outward Bbs I. By introducing a restriction endonuclease site, we facilitated the rapid introduction of maize genomic DNA target sequences into gRNA expression constructs. We promoted the desired polymerase III expression of gRNA using only target sequences starting with a G nucleotide. The gRNA expression cassette was subcloned into the Bluescript SK vector (SEQ ID NO: 6).

[0313] To determine whether the maize-optimized Cas9-gRNA complex could recognize, cleave, and promote target mutations in maize chromosomal DNA via the non-homologous end junction (NHEJ) repair pathway, five maize loci (three different genomic sequences at each loci) were targeted for cleave (see Table 2), and the presence of mutations was investigated by amplicon deep sequencing.

[0314]

[0315] Corn-optimized Cas9 endonuclease and gRNA expression cassettes containing specific corn variable targeting domains were co-delivered to 60–90 Hi-II immature corn embryos by a gene gun (see Example 8) along with a visual selection marker (UBI:MoPAT:DsRED fusion) and developmental genes ZmODP-2 (BBM) and ZmWUS2 (WUS) (see Example 9). Hi-II corn embryos transformed with only Cas9 or gRNA expression cassettes were used as negative controls. After 7 days, 20–30 embryos most uniformly transformed from each treatment (based on transient expression of DsRED fluorescent protein) were collected and whole-genome DNA was extracted. The region surrounding the intended target site was PCR amplified using Phusion® High Fidelity PCR Master Mix (New England Biolabs, M0531L) with "tailed" primers to add sequences necessary for amplicon-specific barcodes and Illumina sequencing through two PCR reactions. The primers used for the first PCR reaction are shown in Table 3.

[0316] PCR primer sequences target area primer Primary PCR primer sequences SEQ ID NO: MS26Cas-1 Forward CTACACTCTTTTCCCTACACGACGCTCTTCCGATCTAGGACCGGAAGCTCGCCGCGT 19 MS26Cas-1 Reverse CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTTCCTGGAGGACGACGTGCTG 20 MS26Cas-2 Forward CTACACTCTTTCCCTACACGACGCTCTTCCGATCTAAGGTCCTGGAGGACGACGTGCTG 21 MS26Cas-2 Reverse CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCCGGAAGCTCGCCGCGT 22 MS26Cas-3 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCTCCGGAAGCTCGCCGCGT 23 MS26Cas-3 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTTCCTGGAGGACGACGTGCTG 20 LIGCas-1 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGGACTGTAACGATTTACGCACCTGCTG 24 LIGCas-1 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCAAATGAGTAGCAGCGCACGTAT 25 LIGCas-2 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCTCTGTAACGATTTACGCACCTGCTG 26 LIGCas-2 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCAAATGAGTAGCAGCGCACGTAT 25 LIGCas-3 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTAAGGCGCAAATGAGTAGCAGCGCAC 27 LIGCas-3 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCACCTGCTGGGAATTGTACCGTA 28 MS45Cas-1 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGGAGGACCCGTTCGGCCTCAGT 29 MS45Cas-1 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCCGGCTGGCATTGTCTCTG 30 MS45Cas-2 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCTGGACCCGTTCGGCCTCAGT 31 MS45Cas-2 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCCGGCTGGCATTGTCTCTG 30 MS45Cas-3 포워드 CTACACTCTTTCCCTACACGACGCTCTTCCGATCTGAAGGGACCCGTTCGGCCTCAGT 32 MS45Cas-3 리버스 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCCGGCTGGCATTGTCTCTG 30 ALSCas-1 Forward CTACACTCTTTTCCCTACACGACGCTCTTCCGATCTAAGGCGACGATGGGCGTCTCCTG 33 ALSCas-1 Reverse CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCGTCTGCATCGCCACCTC 34 ALSCas-2 Forward CTACACTCTTTTCCCTACACGACGCTCTTCCGATCTTTCCCGACGATGGGCGTCTCCTG 35 ALSCas-2 Reverse CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCGTCTGCATCGCCACCTC 34 ALSCas-3 Forward CTACACTCTTTTCCCTACACGACGCTCTTCCGATCTGGAACGACGATGGGCGTCTCCTG 36 ALSCas-3 Reverse CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCGTCTGCATCGCCACCTC 34

[0317] The primers used for the second PCR reaction were AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACG (forward, SEQ ID NO: 37) and CAAGCAGAAGACGGCATA (reverse, SEQ ID NO: 38).

[0318] The obtained PCR amplifications were purified using a Qiagen PCR purification spin column, concentrations were measured using Hoechst dye-based fluorescence analysis, and equimolar combinations were performed. Sequence bias was offset by performing single-transmission 100-nucleotide deep sequencing on Illumina's MiSeq Personal Sequencer with PhiX control v3 (Illumina, FC-110-3001) of 30–40% (v / v) spikes. Only sequences containing one or more nucleotide insertions or deletions occurring within a 10-nucleotide window centered on the expected cleavage site, which were not found at similar levels in the negative control, were classified as mutants. Mutant sequences with identical mutations were counted and separated into a single group, and the top 10 most common mutations were visually confirmed to occur within the expected cleavage site. Subsequently, the percentage of mutant sequences was calculated based on the total number of appropriate-length sequences containing perfect matches with the barcode and forward primers, using the total number of mutations.

[0319] The mutation frequencies revealed by deep amplicon sequencing for the Cas9-gRNA system targeting all 15 sites are shown in Table 4.

[0320] Percentage of mutation sequencing at 5 target loci (15 target sites) Target DSB reagent Total number of decryptions Number of mutation target gene decodings Percentage of mutation decoding in target genes LIG (Chr. 2) LIG-CR1 gRNA+Cas9 716,854 33,050 4.61% LIG-CR2 gRNA+Cas9 711,047 16,675 2.35% LIG-CR3 gRNA+Cas9 713,183 27,959 3.92% MS26 (Chr. 1) MS26-CR1 gRNA+Cas9 575,671 10,073 1.75% MS26-CR2 gRNA+Cas9 543,856 16,930 3.11% MS26-CR3 gRNA+Cas9 538,141 13,879 2.58% MS45 (Chr. 9) MS45-CR1 gRNA+Cas9 812,644 3,795 0.47% MS45-CR2 gRNA+Cas9 785,183 14,704 1.87% MS45-CR3 gRNA+Cas9 728,023 9,203 1.26% ALS1 (Chr. 4) and ALS2 (Chr. 5) ALS-CR1 gRNA+Cas9 434,452 9,669 2.23% ALS-CR2 gRNA+Cas9 472,351 6,352 1.35% ALS-CR3 gRNA+Cas9 497,786 8,535 1.72% control group Cas90,000 640,063 1 0.00% LIG-CR1 gRNA only 646,774 1 0.00%

[0321] Further analysis revealed that the most common type of mutation promoted by the Cas9-gRNA system was a single nucleotide insertion (see, e.g., Fig. 1, SEQ ID NO: 49 to 58). Similar results were observed in most of the gRNAs tested (Table 5).

[0322]

[0323] This example demonstrates that RNA-induced Cas9 generates double-strand breaks with a high mutation frequency. Mutation analysis at various target sites revealed deletions and / or insertions of varying sizes, but single nucleotide insertions and single nucleotide deletions were found to be the most common types of mutations generated by Cas9-gRNA technology at most target sites tested in maize.

[0324] Example 2

[0325] The edited acetolactate synthase gene confers resistance to chlorsulfuron.

[0326] This example shows that specific change(s) introduced into the nucleotide sequence of the natural corn acetolactate synthase (ALS) gene induce resistance to sulfonylurea herbicides, particularly chlorsulfuron.

[0327] Corn has two ALS genes, ALS1 (SEQ ID NO: 39) and ALS2 (SEQ ID NO: 40), located on chromosomes 4 and 5, respectively, which have 94% sequence identity at the DNA level.

[0328] The ALS protein contains an N-terminal transporter, and the mature protein is formed after transport to the chloroplast and subsequent cleavage of the transport peptide. The mature protein starts at residue S41 and produces a 598-amino acid mature protein (SEQ ID NO: 41) with a predicted molecular weight of 65 kDa.

[0329] Modifications in the nucleotide sequences of ALS1 or ALS2 that cause changes in a single amino acid residue (P165A or P165S, gray box) compared to the endogenous corn acetolactate synthase protein provide resistance to herbicides in corn.

[0330] Since acetolactate synthase is a critical enzyme for plant cellular function, simultaneous bi-allelic knockout of the ALS1 and ALS2 genes is not expected to result in survival. Therefore, based on polymorphisms between the ALS1 and ALS2 nucleotide sequences, ALS2-specific ALSCas-4 target sites were identified and validated. ALSCas-1 guide RNA expression constructs targeting both ALS1 and ALS2 genes were used as a control. Table 6 shows information regarding the ALSCas-1 and ALSCas-4 target sites.

[0331]

[0332] As described in Example 1 and shown in Table 7, mutation frequencies in ALSCas-1 and ALSCas-4 were determined by amplicon deep sequencing.

[0333]

[0334] These results demonstrated that the ALSCas-4 gRNA / Cas9 system mutated the ALS2 gene with approximately 90 times higher efficiency than the ALS1 gene. Therefore, the ALSCas-4 target site and the corresponding ALS-CR4 gRNA were selected for ALS gene editing experiments.

[0335] To generate the ALS2 edited allele, a 794 bp polynucleotide modification template (SEQ ID NO: 43) containing homologous fragments was replicated into a plasmid vector, and two 127 nt single-stranded polynucleotide modification templates (also called DNA oligos, Oligo1, SEQ ID NO: 44, and Oligo2, SEQ ID NO: 45) were tested as polynucleotide modification templates (Fig. 2). The 794 bp fragment had the same sequence modification as Oligo 1. The polynucleotide modification templates (repair templates) contained several nucleotide changes compared to the original sequence. The single-stranded Oligo1 and the 794 bp repair templates included a single nucleotide change (P165S) ​​to edit the DNA sequence corresponding to proline at amino acid position 165 to serine, as well as three additional changes within the ALS-CR4 target site and PAM sequence. The modification of the PAM sequence within the repair template changed the methionine codon (AUG) to isoleucine (AUU), which occurs naturally in the ALS1 gene. The second 127 nt single-stranded oligo repair template (Oligo2) was also tested, which preserved the methionine at position 157 but included three additional single nucleotide changes in the sequence that would affect base pairing with ALS-CR4 gRNA (Fig. 2).

[0336] Approximately 1,000 immature embryos per treatment were particle-coordinated with two oligos or single plasma repair templates, Cas9, ALS-CR4 gRNA, and MoPAT-DsRED from DNA expression cassettes and placed in medium to select for PAT-conferred non-aliaphos resistance. Five weeks after transfection, 200 randomly selected independent nascent callus sectors (per treatment) growing in the selection medium were detached from the embryos and transferred to new non-aliaphos plates. The remaining embryos with developing callus events (over 800 per treatment) were transferred to plates containing 100 ppm chlorsulfurone for direct selection of the edited ALS2 gene. After one month, a total of 384 randomly selected callus sectors grown on Bialaphos (approximately 130 events per repair template) and 7 callus sectors continued to grow in a medium containing chlorsulfuron were analyzed by PCR amplification and sequencing. Edited ALS2 alleles were detected in 9 callus sectors: 2 were derived from callus sectors grown on Bialaphos and generated using a 794 bp repair DNA template, and the remaining 7 were derived from chlorsulfuron-resistant callus sectors edited using 127 nt single-stranded oligos (3 by Oligo1 and 4 by Oligo2). The second ALS2 allele in these callus sectors was mutated as a result of NHEJ repair. ALS1 gene analysis revealed that only the wild-type sequence confirmed the high specificity of ALS-CR4 gRNA.

[0337] For further molecular analysis and progeny testing, plants were regenerated from 7 of the 9 callus sectors containing the edited ALS2 allele. DNA sequencing of the ALS2 allele confirmed the presence of the P165S variant (ALS2-P165S), as well as other nucleotide changes associated with each repair template. To evaluate the inheritance of the edited ALS2 allele, T1 and T2 offspring of two T0 plants generated from different callus events (794 bp repair DNA and Oligo2) were analyzed. Offspring plants derived from crosses using pollen from wild-type Hi-II plants were sequencingd and exhibited sexual inheritance of the edited allele observed in the parent plants, with an expected segregation ratio of 1:1 (57:56 and 47:49, respectively). To test whether the edited ALS sequence confers herbicide resistance, four different concentrations of chlorsulfuron (50, 100 (1x), 200, and 400 mg / L) were sprayed on selected 4-week-old T1 isolates carrying the edited wild-type ALS2 allele. Three weeks after treatment, plants with the edited allele exhibited a normal phenotype (Fig. 3, left), while plants with only the wild-type allele showed strong signs of cellular senescence (Fig. 3, right).

[0338] In addition to resistance to sulfonylurea herbicides (specifically, chlorsulfuron), the ALS gene can be modified to confer resistance to other types of AHAS inhibitors, including triazolopyrimidine, pyrimidinylthiobenzoate, and imidazolinone herbicides (Tan S, Evans RR, Dahmer ML, Singh BK, Shaner DL (2005) Imidazolinone-tolerant crops: history, current status and future. Pest Management Science 61: 246-257). Therefore, modifications to the ALS gene should not be limited to the changes described herein and the changes conferring chlorsulfuron resistance.

[0339] These experiments demonstrate that Cas9-gRNA stimulates HDR-dependent target sequence modifications in maize, enabling the generation of plants with edited endogenous genes that are properly inherited by subsequent generations. The data also indicate that a single ALS2 allele edited under the endogenous promoter confers herbicide resistance in maize.

[0340] Example 3

[0341] ALS2 as an Endogenous Selection Marker Gene

[0342] This example demonstrates how a specifically edited ALS2 gene can be used to generate an intracellular select marker that replaces the delivery of exogenous marker genes currently used in plant transformation.

[0343] Because the frequency of plant transformation (recovery of gene transfer events) is relatively low, select marker genes conferring resistance to various herbicides are typically co-transmitted with trait genes. To confer resistance, these select marker genes must be stably integrated into the plant genome and removed over successive generations or through breeding. Some native plant genes can be specifically modified (edited) to confer resistance to herbicides. As described in Example 2, the ALS2 gene with a single amino acid change confers resistance to chlorsulfuron. Therefore, it can be expected that gene mutagenesis, gene editing, co-transmission of trait genes, and simultaneous ALS2 gene editing can be utilized without exogenously supplied marker genes. Given the high mutation frequency resulting from NHEJ repair of DSBs generated by the Cas9-gRNA system (Example 1), this approach may be useful for gene mutagenesis. In this case, the frequency of mutation events is expected to depend on HDR-mediated ALS gene editing. Regarding gene editing, the combination of two low-frequency HDR-dependent genome editing processes in plant cells (one for ALS gene repair for selection and the other for endogenous gene editing or trait gene integration) is likely to make an approach using simultaneous ALS2 gene editing somewhat unrealistic.

[0344] The following example describes a method that can overcome these low efficiencies (and impracticalities) and improve the possibility of selecting plant cells resistant to selective agents. This method relies not on HDR-dependent gene editing, but on the restoration of gene function through targeted mutagenesis via NHEJ DNA repair, which is more common in plant somatic cells (than HDR). As described in Example 2, maize possesses two ALS genes, ALS1 and ALS2, located on chromosomes 4 and 5, respectively. Specific editing of either of the two ALS genes would confer herbicide resistance. These genes play essential roles in plant metabolism; consequently, targeting and mutating both genes leads to apoptosis. Therefore, in this example, the modification involves only the ALS2 gene using an ALS2-specific gRNA that does not target the ALS1 gene, so ALS1 remains wild-type. Specifically, two modifications are introduced into the ALS2 gene; First, specific nucleotide(s) changes conferring resistance to chlorsulfurone, for example, a change from C to T at nucleotide position 493 to convert proline to serine at amino acid position 165 (referred to as ALS2-P165S) ​​(Fig. 2, oligo1), or a change from C to T and a change from C to G at nucleotide positions 493 and 495, respectively (Fig. 2, oligo2) (see Example 2 for details). Second, a translation frame shift resulting from the removal of a single nucleotide, for example, the removal of G at nucleotide position 165 (Figs. 4a to 4b) (Fig. 4b), and the consequent loss of ALS2-mediated chlorsulfurone resistance (referred to as ALS2-P165S-CCΔ).While many designs are expected, for the highest frequency ALS2 gene repair, the single nucleotide position (examples shown in FIGS. 4a to 4c) should preferably be i) the fourth nucleotide upstream (5') from the PAM sequence at the gRNA / Cas endonuclease target site, and ii) the third nucleotide at the codon (Fig. 4a). This third position is flexible for most amino acids and can be occupied by any of the four nucleotides in eight of the 20 amino acids (Table 8). Given this flexibility, a higher frequency of proper repair is expected at the third position compared to the first or second position.

[0345]

[0346] Four different target sites and their corresponding gRNAs satisfying the above criteria were selected. In addition to the aforementioned preferred single nucleotide sites, the corresponding gRNAs must have a high frequency of mutations with a high mutation rate indicating single nucleotide insertion at the cleavage site. Of the four tested target sites that satisfied all described preferences and were therefore suitable for this experiment, only one was identified (referred to as ALSCas-7; Table 9).

[0347]

[0348] Next, the ALS2-P165S gene conferring resistance to chlorsulfuron was further modified (generating a disrupted gene): a translational frameshift and disrupted gene were generated by removing a G nucleotide at the agitation site (the third nucleotide position of the codon) and altering the proline codon encoded by CCG (underlined in Table 9) at the ALSCas-7 target site (referred to as ALS2-P165S-CCΔ; Figures 4a to 4b). As demonstrated in Example 1, the repair of DSBs generated by the Cas9-gRNA system in maize and repaired via NHEJ usually results in a single nucleotide insertion at the cleavage site. Therefore, the function of the ALS2-P165S-CCΔ gene, and consequently, cellular resistance to chlorsulfurone, can be restored by the generation of a double-strand break (DSB) at a modified ALSCas-7 site called ALSCas-7-1 (GCTCCCCCGGCCACCCCCTC; SEQ ID NO: 80) and its repair via NHEJ (see FIG. 4b to 4c).

[0349] Based on the present invention, the simultaneous delivery of two or more gRNAs can be envisioned where one gRNA targets and activates the ALS2-P165S-CCΔ gene disrupted via NHEJ (thus conferring herbicide resistance), and other gRNA(s) promote DSB(s) at ALS2 and other sites and facilitate desired genomic modifications, e.g., targeted mutagenesis, deletion, gene editing, or site-specific phenotypic gene insertion. This approach can enable completely transient targeted genomic modifications because all other necessary components (Cas9, gRNA) can be delivered in the form of proteins and / or in vitro transcribed RNA molecules.

[0350] To validate this approach, maize plants (Hi-II genotype) with the aforementioned ALS2 gene specifically modified were generated. First, the ALS2 sequence was modified at amino acid position 165 to confer resistance to chlorsulfuron as described in Example 2. Subsequently, immature embryos from plants homozygous for editing were particle-boosted with Cas9 and ALS-CR7 gRNAs targeting the ALSCas-7 target site, a selection marker (UBI:MoPAT-DSRED fusion), and a cell growth-enhancing gene (see Examples 8 and 9 for details). Regenerative agents from non-Alphaphos-resistant callus sectors were analyzed by sequencing. Several T0 plants with a single nucleotide deletion (G at nucleotide position 165) were identified (Figs. 4a to 4b). This deletion resulted in a translation frameshift (Fig. 4b) and a loss of ALS2-P165S-mediated chlorsulfuron resistance. Plants homozygous for both edits (ALS2-P165S-CCΔ) were regenerated, confirmed by sequencing, and tested for the loss of herbicide resistance by spraying with chlorsulfuron.

[0351] Embryos from homozygous plants with a specifically modified endogenous ALS2 gene (ALS2-P165S-CCΔ) were used for a validation experiment. To demonstrate that the edited disruptive ALS2-P165S-CCΔ gene can be repaired (and thus encode a functional protein) as previously described and can function as a selection marker, a DNA vector encoding Cas9, gRNA targeting the ALSCas-7-1 site (referred to as ALS-CR7-1), cell growth enhancer genes (ZmODP2 and ZmWUS), and MS45-CR2 gRNA were co-delivered into maize (Hi-II) immature embryonic cells. One week after particle collision, embryos were transferred to a medium containing 100 ppm chlorsulfurone for selection. Herbicide-resistant callus events occurred in approximately 30% of embryos (84 out of 290), which were analyzed by sequencing. The majority of events (79 events) showed a single nucleotide insertion at the expected ALSCas-7-1 DSB site (Fig. 4c) and the complete restoration of the ALS2-P165S gene. Four events had no insertions but had 2 or 5 bp deletions that repositioned the gene within the frame, and one event appeared to be wild. Of the 83 events, 50 (60%) also showed mutations at the MS45Cas-2 target site.

[0352] This embodiment demonstrates the utility and validation of concept of specifically modified inactive ALS2 as an endogenous selection marker gene using an inductive Cas endonuclease system. Based on the results described herein, those skilled in the art may use and extend the described approach to any similarly modified endogenous or pre-integrated exogenous gene(s) to replace the co-transfer of selection marker genes currently used in plant genome editing experiments.

[0353] Example 4

[0354] Alternative design to restore function to non-functional proteins encoded by disrupted genes

[0355] In the previous example, the sequence change was incorporated into the coding region or within ALS2-P165S. It is expected that other sequence changes generating a disrupted gene (which does not encode a functional protein) could also be designed to be used as a reactivation sequence. This example describes the generation of a reactivation sequence that relies on the removal of an out-of-frame start codon upstream of the primary translation start codon of ALS2-P165S, rather than relying on the restoration of a codon within the coding sequence.

[0356] According to the scanning model of eukaryotic translation initiation, the first AUG codon for the 5' cap of mRNA is used to initiate protein synthesis (Kozak M. 1989. The scanning model for translation: an update. The Journal of Cell Biology 108: 229-241). Therefore, if the AUG codon within the non-coding leader of 15 RNA transcripts is out-of-frame upstream of the primary initiation codon, protein synthesis of the polypeptide encoded by the mRNA is disrupted. To utilize this rule and apply it to strategies for reactivating gene expression or function, the endogenous ALS2-P165S allele can be generated to include an upstream out-of-frame translation initiation codon (Figs. 5a to 5b). This allele includes a Cas9 PAM recognition site and an ALS-CRX targeting spacer. In this embodiment, cleavage by Cas9 between nucleotides 3 and 4 located at the 5' of the PAM site can promote nucleotide deletion(s) or insertion(s) that may result in the loss of an ATG codon. This loss of an upstream out-of-frame ATG due to any combination of deletions or insertions resulting from NHEJ repair may cause translation initiation at the primary ALS2-P165S initiation codon that confers herbicide resistance.

[0357] The reactivation strategy using an upstream out-of-frame ATG is not expected to be limited to the design of FIGS. 5a and 5b. As long as targeted cleavage by Cas9 results in the loss of these start codons, the PAM and targeting spacers may be placed at various locations relative to the upstream out-of-frame ATG. For example, the PAM may be located on the 5' antisense strand of the start codon. Other designs may be considered; the out-of-frame ATG start codon may be placed at other locations within the 5' leader sequence. The PAM sequence may be recognized by other Cas9 proteins that recognize nGG PAM or non-nGG PAM sequences, such as Streptococcus pyogenes, for example, Streptococcus thermophilus CR1 (which recognizes the PAM sequence nnAGAAn) and others having the PAM sequence. The utility of other Cas9 proteins will satisfy the reactivation design of Example 3 described above as well as this example.

[0358] Other designs for gene activation are anticipated. As previously mentioned, modifications to the ALS gene, which confers resistance to other herbicides in addition to chlorsulfuron resistance, may be used for reactivation. Additionally, the phosphomannose isomerase gene (PMI), non-alphaphos resistance gene (BAR), phosphinothricin acetyltransferase (PAT), hygromycin resistance gene (NPTII), selection marker genes, fluorescent marker genes (e.g., but not limited to RFP, red fluorescent protein, CFP, GFP, green fluorescent protein), and glyphosate resistance gene may be modified to be introduced into plant cells in an inactive form as described in Example 3, and may be used as targets for reactivation by guide RNA introduction and repair by NHEJ. Furthermore, it is anticipated that having multiple inactive genes may serve as targets. For example, since guide RNA multiplexing has been demonstrated to modify multiple genes simultaneously in a single experiment, targeted reactivation of chlorsulfurone and non-alaphos resistance genes can be further designed for this approach, although not limited to these genes. As previously mentioned, modification of other targets will be achieved simultaneously by adding other guide-polynucleotides while restoring gene function by NHEJ.

[0359] In addition, a similar approach can be applied to any native or introduced gene sequence and can be used as an efficient gene switching mechanism.

[0360] Example 5

[0361] Specific gene editing without introducing polynucleotide modified templates for homology-induced repair

[0362] Example 2 describes a sequence alteration (P165S) ​​within the coding region of the ALS2 gene using a specially designed polynucleotide modification template (repair template). The following examples describe a different approach to generating an edited gene of interest that relies on NHEJ rather than the HDR mechanism.

[0363] As described in Example 1, the two most common mutation types promoted by NHEJ repair of DSBs generated by Cas9 nuclease are 1 bp insertion and 1 bp deletion (Table 4). Based on these observations described herein, a method for gene editing that can be achieved in two consecutive steps or a single step has been developed, as described below.

[0364] Step 1 involves using the RNA-induced Cas nuclease system described herein to target a gene or polynucleotide of interest containing a target site recognized by a Cas endonuclease, thereby generating a cell or organism with a specific nucleotide deletion resulting from NHEJ repair of the cleaved DNA (illustrated in FIG. 6a). Step 2 requires retargeting the mutated site and selecting an event involving the insertion of the desired nucleotide (without using a polynucleotide modification template (repair template)) to specifically alter the corresponding amino acid and gene function. Generally, the idea is illustrated in FIG. 6a through 6c. This method may also be used to edit non-coding DNA fragments.

[0365] Alternatively, the two steps can be combined into a single step. Two different gRNAs may be used, one that recognizes the original target site and the second that recognizes the same site but with a 1 bp deletion. In this case, a sequence of cleavage and repair of the endogenous site can be envisioned, in which the altered site is cleaved after the 1 bp deletion and repaired with a 1 bp insertion. Subsequently, an event involving the insertion of the desired nucleotide can be selected. When editing a coding DNA sequence, this process achieves two goals: restoration of the translation decoding frame and substitution of the amino acid of interest. It is expected that combinations of different endonucleases may be used in such a two-step or one-step system. For example, the introduction of a first double-strand break inducing a single base deletion of the polynucleotide of interest may be achieved by a first endonuclease, while the introduction of a second double-strand break inducing a single base insertion (and editing of the polynucleotide of interest) may be achieved by a second endonuclease different from the first endonuclease. Differences between endonucleases may include, but are not limited to, different PAM recognition sequences, different target recognition sequences, different cleavage activities (smooth ends, 5' or 3' overhangs, single strands, double strands), different DNA or amino acid sequences derived from different organisms, or any combination thereof.

[0366] The ability to edit specific nucleotides within the genome of interest may depend on the endonuclease system of choice and the ability to recognize and cleave specific target sites. The discovery of novel inducible endonucleases (see, for example, U.S. Patent Application 62 / 162377 filed May 15, 2015), and / or modifications of inducible endonucleases having various PAM sequences will further increase the density of target sites that can be recognized and / or cleaved by these endonucleases, ultimately enabling the ability to target any given nucleotide location within the genome using the method described herein.

[0367] Example 6

[0368] Corn lines with stably integrated Cas9 endonuclease

[0369] This embodiment describes the generation and verification of a maize line having a stably integrated Cas9 expression cassette.

[0370] Two Agrobacterium vectors (Fig. 7) containing a corn codon-optimized Cas9 under the transcriptional control of a homeostatic (corn UBI, SEQ ID NO: 46) or thermoregulatory (corn MDH, SEQ ID NO: 47) promoter were introduced into Hi-II embryonic cells to establish a lineage containing a pre-integrated genomic copy of the Cas9 endonuclease. Additionally, these vectors contained discontinuous copies of the DsRED gene, which is transcriptionally regulated by the embryo-preferred END2 promoter and the corn histone 2B promoter, which regulate the expression of the blue fluorescent gene (AmCYAN) as a visual marker. A portion of the DsRED sequence was replicated in the forward direction (a 369 bp fragment) and consisted of two fragments of the DsRED (RF-FP) gene separated by a 347 bp spacer that could be targeted by gRNA. DSBs within the spacer region promote intramolecular recombination that restores function to the disrupted DsRED gene, which generates red fluorescent cells. Maize plants with single-copy T-DNA inserts containing UBI:Cas9 or MDH:Cas9 were used as a source of immature embryos. Blue fluorescent embryos containing pre-integrated Cas9 were excised and cultured at 28°C (UBI:Cas9) or 37°C (MDH:Cas9) for 24 hours. After particle collision, embryos with MDH:Cas9 were cultured at 37°C for 24 hours and then transferred to 28°C. Unlike the control group (no gRNA), UBI:Cas9 and MDH:Cas9, containing embryos particle-collised with two DNA expression gRNAs targeting sequences within the 347 bp spacer, readily produced red fluorescent aggregation.

[0371] These results demonstrate that the aforementioned corn line possesses a single copy of the functional Cas9 endonuclease.

[0372] Example 7

[0373] Transient gRNA delivery within embryonic cells containing pre-integrated Cas9 induces mutations in maize

[0374] This example demonstrates that delivering gRNA in the form of an in vitro transcribed RNA molecule into maize immature embryonic cells containing pre-integrated Cas9 induces mutations at the target site.

[0375] The maize plants described in Example 6 containing UBI:Cas9 or MDH:Cas9 were used as DNA expression cassettes for control or as a source of immature embryos for delivering gRNA as in vitro transcriptional RNA. To measure mutation frequencies at LIG and MS26 endogenous target sites, LIG-CR3 and MS26-CR2 gRNAs were delivered as RNA molecules (100 ng / shot) or as DNA vectors (25 ng / shot) into UBI:Cas9 and MDH:Cas9 containing embryonic cells treated with the temperature treatment described in Example 6. In these experiments, embryos were recovered 2 days after particle collision and analyzed by amplicon deep sequencing. Particularly for Cas9 regulated by a ubiquitin promoter, similar frequencies were found for gRNAs delivered as DNA vectors and RNA molecules (Table 10).

[0376] Percentage of mutation decoding at maize LIG and MS26 target sites generated by delivery of intraembryo transient gRNA containing pre-integrated Cas9 under homeostatic (UBI) or modulated (MDH) promoters target area embryo Transgenic Percentage of mutation detoxification (2 days after particle collision) LIG UBI:Cas9 gRNA (DNA) 1.22% gRNA (RNA) 1.86% MDH:Cas9 Incident 1 gRNA (DNA) 0.25% gRNA (RNA) 0.12% MDH:Cas9 Incident 2 gRNA (DNA) 0.57% gRNA (RNA) 0.26% MDH:Cas9 Incident 3 gRNA (DNA) 0.46% gRNA (RNA) 0.35% MS26 MDH:Cas9 Incident 2 gRNA (DNA) 0.58% gRNA (RNA) 0.17%

[0377] Taken together, these data demonstrate that delivering gRNA in the form of direct RNA into corn cells containing pre-integrated Cas9 is a viable alternative to DNA delivery for inducing mutations in plant cells.

[0378] Example 8

[0379] Transformation of immature corn embryos

[0380] Transformation can be achieved by various methods known to be effective for plants, including particle-mediated delivery, Agrobacterium-mediated transformation, PEG-mediated delivery, and electroporation.

[0381] a. Particle-mediated transport

[0382] Transformation of immature corn embryos using particle transfer is performed as follows. The method for preparing the culture medium is as follows.

[0383] Peel the ears, surface sterilize with 30% Clorox bleach and 0.5% Micro detergent for 20 minutes, and rinse twice with sterile water. Immature embryos are isolated, and 25 embryos per plate are placed in 560Y medium for 4 hours with the embryonic axis side down (blastodisc side up), then aligned within a 2.5 cm target zone to prepare for particle collision. Alternatively, the isolated embryos are placed in 560L (initial medium) and kept in a dark room at a temperature ranging from 26°C to 37°C for 8 to 24 hours before being placed in 560Y medium for 4 hours at 26°C prior to particle collision as described above.

[0384] A plasmid containing a double-strand break inducer and template or donor DNA is constructed using standard molecular biology techniques and co-compensated with a plasmid containing the developmental gene ODP2 (AP2 domain transcription factor ODP2 (ovule developmental protein 2); US20090328252 A1) and WUSCHEL (US2011 / 0167516).

[0385] plasmid and DNA of interest as follows: water-soluble cationic lipid TransPrecipitate on a 0.6 µm (average diameter) gold pellet using IT-2020 transfection reagent (Cat# MIR 5404, Mirus, USA). Prepare a DNA or DNA and RNA solution on ice using a total of 1 µg of DNA and / or RNA construct (10 shots). To the pre-mixed DNA, add 20 µl of prepared gold particles (15 mg / ml) and 1 µl of Trans Carefully add and mix IT-2020. Pellet the gold particles in a microcentrifuge at 10,000 rpm for 1 minute and remove the supernatant. Add 105 µl of 100% EtOH and resuspend by sonication for a short time. Subsequently, apply 10 µl to the center of each macrocarrier and dry before particle collision. Collide the sample plates at 425 PSI using a Biorad Helium Gun (shelf #3).

[0386] After particle collision, embryos are cultured in 560P (maintenance medium) at a temperature ranging from 26°C to 37°C for 12 to 48 hours, then placed at 26°C. After 5 to 7 days, embryos are transferred to 560R selective medium containing 3 mg / L of Bialaphos and subcultured every 2 weeks at 26°C. After selection, about 10 weeks later, selected resistant callus clones are transferred to 288J medium to initiate plant regeneration. After somatic embryo maturation (2 to 4 weeks), well-developed somatic embryos are transferred to germination medium and moved to a lighted culture room. After about 7 to 10 days, developing plants are transferred to hormone-free medium 272V in tubes for 7 to 10 days until the plants are well established. Next, transfer the plant to a flat insert (corresponding to a 2.5" pot) containing potting soil, grow it in a growth chamber for one week, then grow it in a greenhouse for an additional one to two weeks, then transfer it to a Classic 600 pot (1.6 gallons) and allow it to mature. Monitor the plant and score changes in transformation efficiency and / or regenerative capacity.

[0387] The initiation medium (560L) contains 4.0 g / l of N6 base salt (SIGMA C-1416), 1.0 ml / l of Eriksson's Vitamin Mix (1000X SIGMA-1511), 0.5 mg / l of thiamine HCl, 20.0 g / l of sucrose, 1.0 mg / l of 2,4-D, and 2.88 g / l of L-proline (adjusted to pH 5.8 with KOH and then volume adjusted with DI H2O); 2.0 g / l of Gelite (added after volume adjusted with DI H2O); and 8.5 mg / l of silver nitrate (added after sterilizing the medium and cooling it to room temperature).

[0388] The maintenance medium (560P) contains 4.0 g / l of N6 base salt (SIGMA C-1416), 1.0 ml / l of Eriksson's Vitamin Mix (1000X SIGMA-1511), 0.5 mg / l of thiamine HCl, 30.0 g / l of sucrose, 2.0 mg / l of 2,4-D, and 0.69 g / l of L-proline (adjusted to pH 5.8 with KOH and then volume adjusted with DI H2O); 3.0 g / l of Gelite (added after volume adjusted with DI H2O); and 0.85 mg / l of silver nitrate (added after sterilizing the medium and cooling it to room temperature).

[0389] Particle collision medium (560Y) contains 4.0 g / l of N6 base salt (SIGMA C-1416), 1.0 ml / l of Eriksson's Vitamin Mix (1000X SIGMA-1511), 0.5 mg / l of thiamine HCl, 120.0 g / l of sucrose, 1.0 mg / l of 2,4-D, and 2.88 g / l of L-proline (adjusted to pH 5.8 with KOH and then volume adjusted with DI H2O); 2.0 g / l of Gelite (added after volume adjusted with DI H2O); and 8.5 mg / l of silver nitrate (added after sterilizing the medium and cooling it to room temperature).

[0390] Selective medium (560R) comprises 4.0 g / l of N6 base salt (SIGMA C-1416), 1.0 ml / l of Eriksson's Vitamin Mix (1000X SIGMA-1511), 0.5 mg / l of thiamine HCl, 30.0 g / l of sucrose, and 2.0 mg / l of 2,4-D (adjusted to pH 5.8 with KOH and then volume-adjusted with DI H2O); 3.0 g / l of Gelite (added after volume-adjusted with DI H2O); and 0.85 mg / l of silver nitrate and 3.0 mg / l of bialaphos (silver nitrate and bialaphos are added after sterilizing the medium and cooling it to room temperature).

[0391] Plant regeneration medium (288J) comprises 4.3 g / l of MS salt (GIBCO 11117-074), 5.0 ml / l of MS vitamin stock solution (0.100 g nicotinic acid, 0.02 g / l thiamine HCl, 0.10 g / l pyridoxine HCl, and 0.40 g / l glycine, volumetric with purified DI H2O) (Murashige and Skoog (1962) Physiol. Plant. 15:473), 100 mg / l of myo-inositol, 0.5 mg / l of zeatin, 60 g / l of sucrose, and 1.0 ml / l of 0.1 mM abscisic acid (volumetric with purified DI H2O after adjusting to pH 5.6); and 3.0 g / l of gelite (added after volumetric with DI H2O); It contains 1.0 mg / l of indoleacetic acid and 3.0 mg / l of bialaphos (indoleacetic acid and bialaphos are added after sterilizing the medium and cooling it to 60°C).

[0392] Hormone-free medium (272V) comprises 4.3 g / l of MS salt (GIBCO 11117-074), 5.0 ml / l of MS vitamin stock solution (0.100 g / l nicotinic acid, 0.02 g / l thiamine HCl, 0.10 g / l pyridoxine HCl, and 0.40 g / l glycine, volume-adjusted with purified DI H2O), 0.1 g / l of myo-inositol, and 40.0 g / l of sucrose (volume-adjusted with purified DI H2O after adjusting pH to 5.6); and 6 g / l of Bacto agar (volume-adjusted with purified DI H2O, added, sterilized, and cooled to 60°C).

[0393] b. Agrobacterium-mediated transformation

[0394] Essentially Djukanovic et al . (2006) Plant Biotech JAgrobacterium-mediated transformation was performed as described in 4:345-57. Briefly, immature embryos (0.8–2.5 mm in size) 10–12 days old were incised in sterile kernels and placed in liquid medium (4.0 g / L N6 base salt (Sigma C-1416), 1.0 ml / L Eriksson's Vitamin Mix (Sigma E-1511), 1.0 mg / L thiamine HCl, 1.5 mg / L 2,4-D, 0.690 g / L L-proline, 68.5 g / L sucrose, 36.0 g / L glucose, pH 5.2). After collecting the embryos, the medium was replaced with 1 ml of Agrobacterium at a concentration of 0.35–0.45 OD550. Corn embryos were cultured with Agrobacterium at room temperature for 5 minutes, and then the mixture was poured into a medium plate (containing 4.0 g / L N6 base salt (Sigma C-1416), 1.0 ml / L Eriksson's Vitamin Mix (Sigma E-1511), 1.0 mg / L thiamine HCl, 1.5 mg / L 2,4-D, 0.690 g / L L-proline, 30.0 g / L sucrose, 0.85 mg / L silver nitrate, 0.1 nM acetosyringone, and 3.0 g / L Gelite, pH 5.8). Embryos were cultured with their axis facing down in a dark room at 20°C for 3 days, then cultured in a dark room at 28°C for 4 days, and then transferred to a fresh medium plate at pH 5.8 containing 4.0 g / L N6 basal salt (Sigma C-1416), 1.0 ml / L Eriksson's Vitamin Mix (Sigma E-1511), 1.0 mg / L thiamine HCl, 1.5 mg / L 2,4-D, 0.69 g / L L-proline, 30.0 g / L sucrose, 0.5 g / L MES buffer, 0.85 mg / L silver nitrate, 3.0 mg / L bialaphos, 100 mg / L cabbageillin, and 6.0 g / L agar. Embryos were subcultured every 3 weeks until a gene transfer event was confirmed. A small amount of tissue in a regeneration medium (4.Somatic cell development was induced by transferring the sample to 3 g / L MS salt (Gibco 11117), 5.0 ml / L MS vitamin stock solution, 100 mg / L myo-inositol, 0.1 μM ABA, 1 mg / L IAA, 0.5 mg / L zeatin, 60.0 g / L sucrose, 1.5 mg / L bialafos, 100 mg / L cabbageillin, 3.0 g / L Gelite, pH 5.6, and culturing it in a dark room at 28℃ for 2 weeks. All materials showing shoots and roots were transferred to a pH 5.6 medium containing 4.3 g / L MS salt (Gibco 11117), 5.0 ml / L MS vitamin stock solution, 100 mg / L myo-inositol, 40.0 g / L sucrose, and 1.5 g / L Gellite, and cultured under artificial lighting at 28°C. After one week, the plants were transferred to glass tubes containing the same medium and grown until the plants were sampled and / or transplanted into soil.

[0395] Example 9

[0396] Transient expression of ZmODP-2 and ZmWUS enhances transformation

[0397] Parameters of the transformation protocol can be modified to verify whether BBM activity is transient. One such method involves, for example, using chemical PEI to precipitate the BBM-containing plasmid in a manner that allows transcription and expression but excludes the subsequent release of DNA.

[0398] For example, the BBM plasmid is deposited on gold particles containing PEI, whereas the gene expression cassette to be integrated (UBI:MoPAT-GFPm:PinII; MoPAT is a corn-optimized PAT gene) is deposited on gold particles using the standard calcium chloride method.

[0399] In short, gold particles were coated with PEI as follows. First, the gold particles were washed. 35 mg of gold particles with an average diameter of 1.0 (ASI #162-0010) were weighed into a microcentrifuge tube, 1.2 ml of anhydrous EtOH was added, and the mixture was vortexed for 1 minute. The tube was incubated at room temperature for 15 minutes, and then high-speed centrifugation was performed using a microcentrifuge at 4°C for 15 minutes. The supernatant was discarded, a fresh 1.2 ml of ethanol (EtOH) fraction was added, the mixture was vortexed for 1 minute, centrifuged for 1 minute, and the supernatant was discarded again (this process was repeated twice). A fresh 1.2 ml of EtOH fraction was added, and this suspension (gold particles in EtOH) was stored at -20°C for one week. To coat the particles with polyethylimine (PEI; Sigma #P3143), 250 µl of a washed gold particle / EtOH mixture was centrifuged and the EtOH was discarded. The particles were washed once in 100 µl of ddH2O to remove residual ethanol, 250 µl of PEI (0.25 mM) was added, and the particles were suspended by pulse sonication. The tube was then placed in a dry ice / EtOH bath to rapidly cool the suspension, after which it was freeze-dried overnight. At this point, the dried and coated particles could be stored at -80°C for at least 3 weeks. Before use, the particles were washed three times with 250 µl of a 2.5 mM HEPES buffer at pH 7.1, subjected to 1x pulse sonication, and rapidly vortexed before each centrifugation. Subsequently, the particles were suspended in a final volume of 250 µl of HEPES buffer. Before attaching DNA, 25 µl of the particle aliquot was added to a new tube. To attach uncoated DNA, the particles were pulsed sonicated, then 1 µg of DNA (in 5 µl of water) was added, mixed by pipetting up and down several times with a pipetteman, and incubated for 10 minutes.The particles were spun briefly (i.e., 10 seconds), the supernatant was removed, and 60 µl of EtOH was added. The particles containing PEI-precipitated DNA-1 were washed twice in 60 µl of EtOH. The particles were centrifuged, the supernatant was discarded, and the particles were resuspended in 45 µl of water. To attach DNA-2 (DNA-2), Trans Precipitation using IT-2020 was performed. 45 µl of particle / DNA-1 suspension was briefly sonicated, followed by 5 µl of DNA-2 (100 ng / µl) and 1 µl of Trans IT-2020 was added. The solution was placed in a rotary shaker for 10 minutes and centrifuged at 10,000 g for 1 minute. The supernatant was removed, and the particles were resuspended in 60 µl of EtOH. The solution was deposited onto a macrocarrier, and gold particles sequentially attached with DNA-1 and DNA-2 were delivered into 10 blastocysts of DAP Hi-II immature embryos using the standard protocol of PDS-1000. In this experiment, the DAN-1 plasmid contained the UBI:RFP:PinII expression cassette, and DNA-2 contained the UBI:CFP:PinII expression cassette. Two days after particle collision, transient expression of both CFP and RFP fluorescent markers was observed as numerous red and blue cells on the surface of the immature embryos. Subsequently, the embryos were placed in non-selective culture medium and grown for 3 weeks before scoring for stable colonies. After this 3-week period, 10 stably expressing multicellular blue colonies were observed compared to a single red colony. This demonstrated that PEI-precipitation can be used to effectively introduce DNA for transient expression while significantly reducing the integration of PEI-introduced DNA and consequently reducing the reversal of RFP-expression translocation events. In this way, PEI-precipitation can be used to deliver transient expression of BBM and / or WUS2.

[0400] For example, first, the particles are coated with UBI:BBM:PinII using PEI, and then, Trans After coating with UBI:MoPAT-YFP using IT-2020, particles can be collided within blastocysts on the surface of immature embryos. PEI-mediated precipitation is ( Trans Compared to the IT-2020 method, it increases the frequency of transiently expressed cells on the surface of immature embryos and significantly lowers the frequency of restoration of stable transformants. Therefore, the PEI-precipitated BBM cassette is transiently expressed to stimulate explosive embryogenic growth on the particle-impacted tissue surface (i.e., blastocyst surface), but this plasmid is not expected to be incorporated. The MoPAT-GFP plasmid released from Ca++ / gold particles is expected to incorporate and express the selection marker at a frequency that substantially enhances the restoration of the transfusion event. As a control treatment, PEI-precipitated particles containing UBI:GUS:PinII (instead of BBM) are mixed with MoPAT-GFP / Ca++ particles. Immature embryos from both treatments are transferred to culture medium containing 3 mg / l of Bialaphos. After 6–8 weeks, GFP+, Bialaphos-resistant calluses are expected to be observed at a much higher frequency in the PEI / BBM treatment compared to the control treatment (PEI / GUS).

[0401] As an alternative method, the BBM plasmid is deposited on gold particles containing PEI and then introduced into blastocysts on the surface of immature embryos, after which transient expression of the BBM gene induces rapid proliferation of embryogenic growth. During this induced growth period, the explant is treated with Agrobacterium using standard methods for maize (see Example 1), and T-DNA delivery into the cell introduces a gene expression cassette such as UBI:MoPAT-GFPm:PinII. After co-culture, the explant is restored to normal culture medium and then transferred to a culture medium containing 3 mg / l of non-aliaphos. After 6–8 weeks, GFP+, non-aliaphos-resistant calluses are expected to be observed at a much higher frequency in PEI / BBM treatment compared to the control treatment (PEI / GUS).

[0402] It may be desirable to "initiate" callus growth by transiently expressing BBM and / or WUS2 polynucleotide products. This can be achieved by delivering BBM and WUS2 5'-capped polyadenylated RNA, expression cassettes containing BBM and WUS2 DNA, or BBM and / or WUS2 proteins. All of these molecules can be delivered using a biostick particle gun. For example, 5'-capped polyadenylated BBM and / or WUS2 RNA can be easily prepared in vitro using Ambion's mMessage mMachine kit. The RNA is delivered co-with DNA containing the polynucleotide of interest and markers used for selection / screening, such as UBI:MoPAT-GFPm:PinII. Cells receiving the RNA will immediately begin to divide more rapidly, and a significant portion of them are expected to possess the integrated cropological genes. These events can be further confirmed as genetically modified clone colonies because they will also express the PAT~GFP fusion protein (thereby exhibiting green fluorescence under appropriate lighting). Subsequently, plants regenerated from these embryos can be tested for the presence of polynucleotides of interest.

[0403] Example 10

[0404] Direct delivery of gRNA and Cas9 as a guide RNA / Cas endonuclease ribonucleotide-protein complex (RGEN) into embryonic cells induces mutations in maize.

[0405] This example demonstrates that direct delivery of Cas9 in protein form and gRNA in the form of RNA molecules, transcribed in vitro or chemically synthesized, into maize immature embryonic cells induces mutations at the corresponding target sites.

[0406] To generate gRNA in the form of RNA molecules, the corn-optimized U6 polymerase III gRNA expression cassette was amplified by PCR using 5' oligonucleotide primers containing the transcription initiation signal and the sequence of the T7 polymerase promoter at exactly 5' of the spacer for the gene. T7 in vitro transcription was performed using the AmpliScribe T7-Flash kit (Epicenter) as per the manufacturer's recommendations, and the product was purified by ethanol precipitation after using NucAway Spin Columns (Invitrogen; Life Technologies Inc).

[0407] To generate the guide RNA / Cas9 endonuclease protein complex (RGEN) (also known as guide RNA / Cas9 endonuclease ribonucleotide-protein), 7 µg of Cas9 (Streptococcus pyogenes Cas9) protein and 3 µg of gRNA molecules (1:2 molar ratio) were mixed in 1x Cas9 buffer (NEB) to a total volume of 20 µg and incubated at room temperature for 15 minutes. Along with RGEN, plasmids containing ubiquitin promoter-regulated visual selection markers (MoPAT-DsRed fusion), ubiquitin promoter-regulated mace ovule development protein 2, ZmODP2 (see US20090328252 published December 31, 2009), and corn IN2 promoter-regulated WUSCHEL, ZmWUS (see US20110167516 published July 7, 2011) were mixed with a particle delivery matrix containing commercially available gold particles (0.6 µm, Bio-Rad) and water-soluble cationic lipid TransIT-2020 (Mirus, USA). A particle delivery matrix containing a guide RNA / Cas endonuclease ribonucleotide-protein complex was delivered into corn embryo cells using particle-mediated delivery (see particle-mediated delivery described in Example 8) with slight modification. Specifically, gold particles were pelleted in a microcentrifuge at 10,000 rpm for 1 minute, and after removing the supernatant, the particles were resuspended in 105 µl of sterile water instead of 100% ethanol. Subsequently, 10 µl was applied to the center of each macrocarrier and dried prior to particle collision.

[0408] Wild-type maize plants were used as a source of immature embryos for the co-delivery of Cas9 and gRNA in the form of guide RNA / Cas endonuclease ribonucleotide-protein complexes (RGEN) along with visual selection markers (UBI:MoPAT-DsRED) and developmental genes (UBI:ZmODP2 and IN2:ZmWUS). To measure mutation frequencies at LIGCas-3, MS26Cas-2, MS45Cas-2, and ALSCas-4 endogenous target sites, embryos were collected 2 days after particle collision and analyzed by amplicon deep sequencing. Untreated embryos and embryos particle-collision with Cas9 protein alone were used as negative controls, while embryos particle-collision with DNA vectors expressing Cas9 and gRNA were used as positive controls. Similar frequencies were found for the Cas9-gRNA component delivered as a DNA vector and the Cas9-gRNA component delivered as a guide RNA / Cas endonuclease ribonucleotide-protein complex (Table 11).

[0409] Percentage of mutation decryption at LIG, MS26, MS45, and ALS target sites generated by direct delivery of the RGEN complex into corn embryonic cells target area delivered molecules Total number of decryptions Mutant detoxification number Percentage of mutation decoding LIGCas-3 (Chr. 2) Untreated embryos (control group 1) 915,198 38 0.004% Cas9 protein only (control group 2) 408,348 17 0.004% Cas9-Lig-CR3 RGEN 439,827 2,510 0.57% Cas9 (DNA)+Lig-CR3 (DNA) 369,443 2,058 0.56% MS26Cas-2 (Chr. 1) Untreated embryos (control group 1) 245,476 8 0.003% Cas9 protein only (control group 2) 429,388 20 0.004% Cas9-MS26-CR2 RGEN 252,519 533 0.21% Cas9 (DNA)+MS26-CR2 (DNA) 186,857 812 0.43% MS45Cas-2 (Chr. 9) Untreated embryos (control group 1) 255,877 12 0.005% Cas9 protein only (control group 2) 487,876 12 0.002% Cas9-MS45-CR2 RGEN 241,287 2,075 0.86% Cas9 (DNA)+MS45-CR2 (DNA) 304,622 1591 0.52% ALS2Cas-4 (Chr. 5) Cas9 protein only (control group 2) 807,014 125 0.02% Cas9-ALS-CR4 RGEN 791,084 3,613 0.45% Cas9 (DNA)+ALS-CR4 (DNA) 833,130 4251 0.51%

[0410] To measure mutation frequency at the plant level, 60 embryos co-particle-coordinated with the Cas9-MS45-gRNA complex, ZmODP2, ZmWUS, and MOPAT-DSRED were placed in a medium containing Bialaphos as a selective agent. Multiple plants were regenerated from each of the 36 herbicide-resistant callus sectors and tested for mutations. Of the 36 events, 17 (47%) contained mutant alleles (10 monoalleles and 7 bialleles), while 19 (53%) were wild-type. MS45Only alleles were shown. Among the plants with mutations, the number of sequencing sequences for each allele was similar, indicating that the plants were not chimeric plants.

[0411] To demonstrate that direct RGEN delivery is sufficient to induce specific editing of endogenous genes in plants, the maize ALS2 gene was targeted as described in Example 2 (ALS2-specific ALSCas-4 target site). As a repair template, 127 nt single-stranded DNA Oligo2 (SEQ ID NO: 45) was co-delivered with the Cas9 / ALS-CR4 RGEN complex in a manner similar to that described above. Embryos were recovered 2 days after particle collision and analyzed by Amplicon deep sequencing (Table 12).

[0412] Percentage of mutant decoding and edited decoding at ALS target sites generated by delivering the RGEN complex and donor DNA template into corn embryonic cells target area delivered molecules Total number of decryptions Mutant detoxification number % of mutation detoxification Edited decryption number % of edited decryption ALS2 Cas9 protein only 807,014 105 0.01% - - Cas9-ALS-CR4 RGEN + ss Oligo2 791,084 3,613 0.45% 209 0.02%

[0413] In addition, in two independent experiments, 40 to 50 particle-impregnated embryos were transferred to plates containing 100 ppm of chlorsulfuron as direct selection for the edited ALS2 gene. After 6 weeks, two callus sectors (one from each experiment) that continued to grow in the chlorsulfuron-containing medium were analyzed by sequencing. In both events, one ALS2 allele was specifically edited, while the second allele remained wild-type. Plants regenerated from these callus sectors contained the edited ALS2 allele and were resistant to chlorsulfuron when the herbicide was applied.

[0414] These data demonstrate that directly delivering Cas9 and gRNA into maize immature embryonic cells in the form of guide RNA / Cas endonuclease ribonucleotide-protein complexes (with or without polynucleotide-modified template DNA) is a viable alternative to DNA delivery (such as recombinant DNA and plasmid DNA) for targeted mutagenesis and gene editing in plants.

[0415] Example 11

[0416] Direct delivery of Cas9 in mRNA form and gRNA into embryonic cells induces mutations in maize.

[0417] This example demonstrates that direct delivery of Cas9 in the form of mRNA molecules and gRNA in the form of RNA molecules, transcribed in vitro or chemically synthesized, into maize immature embryonic cells induces mutations at the corresponding target sites.

[0418] In previous experiments (Svitashev et al (Plant Physiology, 2015, Vol. 169, pp. 931-945), when gRNA in the form of in vitro synthesized RNA molecules was co-delivered with Cas9 expressing a DNA vector, the mutation frequency was approximately 100 times lower than in experiments where both Cas9 and gRNA were delivered as DNA vectors. One possible explanation for this difference is that the requirements for the simultaneous function of Cas9 and gRNA were not met when gRNA was delivered as RNA and Cas9 was delivered as a DNA vector. To overcome this problem, Cas9 can be delivered as an mRNA molecule to shorten the time from the moment of delivery to functional Cas9 protein expression. Commercially available Cas9 mRNA (TriLink Biotechnologies) was used in the experiment.

[0419] To test this idea, corn embryo cells were co-particle collided with DNA vectors containing Cas9 mRNA (200 ng), gRNA in the form of in vitro synthesized RNA molecules (100 ng), a ubiquitin-regulated MoPAT-DsRED fusion (25 ng), and developmental genes, ubiquitin-promoter-regulated ODP2, and IN2-promoter-regulated WUS (12 ng each) per shot. Commercially available Cas9 mRNA (TriLink Biotechnologies) and in vitro synthesized RNA molecules as described above were used in the experiment. Mutation frequency analysis was performed on embryos collected 2 days after transfection using amplicon deep sequencing (Table 13).

[0420] Percentage of mutation decoding at the MS45 target site generated by transient delivery of Cas9 as mRNA and gRNA as an RNA molecule into maize embryonic cells target area delivered molecules Total number of decryptions Mutant detoxification number Percentage of mutation decoding MS45 Cas9 mRNA only 1,097,279 799 0.07% Cas9 mRNA+Ms45 CR2 gRNA 1,260,332 2,304 0.18% Cas9 (DNA)+Ms45 CR2 (DNA) 1,106,125 3,490 0.31%

[0421] These data show that delivering both Cas9 and gRNA in RNA molecular form enhances the frequency of targeted mutations and, together with Cas9-gRNA delivery as an RGEN complex, is a viable alternative to DNA delivery for targeted mutagenesis and gene editing in plants.

[0422] Example 12

[0423] Direct delivery of Cas9 and gRNA as a guide RNA / Cas endonuclease ribonucleotide-protein complex (RGEN) into embryonic cells without the use of selection markers induces mutations in maize.

[0424] This example demonstrates that delivering Cas9 in protein form and gRNA in the form of an in vitro transcribed or chemically synthesized RNA molecule into maize immature embryonic cells without co-delivery of the select marker gene(s) is sufficient to regenerate plants with mutations at the corresponding target site at a practical frequency.

[0425] The need for selection markers to provide growth advantages to transformed or modified cells has been a long-standing paradigm in plant transformation and genome modification protocols. Therefore, in all mutation, gene editing, and gene integration experiments, selection markers are used to select genome editing events. Considering the unexpectedly high activity (mutation frequency) of the RGEN complex in the experiment described in Example 10, completely DNA-free (vector-free) genome editing without selection markers was attempted. Corn embryonic cells were modified with three different genes ( liguleless1 ( LIG ), MS26 and MS45 Particles were collided with guide RNA / Cas endonuclease ribonucleotide-protein (RGEN) complexes targeting ) Cas9 endonuclease and MS45-gRNA on DNA vectors were delivered in parallel experiments using them as controls. Plants were regenerated and analyzed by sequencing for target mutations. In all experiments, mutant plants were restored at a surprisingly high frequency ranging from 2.4 to 9.7% (Table 14).

[0426] Mutation frequencies at LIG, MS26, and MS45 target sites when Cas9 and gRNA were delivered as DNA vectors and when the RGEN complex was delivered directly into maize immature embryonic cells. Analysis was performed on T0 plants regenerated without selection (without using selection markers). target area Cas9 and gRNA delivery methods Analysis of plants Plants with mutant alleles SEQ ID NO: LIGCas-3 RGEN 756 73 (9.7%) 12 MS26Cas-2 RGEN 756 18 (2.4%) 14 MS45 Cas-2 RGEN 1,880 70 (3.7%) 8 MS45 Cas-2 Vector DNA 940 38 (4.0%) 8

[0427] In addition, the regenerated T0 plants were crossed with wild-type Hi-II plants, and the offspring plants were used for isolation analysis. The expected Mendelian isolation (1:1) mutations were observed in all analyzed offspring plants. ms45 Sexual inheritance of alleles has been proven.

[0428] To evaluate the potential of RGEN delivery to reduce off-target cleavage in maize, mutation frequencies in off-site MS45 were assessed using DNA vectors and RGEN delivery. A Bowtie sequence aligner (Langmead, B., Trapnell, C., Pop, M. & Salzberg, SL Ultrafast and memory-efficient alignment of short DNA sequences to the human genome) allowing for accurate target sequences and up to two mismatches. Genome Biol Using the Maize Genetics and Genomics Database (*. 10:R25, 2009*), the protospacer region of the MS45Cas-2 target site (the region of the target site that forms base pairs with the guide RNA spacer) was aligned with the maize B73 reference genome (*B73 RefGen_v3*, Maize Genetics and Genomics Database) to investigate regions with close homology to the exact target site. Subsequently, potential off-target sites were searched for the presence of the NGG protospacer adjacent motif (PAM) sequence immediately 3' from the identified off-target protospacer. Using these search criteria, only a single off-target site (5'-CGCCGAGGGCGACTACCGGC-3', SEQ ID NO:81) was identified. This contained a 2 bp discrepancy with the MS45 protospacer target and the AGG PAM (Table 15). To confirm whether the site was cleaved in vivo, the presence of mutations in maize embryos transformed with DNA vectors expressing Cas9 and MS45-CR2 gRNA was analyzed by deep sequencing. As shown in Table 15, the mutational activity of the off-target site was 2%, compared to the 4% frequency observed at the correct target site. As shown in Table 15, RGEN off-target activity was significantly reduced (from 2% to 0%) compared to Cas9 and gRNA delivery on the DNA vector.

[0429]

[0430] This example demonstrates that the generation of plants with targeted mutations using RNA-induced endonucleases does not require the co-transfer of selection or screening marker genes, thereby increasing the specificity and accuracy of the introduced modifications. The regenerated plants contained only the targeted mutation or targeted gene editing (where a repair template was included to modify the DNA sequence) without random integration of the DNA vector. This delivery method provides a completely DNA-free approach to gene mutagenesis within plant cells of major crop species, including but not limited to maize, soybean, wheat, rice, millet, sorghum, and canola.

Claims

Claim 1 A method for restoring the function of a non-functional gene product within the genome of a plant cell, comprising the step of introducing a guide RNA / Cas endonuclease complex into a plant cell containing a disrupted gene within the genome by particle bombardment, wherein the complex generates a double-strand break, and the disrupted gene does not encode a functional gene product, and the disrupted gene is restored to a non-disrupted gene capable of encoding the functional gene product without the use of a polynucleotide modification template. Claim 2 A method according to claim 1, wherein the destroyed gene comprises a base pair deletion of the fourth nucleotide upstream (5') of the PAM sequence compared with the corresponding non-destructive gene, and the base pair deletion causes an amino acid frame shift in the gene product of the destroyed gene, thereby making the gene product of the destroyed gene non-functional. Claim 3 In paragraph 2, the method wherein the base pair deletion is the first, second, or third nucleotide of the codon sequence. Claim 4 A method according to claim 1, wherein the restoration is achieved by a non-homologous end junction (NHEJ) that inserts a single base into a double-strand break. Claim 5 A method for modifying a nucleotide sequence within the genome of a plant cell, comprising the steps of: introducing a first guide RNA, a Cas endonuclease, and a second guide RNA by particle collision into a plant cell comprising a target site and a destroyed selection marker gene; wherein the first guide RNA and the Cas endonuclease can form a first complex capable of introducing a double-strand cut into the destroyed selection marker gene, and without the use of a polynucleotide modification template, the destroyed selection marker gene is restored to a non-destructive selection marker gene capable of encoding a functional selection marker protein; and wherein the second guide RNA and the Cas endonuclease can form a second complex capable of recognizing, binding to, and nicking or cleaving the target site located in the nucleotide sequence; and selecting a plant cell having a modification in the nucleotide sequence by the functional selection marker protein. Claim 6 A method according to paragraph 5, wherein the introduction and selection steps do not include the introduction of a selection marker gene. Claim 7 A method according to claim 5, wherein the modification is selected from the group consisting of insertion of a nucleotide, deletion of a nucleotide, and substitution of a nucleotide at the target site. Claim 8 A method according to claim 5, further comprising the step of introducing a polynucleotide modified template into a plant cell, wherein the polynucleotide modified template comprises a nucleotide modification of the nucleotide sequence. Claim 9 A method according to claim 8, wherein the nucleotide modification of the polynucleotide modified template is selected from the group consisting of (i) substitution of nucleotides, (ii) deletion of nucleotides, (iii) insertion of nucleotides, and (iv) combinations of (i) to (iii). Claim 10 A method according to claim 5, further comprising the step of introducing donor DNA into a plant cell, wherein the donor DNA comprises a polynucleotide of interest to be inserted into the target site. Claim 11 In paragraph 5, the method in which the plant cell is a monocotyledonous or dicotous plant cell. Claim 12 In paragraph 5, the plant cell is corn, rice, sorghum, rye, barley, wheat, millet, oats, sugarcane, grass, or switchgrass, soybean, canola, alfalfa, sunflower, cotton, tobacco, peanut, potato, tomato, tobacco, Arabidopsis thaliana ( Arabidopsis ), or a method of being a safflower cell. Claim 13 A method according to claim 5, further comprising the step of producing a plant or offspring plant from the plant cell. Claim 14 A plant or offspring plant produced by the method of paragraph 13, the plant or offspring plant lacking the first guide RNA, the second guide RNA, and Cas endonuclease. Claim 15 A method according to claim 1, wherein the guide RNA and Cas endonuclease forming the guide RNA / Cas endonuclease complex are introduced into the cell as RNA and protein, respectively. Claim 16 A method according to claim 1, wherein the guide RNA / Cas endonuclease complex is introduced into the cell as a ribonucleotide-protein complex. Claim 17 A method according to claim 1, wherein the component of the guide RNA / Cas endonuclease complex is introduced as RNA comprising mRNA encoding a Cas endonuclease protein and guide RNA. Claim 18 A method for producing a genome-modified cultivated plant comprises: (a) a step of forming a ribonucleotide-protein complex by combining a guide RNA molecule with a Cas endonuclease protein, wherein the guide RNA molecule comprises a polynucleotide sequence complementary to a genomic target site within the genome of a plant cell; (b) a step of forming a ribonucleotide-protein-microparticle complex by coating microparticles with the ribonucleotide-protein to bind the ribonucleotide-protein to the microparticles; (c) a step of introducing the ribonucleotide-protein complex into the embryonic tissue of a cultivated plant by colliding the embryonic tissue with the ribonucleotide-protein-microparticle complex; and (d) a step of regenerating a modified cultivated plant from the embryonic tissue, wherein the guide RNA comprises a polynucleotide sequence complementary to a genomic target site within the embryonic tissue, the ribonucleotide-protein complex binds to a genomic target site within the embryonic tissue, and the modified cultivated plant has a genomic target site in its genome A method comprising a modification in a region, wherein the modification is selected from the group consisting of the insertion of a nucleotide, the deletion of a nucleotide, the substitution of a nucleotide, the alteration of a nucleotide, or a combination thereof. Claim 19 A method according to claim 18, further comprising the step of introducing a polynucleotide modified template into a plant cell, wherein the polynucleotide modified template comprises a nucleotide modification relative to a genomic target site. Claim 20 A method according to claim 18, further comprising the step of introducing donor DNA into a plant cell, wherein the donor DNA comprises a polynucleotide of interest to be inserted into the genomic target site. Claim 21 In paragraph 18, the method in which the microparticles are combined with cationic lipids. Claim 22 A method according to claim 18, wherein the Cas endonuclease is selected from the group consisting of Cas9 protein, Cpf1 protein, C2c1 protein, C2c2 protein, C2c3 protein, Cas3, Cas3-H, Cas5, Cas7, Cas8, or Cas10. Claim 23 In paragraph 18, the cultivated plant is selected from the group consisting of corn, soybeans, cotton, canola, wheat, rice, Arabidopsis thaliana, alfalfa, tobacco, and sorghum. Claim 24 delete

Citation Information

Patent Citations

  • Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and cas protein-encoding nucleic acid or cas protein, and use thereof

    KR1020150101446A

  • Methods for altering the reactivity of plant cell walls

    KR1020130122635A

  • Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and cas protein-encoding nucleic acid or cas protein, and use thereof

    WO2014065596A1